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Abstract 
 
The symptomology associated with allergic diseases are a direct consequence of 
the release of pro-inflammatory mediators from mast cells following bi- or multi-
valent antigen cross-linking with the high affinity immunoglobulin (Ig) E receptor, 
FcεR1. Chemokines, small 8-15 kDa polypeptides, control the activation and 
recruitment of immune cells during the allergic response.   
 
Previous studies have demonstrated that co-stimulation by the chemokine, 
macrophage inflammatory protein-1α (Mip-1α) and cross-linking by IgE with 
antigen result in four phenomenon 1) enhanced degranulation in ex vivo 
conjunctival mast cells and rat basophilic leukemia (RBL-2H3) cell line via its 
chemokine receptor (CCR) 1, cell line also referred to as RBL-CCR1; 2) arrested 
Mip-1α-induced chemotaxis of RBL-CCR1 cells; 3) enhanced production of pro-
inflammatory mediators from RBL-CCR1 cells and 4) enhanced gene expression in 
RBL-CCR1 cells of regulatory molecules downstream of CCR1 and FcεR1 
signaling pathways, Regulator of G-protein Signaling (RGS)-1 and Tribbles (TRB)-
3. It has therefore been proposed that co-engagement of CCR1 and FcεR1 affects 
other mast cell processes such as chemotaxis, and moreover these data indicate 
cross-talk between CCR1 and and FcεR1 signaling pathways. Chemotaxis of mast 
cells to sites of inflammation and the subsequent release of pro-inflammatory 
mediators are key to eliciting allergic response. Although there is a vast amount of 
information pertaining to the molecular mechanisms of chemotaxis in several cell 
types, there is very little evidence to understand mast cell chemotaxis at this level. 
Based on current knowledge, the main objective of this thesis was to investigate 1) 
the effect of CCR1 and FcεR1 co-engagement on mast cell motility and 2) the role 
of RGS1 and TRB3 on mast degranulation, mediator release and chemotaxis. 
 
The data obtained from this thesis is the first to demonstrate the role of WASP, 
CCR1 and actin polymerisation as mechanisms underlying Mip-1α induced RBL-
CCR1 chemotaxis, using real time microscopy. Moreover, CCR1 and FcεR1 
engagement inhibits RBL-CCR1 actin cytoskeletal re-organisation and significantly 
increases other cell motility parameters such as directionality and Euclidean 
distances which are required for efficient Mip-1α-induced chemotaxis. Also, by 
using a murine model of allergic conjunctivitis, conjunctival mast cells accumulate 
in the forniceal area of an inflamed conjunctiva in comparison to non-diseased 
 vi 
mice. In addition, by using siRNA the present study is also the first to show that 
RGS1 and TRB3 serve as negative regulators of RBL-CCR1 degranulation, 
mediator release and chemotaxis upon CCR1 and FcεR1 engagement. In 
conclusion, the data presented in this thesis could advance our understanding of 
the mechanisms responsible for mast cell migration and arrest during an allergic 
response, and hence provide new targets for anti-allergic drugs. 
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Chapter 1. 
General introduction and hypothesis
 2 
1. Introduction 
 
The immune system is a complex highly orchestrated network of cells, receptors, 
and chemical mediators, which collectively maintain the homeostasis of an 
organism. Over the past century scientists have identified and elucidated how 
various immune cells and their mediators protect us from disease. The protective 
role of the immune system is highly regulated, and is designed to be self-limiting 
once the pathologic condition is resolved. However, there are instances when this 
regulation breaks down causing the immune system to initiate diseases such as 
allergy, autoimmunity and cancer.  
 
The immune system consists of two components, the innate (non-specific) and 
adaptive (specific). The innate immune response responds rapidly as the first line 
of defence against viral and bacterial infections, responding to foreign agents by 
phagocytosis and by releasing reactive chemicals, which non-specifically destroy at 
the site of inflammation. In contrast, the adaptive immune response is slower to 
respond. It relies on cells of the innate system to capture, internalize and present 
foreign agents, which it utilises to prepare a highly specific response upon 
secondary exposure.  
 
Recently it has been realized that some immune cells, including the mast cell can 
cross the boundaries between innate and adaptive immunity exhibiting roles in both 
components of the immune system. 
 
Mast cells are tissue-resident cells of hematopoietic origin, which are located at 
strategic sites such as the skin and vascular and mucosal barriers enabling them to 
respond to invading pathogens, allergens and environmental agents. Since their 
discovery in 1878, mast cells have been long implicated as the key effector cells of 
allergic disorders by virtue of their ability to be activated through antigen that binds 
antigen-specific immunoglobulin E (IgE) via FcεRI receptor expressed on the mast 
cell surface (Mota and Vugman, 1956; Ishizaka et al., 1970; Eiseman and Bolen, 
1992; Parravicini et al., 2002; Gould and Sutton, 2008). However, mast cells have 
been recognised for their critical role during innate immunity to bacteria 
(Echtenacher et al., 1996; Malaviya et al., 1996, Wang et al., 2012), adaptive 
immunity to parasites (Ruitenberg et al., 1976, Han et al., 2012; Hepworth et al., 
2012), tissue remodeling during wound healing (Garbuzenko et al., 2002), immune 
suppression, angiogenesis and cancer (Littlepage et al., 2005).  
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Allergic conditions range from the annoying hay fever to the more fatal anaphylaxis 
and costs associated with them dominate public health budgets. As current 
treatments are not completely effective and in the eye can give rise to adverse side 
effects such as glaucoma and cataracts there is a continuing effort to better 
understand the allergic cascade. In light of this the focus of this study has been to 
further characterise the molecular basis of mast cell degranulation, mediator 
release and chemotaxis during the allergic response and thereby identify 
alternative anti- inflammatory therapies.   
 
 
1.1 Mast cell biology 
 
1.1.1 Mast cell origins and development 
 
The tissue-resident mast cell is a 10-20µm in diameter with an in situ appearance 
ranging from elongated to ovoid (Schulman et al., 1983; Metcalfe et al., 1997). 
Defined by the presence of dense cytoplasmic granules which, when stained with 
toluidine blue, cause metachromasia.  
 
Mast cells are hematopoietic in origin and differentiate from cluster of differentiation 
(CD)-34+ bone marrow progenitor cells.  Progenitor mast cells migrate from the 
bone marrow into the circulation, migrating through blood vessel endothelium and 
localise into vascularised mucosal and connective tissue, where they undergo final 
maturation expressing the FcεRI receptor (R) capable of binding immunoglobulin 
(Ig) E and hence effector function (Kitumura et al., 1977; Metcalfe, 1997; Kawakami 
et al., 2002; Galli et al., 2008) (Figure1). Subsequent studies have validated that 
the development of mast cell progenitors requires constitutive signals from 
cytokines such as interleukin (IL)-3, IL-4, IL-5 and IL-9 (Metcalfe, 1997) and growth 
factors such as stem cell factor (SCF) (Huang et al., 1990), that dictate their 
trafficking from circulation, survival and maturation.  
 
The most crucial viability and differentiation signal for mast cells is provided from 
the interaction between the membrane-associated c-kit receptor and its ligand SCF 
(Huang et al., 1990), a growth factor that is expressed constitutively by endothelial 
cells and fibroblasts. Studies have demonstrated membrane bound SCF, its soluble 
isoform or a combination are chemotatic for mast cells and their progenitors 
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(Nillson et al., 1994), elicit their adhesion (Lorentz et al., 2002), facilitate their 
proliferation (Yee et al., 1994) and sustain their survival, differentiation and 
maturation (Irani et al., 1992). 
 
Mouse bone marrow cultured in IL-3 gives rise to a population of 85% or more of 
mast cells by 4-5 weeks (Rottem et al., 1993). It has been reported that after one 
week of culture in IL-3, a third of mouse bone marrow mast cells (BMMC) express 
IgE receptors (Metcalfe, 1997), however these cells contain sparse granules and 
hence lack characteristics of mature mast cells. The expression of FcεRI+ mast 
cells increases over 3 weeks of culture and in parallel a progressively large number 
of cells become increasingly granulated which is accompanied by an increase in 
histamine content (Rottem et al., 1993). Moreover, IL-4 in the presence of IL-3 
enhances proliferation and maturation in vitro of both bone marrow derived and 
peritoneal mast cells (Metcalfe, 1997). In addition IL-4, along with IL-6, can induce 
apoptosis in mast cells. IL-9 alone has no proliferative effects on BMMC, although, 
in combination with IL-3, growth of BMMC can be observed (Hultner et al., 1990). 
Development of the reactive mast cell requires additional cytokines such as IL-3, 
IL-4, IL-5 and IL-9 from activated T cells. 
 
Variation in the phenotype of mast cells during the course of individual biological 
responses or at different anatomical sites has been called mast cell ‘heterogeneity’ 
(Galli et al., 2008; Beaven, 2009).  The capacity of the mast cell lineage to 
generate individual populations that exhibit various functional properties, mediator 
content and/or other aspects of phenotype may contribute to their multifunctional 
capability in immunological and pathological responses.  
 
In mouse, there are two main mast cell subtypes, connective tissue mast cells that 
are found in the intestinal submucosa, peritoneum, eye and skin and mucosal mast 
cells that are associated with the epithelium of the lung and gastrointestinal tract.  
Intestinal mucosal mast cells express the chymases, mouse Mast Cell Protease 
(mMCP)-1 and mMCP-2, while, connective tissue mast cells are characterised by 
expression of chymase, mMCP-4, an elastinolytic enzyme, mMCP-5, and two 
tryptases, mMCP-6 and mMCP-7 (Miller et al., 2002). Whist in humans there are 
two main mast cell subtypes, those containing tryptase alone and those containing 
chymase and tryptase (Pejler et al., 2010). 
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Figure 1. Mast cell development and tissue distribution. Changes in 
chemokine receptor expression and cytokines involved during mast cell 
development, from bone-marrow derived mast cell progenitors to tissue resident 
mature mast cells. This figure was adapted from Ono et al., 2003.  
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1.1.2 Mast cell activation and mediator release 
 
Mast cell activation in response to both exogenous and endogenous stimuli occurs 
through distinct receptors. The kinetics, amounts and/or profile of mediators 
released is determined by the nature of the activating stimulus and is under the 
influence of the local environment in which activation takes place.   
 
The most studied mechanism of mast cell activation is through the high affinity IgE 
receptor, FcεRI. The binding of multivalent allergen to IgE-FcεRI complex triggers 
mast cell activation, and initiates classic mast cell- mediated allergic reactions, 
which will be further discussed in section 1.1.3.2. IgE-dependent activation of mast 
cells results in their release of 1) preformed mediators that are stored in the cells 
cytoplasmic granules, including histamine, proteases chymase and tryptase, 
cytokines and proteoglycans (PGN) and 2) growth factors, cytokines and 
chemokines (Segal et al., 1977; Gordon et al., 1991; Okayama et al., 2001). In 
contrast, mast cells also secrete newly synthesised lipid mediators that are the 
products of endogenous arachidonic acid metabolism, such as prostaglandin D2 
(PGD2), leukotriene (LT)-B4, platelet- activating factor (PAF), LTC4 (Roberts et al., 
1979; Lewis et al., 1982) and a diverse range of cytokines and chemokines 
(Bissonnette et al., 1997; Okayama et al., 2003). In 1989 Wodnar-Filipowicz and 
Plaut along with co-workers demonstrated that stimulated mast cells synthesized 
and released IL-3, IL-4, IL-5, IL-6 and granulocyte-macrophage colony-stimulating 
factor, (GM-CSF) (Plaut et al., 1989; Wodnar-Filipowicz et al., 1989). Thereafter in 
1990, Gordon and Galli reported that mast cells were a biologically significant 
source of both pre-formed and antigen-inducible tumor necrosis factor (TNF)-α 
(Gordon and Galli, 1990).  
 
The diversity of these biologically active mediators allows the mast cell to 
participate in a wide variety of biological functions, thereby mediating pro-
inflammatory, anti-inflammatory and immunoregulatory effects (Table 1).  
Preformed mediators including histamine and serotinin, increase vascular 
permeability and smooth muscle contraction, while proteases such as tryptase 
and/or chymase induce bronchial mucus secretion, degradation of blood vessel 
basement membrane, degradation of microbial structures and generation of 
complement pathway products. Newly synthesised lipid mediators induce 
vasodilation, increase vascular permeability, bronchoconstriction of the lungs and 
mucus secretion. In addition, newly synthesized cytokines and chemokines 
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promote proliferation of mast cells, recruitment of other immune cells and hence 
promotion of inflammation. 
 
Although FcεRI-IgE dependent mast cell activation is well characterized, it is only 
one of several potential mechanisms that can initiate mast cell effector function. 
Mast cells can be activated by: complement components (Wojta et al., 2002) 
through complement receptors, microbes (Supajatura et al., 2001) through Toll-like 
receptors (TLRs), IgG, and chemokines through chemokine receptors.  
 
The inititial recognition of pathogens is mediated by pattern recognition receptors 
(PRR), which include TLRs. TLRs are present on many immune cells, including 
mast cells (Haidl et al., 2010; Franchi et al., 2008), and are a family of cytosolic and 
cell-surface receptors that collectively recognize pathogen associated molecular 
patterns (PAMPs) (Applequist et al., 2002), and provide a critical link between 
innate and adaptive immunity.  Human and mouse mast cells have been shown to 
express TLR 1-7 and TLR9 under defined conditions (Supajatura et al., 2002; 
Varadaradjalou et al., 2003), and specific TLR stimulation by various pathogens 
induces different mast cell responses. Each of these recognition receptors 
recognize a distinct category of microbial products such as PGN via TLR2 (Kochan 
et al., 2012), double stranded ribonucleic acid (dsRNA) by TLR3 (Kulka et al., 
2004), lipopolysaccharide (LPS) by TLR4 (Tsukamoto et al., 2012), and bacterial 
deoxyribonucleic acid (DNA) by TLR9 (Matsushima et al., 2004). Expression of 
TLR varies among different subsets of mast cells and conditions, for example 
reports suggest mast cells derived from human cord blood lack TLR4 under certain 
culture conditions but then express functional TLR4 after stimulation with interferon 
(IFN)-γ or IL-4 (Varadaradjalou et al., 2003; Okumura et al., 2003). The interaction 
between mast cells and TLR’s during innate immunity will be further discussed in 
section 1.1.3.3. 
 
The complement pathway constitutes a significant component of innate immunity to 
various infections, comprising of more than 30 serum proteins and cell-surface 
receptors that co-ordinate host defense through opsonization, leukocyte activation, 
cell lysis, and chemotaxis. Mast cells express receptors for several complement 
products, which include complement receptor (CR) 3, CR4, and CR5, and split 
products of complement activation such as C3aR and C5aR (Metz et al., 2008). 
Complement peptides induce histamine release from mast cells and a wheal and 
flare reaction in the skin. C3a induces degranulation and production of the 
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chemokines, Regulated upon Activation, Normal T cell Expressed, and Secreted 
(RANTES) and monocyte chemotactic protein (MCP)-1 (Venkatesha et al., 2005; 
Woolhiser et al., 2004). In addition, C3a and C5a have been reported as potent 
chemoattractants for mast cells (Nilsson et al., 1996). 
 
Mast cells can be positively or negatively regulated through IgG receptors, of these 
FcγRI and FcγRIII are activating receptors and are inducible (Kirshenbaum et al., 
2003; Katz et al., 1992). 
 
Exogenous components such as wasp venom (associated with pathogens) can 
also activate mast cells. Although the mechanisms are not completely elucidated, 
certain venom components may directly activate trimeric G proteins and other 
signalling molecules (Ferry et al., 2002; Chahdi et al., 2004). 
 
Parasitic infections are often associated with elevated levels of IgE (parasite-
specific or non-specific), mast cell activation and increased mast cell numbers, 
strongly indicating mast cell participation in host response to parasite infection 
(Anthony et al., 2007). Mast cell activation upon subsequent exposure to the 
parasite itself or parasite antigen leads to the release of an array of pro-
inflammatory mediators as well as cytokines, which augment the adaptive response 
(Knight et al., 2000; Gurish et al., 2004; Watanabe et al., 2009; Hepworth et al., 
2012). 
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Table 1. The effects of mediators released by activated mast cells 
 
Mediator  Function 
 
Stored preformed in 
cytoplasmic 
granules 
 
Histamine 
 
 
 
Enzymes- tryptase, 
chymase, cathepsin 
G, carboxypeptidase 
 
 
Promotes smooth muscle 
contraction. Increases vascular 
permeability 
 
Degrade microbial structures. 
Tissue remodelling and damage 
 
Lipid mediators 
synthesized on 
activation 
 
Prostoglandin D2 
 
Leukotriene C4,  
 
 
 
Platelet-activating 
factor 
 
Vasodialation,bronchoconstriction 
 
Prolonged bronchoconstriction, 
mucus secretion, increased 
vascular permeability 
 
Bronchoconstriction,chemotaxis 
and activation of leukocytes.  
Increased vascular permeability  
 
 
Cytokines, 
chemokines and 
growth factors 
produced on 
activation 
 
IL-3, SCF 
 
TNF-a, Mip-1α 
 
IL-4 and IL-13 
 
IL-5 
 
 
 
Promotes mast cell proliferation 
 
Promotes inflammation.  
 
Promotes Th2 differentiation 
 
Promotes eosinophil activation 
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1.1.3 Roles of mast cells in physiology, disease and immunity  
 
The constitutive development of mast cells and their diverse effector functions likely 
evolved to serve significant homeostatic and protective functions. It is now evident 
that mast cells can enhance initiation of both innate and adaptive immune response 
to allergens as well as to foreign pathogens. Whilst for allergens these immune 
responses are pro-inflammatory, in contrast for pathogens these immune 
responses are protective. The following sections discuss the multi-faceted roles of 
mast cells. 
 
1.1.3.1 Mast cells in physiology 
 
Mast cells exist in many different tissues not only to act as immune surveillance 
cells to detect and respond to pathogens but also to maintain physiological 
homeostasis. 
 
Mast cells are important in the homeostasis of organs that undergo remodeling and 
continuous growth such as bones and hair follicles. Mast cell-derived TNF-α is 
implicated in deterioration of hair follicles and regulating growth between periods of 
hair growth and rest (Maurer et al., 2003). In addition, mast cells also contribute to 
bone remodeling. It has been suggested that mast cell mediators, transforming 
growth factor (TGF)-β, IL-6, IL-1 and histamine could manipulate osteoclast 
development and recruitment (Silberstein et al., 1991; Nagasaka et al., 2008). 
Homeostasis can also be maintained by mast cells by degrading toxins such as 
endothelin-1 (ET-1), a potent vasoconstrictor. Mast cells are activated by ET-1, 
releasing proteases, which degrade this protein, therefore promoting survival in 
mice during bacterial peritonitis (Maurer, et al., 2004). In the gut, mast cells and 
neurons work co-operatively to maintain homeostasis by regulating secretory 
activity of mucus, vascular permeability ion transport, epithelial cells, and intestinal 
motility (Van et al., 2007). 
 
Mast cells are thought to be critical for the maintenance of tissue integrity and 
function. Mast cells synthesise several different growth factors including vascular 
endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), fibroblast 
growth factor (FGF)-2, which are involved in proliferation of fibroblasts and 
epithelial cells (Abe et al., 2000). 
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Mast cells localise near nerve endings in many different tissues, such the central 
nervous system, skin, lungs and intestinal mucosa. Mediators released from mast 
cells, for example histamine, tryptase and serotonin can regulate neuronal activity 
(Welle, 1997). The interaction between mast cells and neurons may also lead to 
immunosuppression demonstrated by the observation that upon UV irradiation 
mast cells migrate to lymph nodes and secrete increased levels of IL-10, a potent 
anti-inflammatory cytokine, avoidance of which abrogates the induction of 
immunosuppression (Byrne et al., 2008). 
 
1.1.3.2 Mast cells in disease: allergy and the allergic cascade 
 
Although mast cells have been implicated in several disease types such as: 
autoimmune diseases, heart disease, cancer and allograft rejection, for the 
purpose of this thesis the following sections will discuss allergy, the allergic 
cascade and the role of mast cells during the allergic response. 
 
In 1906, Clemens von Pirquet coined the term ‘allergy’.  It has been suggested that 
allergies are the result of a hypersensitive immune system reacting inappropriately 
to normal innocuous substances (allergens), which the immune system 
misidentifies as harmful. For an adaptive immune response, a normal host 
response to antigen presentation brings forth a mixed humoral and cellular 
response. In general intracellular pathogens including viruses, fungi and 
mycobacteria incite a cell-mediated response while extracellular pathogens like 
bacteria elicit primarily a humoral response. The equilibrium between humoral 
versus cellular responses to antigen challenge is maintained by a specific cytokine 
profile derived from T cells, which will be discussed in further detail later in this 
section. 
 
There are two types of allergen: the first being any non-infectious, environmental 
substance that can generate IgE production, thereby sensitizing the individual, so 
that subsequent re-exposure to that specific substance induces an allergic 
response; these include: grass, tree pollen, sheddings from animal skin and fur and 
certain foods; the second type is a non-infectious environmental substance that can 
generate an adaptive immune response, but occurs independently of IgE, for 
example allergic dermatitis.  
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The allergic response consists of two components, the early phase and late phase. 
The early phase, in which a single allergen exposure produces an acute reaction 
often known as type 1 immediate hypersensitivity reaction contributes to the 
development of the late phase. This typically occurs within minutes of allergen 
exposure. A further six to 24 hours later, a second round of symptoms, known as 
the late phase response, develops from the recruitment and activation of 
eosinophils, basophils and persistent mediator production by resident mast cells 
and resident or recruited T cells that recognise allergen derived peptides. The 
clinical symptoms, which manifest as consequence of mast cell activation range 
from itching, oedema and wheezing to more severe or fatal consequences 
associated with vascular collapse and systemic anaphylaxis. 
 
The mechanisms driving allergic disease, involve both innate and adaptive 
responses. Allergens are processed and presented in Major Histocompatibility 
Complex (MHC) class II peptide complexes to naïve CD4+ T helper (Th) cells by 
activated and mature dendritic cells. In 1986, Mosmann and co-workers showed 
the existence of two subtypes of mouse Th cells, Th1 and Th2, differing in cytokine 
secretion patterns and functions. However, in contrast to murine studies, polarised 
Th cytokine patterns are seldom apparent in human tissues. Studies have 
demonstrated that human Th1 cells produce IFN-γ and TNF-β, but not IL-4 and IL-
5, whilst Th2 cells do not produce IFN-γ, but primarily produce IL-4, IL-5, IL-9 and 
IL-13, and more recently, several new subtypes of Th cells have been identified, 
namely: Th9 cells, predominantly secreting IL-9; Th17 cells, predominantly 
secreting IL-17; Th22 cells predominantly sereting IL-22 and regulatory T cells 
(Tregs) predominantly secreting IL-10 (Manetti et al., 1993; Park et al., 2005; 
Veldhoen et al., 2008; Rubtsov et al., 2008; Dardalhon et al., 2008; Eyerich et al., 
2009). 
 
The development of allergic immunity is largely mediated by Th2 cells and their 
associated cytokine profiles. However, recent investigations have identified other 
Th subtypes namely Th9, Th17, Th22 and Tregs each with their own distinct 
cytokine profile involved in Th2 responses.  
 
Although IFN-γ is the signature cytokine produced by Th1 cells, Th1 polarization 
and IFN-γ production were initially considered protective responses to allergic 
disorders, based on IFN-γ suppression of many Th2/IL-4 mediated effects. 
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However, this paradigm in allergic disorders has been challenged by data showing 
that immune responses to allergen include mixed Th1 and Th2 cells (Dahl et al., 
2004; Woodfolk et al., 2006; Yang et al., 2010). 
 
IL-4, the most established determinant driving Th2 differentiation (Seder et al., 
1992) induces class switching of B cell Ig production towards IgE. Antigen-specific 
IgE subsequently primes effector cells, basophils and mast cells, which rapidly 
degranulate upon re-encounter with the allergen. IL-4 activates signal transducer 
and activator of transcription (STAT)-6, which in turn promotes expression of GATA 
binding protein 3 (GATA3), the master regulator of Th2 cells. In addition, mast 
cells, basophils, nuocytes and invariant natural killer (iNKT) cells are capable of 
robust IL-4 secretion (Bilenki et al., 2004; Akbari et al., 2006; Neill et al., 2010). Th2 
cells produce IL-5, which stimulates the differentiation of eosinophils, which play 
important roles in killing helminths and other parasites, whereas IL-13 and IL-4 
together stimulate excessive production of mucus and contraction of smooth 
muscle, which helps in expulsion of helminths from the lung and gut (Kool et al., 
2012).  
 
Th9 T cells, a proposed subfamily of Th2 cells, are characterized by the major 
production of IL-9 and relatively little IL-4, which result from the concomitant 
presence of TGF-β and IL-4 (Veldhoen et al., 2008; Dardalhon et al., 2008). IL-9 
supports Th2 cell differentiation, survival, and cytokine production. It promotes 
recruitment of Th2 cells in part through enhancing their expression of chemokine 
receptor (CCR)-4. The transgenic IL-9 lung model is also associated with elevated 
Th2 cytokine expression, bronchial hyper-reactivity, and hyper-secretion of mucus 
(Temann et al., 2002). IL-9 was initially described as a mast cell growth factor 
(Hultner et al., 1990), contributing to mast cell–mediated allergic responses through 
its ability to stimulate FcεRI expression, protease production and mast cell 
recruitment (Temann et al., 2002). In addition, IL-9 co-operates with IL-4 to 
enhance the production of IgE and increases expression of IL-5 receptors and 
thereby interacts with IL-5 to enhance the production of eosinophils (McLane et al., 
1998). 
 
Another CD4+ T cell subset, Th17 cells secrete IL-17, which induces expression of 
a variety of cytokines and chemokines including IL-6, IL-8, IL-11 and TGF-β, all of 
which are important to both fibroblast activation and neutrophil recruitment. IL-17 
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family members are expressed in asthma (Molet et al., 2001). In asthma the 
tendency to induce neutrophil migration, and not eosinophil migration suggests that 
IL-17 plays a role in asthma, in which the accumulation of neutrophils is 
characteristic of this phenotype. Hyper-IgE syndrome in humans is characterized 
by a genetically determined deficiency in Th17 cell differentiation (Milner et al., 
2008). The mechanisms underlying Th17 differentiation in humans are not fully 
elucidated. However, in mice, IL-6 in the presence of TGF-β, is the most important 
cytokine responsible for Th17 cell differentiation (Iwakura et al., 2006). 
 
Th22 cells are characterized by their major production of IL-22. Th22 polarisation is 
determined by IL-6 and TNF-α, typically being produced by epithelial cells or 
keratinocytes (Duhen et al., 2009). Notably, Crohn’s disease, psoriasis and 
rheumatoid arthritis all demonstrate elevated levels of IL-22 that correlate with 
disease severity (Ikeuchi et al., 2005; Wolk et al., 2007; Duhen et al., 2009). 
 
Unlike other Th cell subsets in which T cell receptor (TCR) engagement under 
appropriate co-stimulation conditions leads to activation and proliferation, Treg cells 
proliferate poorly in response to TCR stimulation; instead, they suppress the 
proliferation of other T cells (orchestrated by forkhead box P3 (Foxp3) expression) 
or by IL-10 secretion (Itoh et al., 1999; Baecher-Allan et al., 2001; Campbell et al., 
2007). In this light, Tregs are therefore regarded as essential players for 
modulating allergic inflammation (Woodfolk et al., 2006; Xystrakis et al., 2006), 
preventing autoimmune disease (Sakaguchi et al., 1995) and controlling chronic 
inflammatory disease (Coombes et al., 2005). The proposed mechanisms of Treg-
mediated suppression have been studied and include cell contact and TGF-β, IL-10 
and IL-35 dependent mechanisms (Shevach, 2009; Apostolou et al., 2008).  
 
The allergic response consists of sensitization of mast cells and the generation of a 
specific immune response towards the allergen. The following events occur during 
sensitization: 1) priming of allergen-specific CD4+ Th2 cells and 2) production of IL-
4 and IL-13 (Th2 cytokines) and hence induction of IgE (Figure 2). In brief, in the 
presence of IL-4, CD4+ Th cells differentiate into Th2 cells producing IL-4 and IL-
13. Thereafter, these cytokines cause B cells (in the presence of co-stimulatory 
molecules) to undergo Ig class switch recombination, whereby the gene segments, 
which encode the heavy chain are reorganized so as to produce IgE. Thereafter, 
IgE diffuses locally entering the lymphatic vessels and subsequently enters the 
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blood circulation binding to mast cells. Binding of IgE to FcεRI on the mast cell 
surface sensitizes the cell, hence, upon subsequent exposure to antigen the mast 
cell is activated, promoting release of pro-inflammatory mediators, which cause the 
acute symptoms of an allergic response, previously discussed in section 1.1.2 and 
Table 1 (Roitt et al., 2011).  
 
Reports have demonstrated the potential role for mast cells in allergen 
sensitisation. Using a mouse model of asthma, intranasal administration of low 
doses of antigen and LPS resulted in increased eosinophil numbers in the lung 
upon antigen re-challenge, compared to mice that were sensitised with antigen 
alone or sensitised with antigen and increased doses of LPS (Eisenbarth et al., 
2002; Nigo et al., 2006). In addition, once allergen sensitisation has taken place, it 
is possible that mast cells expressing allergen-specific IgE may further promote the 
allergic response by acting as antigen presenting cells, to further amplify allergen-
specific Th2 proliferation. 
 
As previously described, mast cells synthesise and secrete a diverse range of pro-
inflammatory cytokines, including IL-4, IL-5 and IL-13, which regulate both the 
development of eosinophilic inflammation and IgE synthesis, and profibrogenic 
cytokines, including TGF-β and FGF-2 (Yu et al., 2006). In addition, activated mast 
cell products may also inhibit the pathology of allergic inflammation as 
demonstrated in MCP-4 deficient mice that displayed increased airway 
inflammation and airway hyper-responsiveness in response to methacholine 
(Waern et al., 2009). 
 
Mast cells express the IL-33 receptor (Moritz et al., 1998), and secrete IL-33 
following IgE/antigen activation (Hsu et al., 2010). Pushparaj and co-workers 
(2009) demonstrated that systemic administration of the IL-33 increases IgE-
mediated anaphylactic shock in a mast cell dependent manner. These findings 
indicate that the IL-33 signalling pathway may be important for the regulation of 
IgE-dependent inflammation in mast cells. 
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Figure 2. Differentiation of naïve CD4+ T cells into Th 2 cells, IgE 
production and sensitisation of mast cells. Allergens can be sampled by 
dendritic cells (DC) and can enter tissues through disrupted epithelium. DC then 
present peptides in the context of the major histocompatiability complex (MHC) 
to naïve T cells. Naïve T cells, in the presence of IL-4 acquire the 
characteristics of T helper 2 cells, producing IL-4 and IL-13. In the presence of 
these cytokines and ligation of co-stimulatory molecules, B cells produce IgE, 
which diffuses locally and enters the lymphatic system. IgE enters the blood 
and is then distributed systemically. After gaining access to the interstitial fluid 
IgE binds to FceR1 on tissue resident mast cells, thereby sensitising them to 
respond when the host is re-exposed to the allergen. This figure was adapted 
from Galli et al, 2008. 
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1.1.3.3 Mast cells in innate and acquired immunity 
 
Although the role of mast cells in orchestrating many of the pathological sequelae 
of allergy is well established, it is also recognised that mast cells can enhance 
initiation of both innate and adaptive immune responses to foreign pathogens as 
well as to allergens, during coexposure to bacteria or its products. 
 
Mast cells have come to the forefront as activators of innate immune defenses 
against pathogens. As mast cells are strategically located at many sites of initial 
antigen entry such as the skin, eye, lung, and gastrointestinal tract, they are ideally 
positioned to be first responder cells during microbial attack, making them capable 
immune surveillance cells of innate immunity, thereby participating in protective 
immune responses. To function as immune surveillance cells during innate 
immunity, mast cells have developed three mechanisms of pathogen recognition: 
1) direct binding of pathogens or their components by PAMP receptors located on 
the mast cell surface. As previously discussed, one class of PAMP receptors are 
TLRs, 2) binding of complement coated bacteria or antibody, by complement 
receptors or immunoglobulin receptors respectively, or 3) recognition of 
endogenous peptides produced by injured host cells. 
 
Activated human mast cells expressing TLR2 or TLR4 release TNF-α, IL-5, IL-6 IL-
10 and IL-13, which mediate the recruitment of phagocytic as well as other immune 
cells such as neutrophils and eosinophils to sites of infection (Varadaradjalou et al., 
2003). The influx of these immune cells are crucial to eliminate and control invading 
pathogens, as displayed by mast cell deficient mice which have decreased survival 
due to impaired innate host immune responses (Echtenacher et al., 1996; Malaviya 
et al., 1996; Thakurdas et al., 2007; Ketavarapu et al., 2008; Piliponsky et al., 
2010).  
 
In addition, mast cells can also directly destroy opsonised bacteria, those which 
have been coated with complement proteins or IgG antibody. Thereafter, bacteria 
is endocytosed through an endosome lyosome pathway and killed via oxidative and 
non-oxidative pathways (von Kockritz-Blickwede et al., 2009). Mast cells can also 
contribute to host defence against bacteria by proteolytic degradation of 
endogenous mediators such as endothelin-1 (Maurer et al., 2004) and neurotensin 
(Piliponsky et al., 2008), which would otherwise be upregulated to toxic levels.  
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The role of mast cells and TLRs in viral infections is still being elucidated. One 
study has shown TLR3 activation by dsRNA from viruses in human cultured mast 
cells   induces production of type I IFNs (Kulka et al., 2004). Any synergistic effect 
of TLR3 activation by viruses in the prescence of FcɛRI activation by allergens on 
mast cell cytokine production remains to be examined. 
 
In addition to activating the innate immune system during infection, mast cells can 
have profound effects on two central cells of adaptive immunity, T cells and 
dendritic cells. 
 
Immature dendritic cells can process antigens but due to low expression of MHC II 
and costimulatory molecules, such as CD80 and CD86 are unable to act as antigen 
presenting cells. In addition, they are unable to migrate to peripheral lymph nodes 
where significant interactions with T cells occur (Galli et al., 2005). Studies have 
shown that mast cells degranulate at sites of infection releasing prestored TNF-α, 
which has been demonstrated to increase dendritic cell expression of CCR7, which 
responds to chemokines, macrophage inflammatory protein (Mip)-3-β and 6Ckine, 
which are critical for dendritic cell homing to lymph nodes (Sozanni et al., 1998; 
Yamazaki et al., 1998; McLachlan et al., 2003). In addition, TNFα also induces 
maturation of dendritic cells, allowing dendritic cells to express antigen in 
association with MHC II and costimulatory molecules, thereby becoming an antigen 
presenting cell for T cells (Ritter et al., 2003).  
 
Under certain conditions mast cells have been shown to express MHC class I and 
II, and along with co-stimulatory molecules are capable of directly activating T cells 
by functioning as antigen presenting cells (Malaviya et al., 1996; Kambayashi et al., 
2009). Expression of bacterial antigens in association with MHC Class I by murine 
BMMCs is a likely basis for the induction of CD8 T cell responses to pathogens 
endocytosed by mast cells (Malaviya et al., 1996). One group recently 
demonstrated that MHC class II expressing murine BMMCs were poor stimulators 
of naïve CD4 T cells, however, they were able to restimulate previously activated 
CD4 T cells (Kambayashi et al., 2009). Nakano and co-workers (2009) 
demonstrated on the surface of murine BMMCs that Notch signaling induced 
expression of MHC class II and OX40L, a key costimulatory molecule. These 
BMMCs were able to promote proliferation of naïve CD4+ T cells into Th2 cells in 
vitro. Further studies are needed to validate if human mast cells are able to express 
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MHC II and how MHC class II expressing mast cells influence T cell activation in 
vivo. 
 
Mast cells greatly influence the type of adaptive immune response made to a 
pathogen through their modulation of T cell responses. Activated mast cells release 
Th2 polarizing cytokines such as IL4, IL10, and IL13, which can induce stimulated 
naïve CD4+ T cells to differentiate into Th2 cells when activated in the lymph node. 
These Th2 cells induce humoral immune responses to pathogens by producing 
cytokines that stimulate B cell production of antibody (McLachlan et al., 2008; 
Stelekati et al 2009).  
 
In addition, mast cells can also increase proliferation of suboptimally activated T 
cells, in which T cells are already exposed to antigen but at suboptimal 
concentrations through FcεRI dependent and independent pathways (Nakae et al., 
2005). 
 
1.1.4 Experimental models for studying mast cell function and signaling 
 
The study of mast cell signaling events, which is fundamental for understanding 
their role in disease processes such as allergy, is also vital for the generation of 
effective novel therapies for immune-mediated diseases. Techniques for generating 
primary cultures of murine mast cells from bone marrow progenitor cells are 
available, whilst similar approaches have been established for humans using 
peripheral blood or cord blood as a progenitor source (Jamur et al, 2010; McAlpine 
et al., 2012; Hoffmann et al., 2012). However, all of these tools to study mast cell 
function are limited by the fact that mast cell maturation cannot be fully achieved by 
the various mast cell culture protocols, as indicated by functional studies. To 
overcome such limitations, primary cultures of human tissue mast cells are 
desirable, in which human mast cells can be isolated from tissue (skin, lung or 
intestine) and purified by complicated selection means; however, a disadvantage of 
this method is the availability of fresh human tissue and the limited yield of purified 
mast cells. In addition to primary cultures of mast cells, transformed mast cell lines 
have also been used to study mast function, these are:  human mast cell (HMC)-1, 
rat basophilic leukemia (RBL-2H3) and laboratory of allergic disease (LAD)-1 and 2 
(Alexandrakis et al., 2003; Castellani et al., 2009; Hewson et al., 2011). LAD mast 
cells require SCF for survival and hence might be more appropriate as a human 
mast cell model. Despite the fact that the RBL- 2H3 cell line is derived from 
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basophils, it is widely used in allergy research since it is a histamine releasing cell 
line. Although, it has been acknowledged that signaling events in these RBL-2H3 
cells may not accurately reflect the signaling events of mature human mast cells, a 
vast amount of information has been acquired about signaling processes and 
mediator release with these cells (Anfossi et al., 2003; Naveen et al., 2005; 
Sanderson et al., 2010; Chung et al., 2012).  
 
1.1.4.1 FcεR1 -mediated signaling in mast cells   
 
Rapid advances over the past several years reveal antigen – dependent mast cell 
activation is orchestrated by a series of complex intracellular signaling processes, 
which are continually evolving. Moreover, these findings also reveal new areas of 
investigation for therapeutic strategy in disease. 
 
 
1.1.4.2 The FcεR1 receptor and IgE binding 
 
The high affinity IgE receptor, FcεR1, exists in two forms and can be expressed as 
a trimer or tetramer consisting of an IgE-binding α-chain, a membrane 
tetraspanning β-chain that is absent in the trimeric receptor and a di-sulphide-linked 
homodimer of γ-chains (Nadler et al., 2000) (Figure 3). While the trimeric form can 
be expressed on a variety of immune cells such as eosinophils, monocytes and 
Langherhan cells, the tetramer is primarily expressed on mast cells and basophils, 
suggesting that the absence of the β-chain in the trimeric receptor is not required 
for efficient FcεR1 signaling and function.  
 
The β and γ chains each contain immunoreceptor tyrosine-based activation motifs 
(ITAMS). ITAMS, a structural motif that contain tyrosine residues and is found in 
the cytoplasmic tail of several signalling molecules. The tryrosine residues are a 
target for phosphorylation by protein tyrosine kinases (PTK) of the Src family and 
subsequently, for the binding of proteins that contain Src-homology-2-domains 
(SH2 domains). 
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Figure 3. The FcεR1 receptor. 
The FcεR1 receptor is expressed on resident mature mast cells and consists of a 
single extracellular α chain, a single β chain which passes through the membrane 
four times and a homodimer of two disulphide linked γ chains.  
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The FcεR1 receptor can bind to IgE in the absence of antigen with very high affinity 
(affinity constant of 1010M (Kulczycki and Metzger, 1974) compared to FcγR for IgG 
binding (affinity constant of 108M (Unkeless and Eisen, 1975). It has been 
considered that IgE binding therefore provides a form of passive sensitisation prior 
to subsequent antigen cross-linking. Interestingly, studies have shown that IgE 
alone can actively promote cytokine production, increased expression of cell 
surface FcεR1 and mast cell survival (Asai et al., 2001; Kalensnikoff et al., 2001; 
Matsuda et al., 2005). 
  
IgE-FcεR1 receptor complexes are distributed in a random order, however in the 
first 30-60 seconds after exposure to multi-valent antigen the complexes 
redistribute into chain-like aggregates, as demonstrated by electron microscopy 
(Menon et al., 1986; Seagrave et al., 1991), that are eventually internalised within 
6-10 minutes.  Ishizaka and co-workers demonstrated that bivalent antibodies to 
FcεR1 caused degranulation in the absence of IgE implicating the aggregation of 
FcεR1 as the exocytotic trigger. Maximal histamine release is obtained when 10% 
of the receptors are aggregated. 
 
1.1.4.3 General outline of mast cell FcεR1 signaling 
 
Stimulation of FcεR1 by IgE with antigen results in aggregation of the receptor on 
the mast cell membrane, which initiates a series of phosphorylation and 
dephosphorylation events that are required for early transduction events (Figure 4). 
It is important to bear in mind that variations of mast cell FcεR1   signaling are likely 
to exist, and this can be further complicated by the existence of mast cell 
heterogeneity. 
 
The following section describes a general outline of FcεR1 mediated signaling in 
mast cells. FcεR1 receptor lacks intrinsic tyrosine kinase activity, and must 
therefore associate with the PTK, Lyn (Eiseman and Bolen, 1992). FcεR1 
engagement activates Lyn and Fyn, by an undefined mechanism (Colgan et al., 
2010). Lyn is key for the subsequent phosphorylation of the tyrosine residues in the 
β and γ subunits of FcεR1.  The phosphorylated tyrosine residues within FcεR1 
subsequently act as docking sites for another PTK, spleen tyrosine kinase (Syk), 
which binds via its SH2 domains to the γ subnunit of FcεR1. Once activated, Syk is 
able to phosphorylate and activate several cytosolic adapter molecules, which 
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include linker for activation of T cells (LAT) and Grb2-associated binder 2 (Gab2) 
(Rivera, 2002; Iwaki et al., 2005). Adapter molecules are those that have one or 
more binding motifs and/or tyrosine residues that can be phosphorylated by Syk 
and ζ-chain-associated protein kinase of 70kDa (ZAP70). They function as 
components of a molecular scaffold that organize activated receptor signaling 
complexes. Adapter molecules bind a variety of signaling proteins such as lipases 
which include phospholipase C (PLC)-γ; phosphatases, SH2 domain-containing 
inositol phosphatase (SHIP)-1 and -2 and protein and lipid kinases, Lyn, Fyn, 
Bruton’s tyrosine kinase (Btk): phosphoinositide 3-kinase (PI3K); and mitogen-
activated protein kinase (MAPK) which result in the activation of signaling pathways 
which eventually lead to mast cell degranulation and de novo synthesis of 
inflammatory mediators, chemokines and cytokines (Kawakami and Galli, 2002). 
 
A significant signaling enzyme recruited to phosphorylated LAT is PLCγ. PLCγ 
activation is essential for inducing the calcium signal required for antigen –
mediated mast cell activation. PLCγ hydrolyses phosphotidylinositol 4,5-
biphosphate (PI(4,5)P2) to generate diacylglycerol (DAG) and inositol -1,4,5 
triphosphate (IP3). DAG, which activates various protein kinase C (PKC) isoforms, 
which play major roles in the regulation of mast cell activation. The binding of IP3 to 
its receptor, IP3R, in the endoplasmic reticulum (ER) rapidly induces calcium 
release from the ER stores into the cytosol. This release of intracellular calcium 
stores leads to an influx through store-operated calcium channels, resulting in a 
prolongation of the calcium signal (Hoth et al., 1992). Recent studies have 
identified the molecular sensor for store emptying on the ER membrane as stromal 
interaction molecule 1 (STIM-1)(Roos et al., 2005). Collectively, these signals lead 
to mast cell degranulation and eicosanoid generation and contribute to the 
activation of transcription factors required for cytokine and chemokine production 
(Metcalfe et al., 2009). As described above, the sequence of events that leads from 
LAT to mast cell degranulation has been clearly defined, although, the sequence of 
events leading from LAT to cytokine production still remains unclear. The signaling 
pathways that lead to cytokine gene expression require guanine exchange factors 
(GEFs), Vav (Manetz et al., 2001) and son of sevenless (Sos)  (Jabril-Cuenod et 
al., 1996) to convert RAS from the inactive state to the active state. Activated RAS 
positively regulates the RAF-dependent pathway that leads to phosphorylation and 
activation of MAPKs, extracellular-signal-regulated kinase (ERK)-1 and ERK2. 
Other MAPKs, p38 and JUN amino-terminal kinase (JNK) are similarly activated in 
 24 
a LAT-dependent manner, but the mechanisms responsible are yet to be 
elucidated. Together, ERK1, ERK2, JNK and p38 activate transcription factors 
which include activator protein 1(AP1), nuclear factor of kappa light chain gene 
enhancer in B cells (NF-κB) and nuclear factor of activated T cells (NFAT) 
(Marquardt and Walker, 2000; Pelletier et al., 1998) which ultimately result in 
cytokine generation. 
 
In addition to Lyn, another Src-family kinase Fyn, was also required for 
degranulation and cytokine production in mast cells (Parravicini et al., 2002). The 
Fyn-dependent pathway did not require LAT and did not lead to PLCγ activation, 
but instead, led to the activation of PI3K. PI3Ks are a family of enzymes which 
regulate multiple processes within mast cells, which include, the maintenance of 
LAT/PLCγ-regulated degranulation, chemokine production, mast cell proliferation, 
differentiation and survival (Kim et al., 2008).    PI3K is activated after binding the 
adaptor protein Gab2, on phosphorylation by Fyn, Syk, or both. Class 1 PI3Ks can 
phosphorylate PI(4,5)P2 in the plasma membrane to generate phosphotidylinositol 
3,4,5-triphosphate  (PI(3,4,5)P3).  
 
PI(3,4,5)P3 is a well recognised regulator of mast cell effector functions (Rivera et 
al., 2008) and moreover, controls the activity and subcellular localisation of a 
diverse range of signal transduction molecules namely AKT, Btk and 
phosphoinositide-dependent kinase 1 (PDK1) (Cantrel, 2001; Fruman and Cantley, 
2002). Once Btk has been membrane targeted by PI(3,4,5)P3, it phosphorylates 
and activates PLCγ. Initial release of calcium from the ER and a Btk sustained 
calcium influx promotes degranulation, and the release of granule-associated 
products. Recent studies have suggested that increased or decreased PI(3,4,5)P3 
levels in mast cells is associated with upregulated or downregulated mast cell 
responsiveness (Ali et al., 2004; Furumoto et al., 2006; Odom et al., 2004), which, 
in most cases, similarly affects calcium responses. The mechanisms by which 
PI(3,4,5)P3 levels might affect calcium responses are not fully understood but it is 
known that proteins such as PLCγ that regulate calcium also require PI(3,4,5) P3 
for their translocation and function.  
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1.1.4.4 TRB3: a regulator of cell signaling 
 
Tribbles (TRB) have been described as a family of proteins with potent signaling 
regulatory functions (Figure 4). The tribbles homolog 3 (TRB3) was originally 
discovered in drosophila as a novel regulator of string in morphogenesis.  String 
plays a key role in regulating cell cycle regression beyond G2 by activating the 
cyclin-dependent kinase (cdk1).  However, during morphogenesis high levels of 
string are expressed in the gastrulating mesoderm yet the migrating cells do not 
divide.  An inhibitor to string was found and tribbles was identified as a gene that 
fits this function. Grosshans and Wieschaus showed that overexpression of TRB 
inhibits mitosis (Grosshans et al., 2000). Drosophila tribbles have been shown to 
regulate embryonic development at several stages either by regulating protein 
levels by mediating their degradation or by acting as part of a larger protein 
complex that regulates development. 
  
In humans, the homolog to the TRB3 gene is located on chromosome 20 at p13-
p12.2.  In 1999, Mayumi-Matsuda and co-workers first described TRB3 as a gene 
that is upregulated in a neuronal cell line undergoing nerve growth factor 
withdrawal induced apoptosis. Through various investigations, TRB3 has been 
identified to affect several protein regulation pathways.  TRB3 interacts with several 
transcription factors, activating transcription factor (ATF)- 4, C-homologous protein 
(CHOP) and NF-κB, has been shown to be an important regulator of glucose 
metabolism during fasting (Kiss-Toth et al., 2004; Bowers et al., 2003; Ord et al., 
2003; Ohoka et al., 2005; Du et al., 2003; Kiss-Toth et al., 2006). 
 
TRB3 is able to bind to various MAPK kinases (MAPKK), specifically ERK1 and 
MAPKK7, and the concentration of these protein complexes regulates preferential 
activation of the various MAPK pathways, presumably leading to different cellular 
responses (Hegedus et al., 2007).  It has been demonstrated that activation of 
MAPK cascades occurs in response to a wide range of stimuli, including pro-
inflammatory cytokines, growth factors, mechanical stimuli, stress and integrin-
dependent cell/matrix interactions (Li et al., 2000; Goldschmidt et al., 2001; Jones 
et al., 2001). This suggests that TRB3 may also stimulate pro-inflammatory 
cytokines to activate a MAPK response when gene expression levels are high as 
well as play an important role in the allergic response. 
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ATF4 has been shown to have several important regulatory effects including 
osteoblast differentiation in development and targeting genes such as CHOP and 
Heme oxygenase-1 (HO-1), which are involved in the regulation of apoptosis.  
TRB3 has a negative regulatory effect on ATF4-mediated gene activation, and 
because of ATF4’s relation to CHOP, it is reasonable to link the modulation of 
TRB3 expression in apoptotic cells to the co-ordination of programmed cell death 
(Hegedus et al., 2006). It has been hypothesized that the ATF4-CHOP pathway 
regulates TRB3 expression as well.  Ohoka et al. found that increasing TRB3 levels 
inhibited CHOP-mediated transcription, but also showed that the promoter 
sequence of TRB3 is regulated in an ATF4 and CHOP-mediated manner (Ohoka et 
al., 2005). This means that interactions between TRB3, CHOP, and ATF4 create a 
self-regulatory network to fine tune TRB3 expression, and in turn TRB3 mediated 
cell death.  These results corroborate another report that TRB3 expression is up-
regulated in stressful conditions through the ATF4/CHOP pathway (Ord et al., 
2005). Other studies using fibrates are in concurrence with previous data regarding 
CHOP and TRB3 expression.  Fibrates have been used in the clinical setting as a 
treatment for hyperlipidemia and atherosclerosis.  In lymphocytes, fibrates augment 
TRB3 and CHOP expression which act as mediators of cell growth, differentiation, 
proliferation, and inflammation (Selim et al., 2007; Ramji et al., 2002). 
 
NF-κB plays a key role in immune regulation and inflammation through induction of 
a large set of chemokines, cytokines, adhesion molecules, and effectors (Karin et 
al., 2002; Ghosh et al.,2002; Baldwin et al., 2001) . Some studies also suggest that 
NF-κB is involved with the transcriptional activation of genes important for 
apoptosis and cell proliferation (Wang et al., 1998; Zong et al., 1999; Micheau et 
al., 2001; Locksley et al., 2001). TNF-α is a major pro-inflammatory cytokine whose 
effects are mediated through the activation of NF-κB.  The signaling pathway that is 
responsible for TNF-induced NF-κB activation has been well studied and for the 
most part resolved.  In a study by Wu et al., the protein SINK, a protein identical to 
that produced by the gene TRB3, was found to be an NF-κB-inducible protein (Wu 
et al., 2003). Over-expression of this protein inhibited NF-κB-dependent 
transcription induced by TNF-α stimulation.  In vitro assay studies indicated that the 
TRB3 protein interacted with the NF-κB transactivator p65 and inhibited 
phosphorylation of p65, which has been shown to regulate NF-κB activation. The 
TRB3 protein has also been associated with the sensitisation of cells to apoptosis 
induced by TNF-α and its related apoptosis inducing ligand.  This mechanism 
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occurs through inhibited expression of NF-κB activated anti-apoptotic genes. 
Therefore, it is suggested that TRB3 is involved in a negative feedback control 
pathway. However, this same study suggested that while TRB3 inhibits NF-κB-
dependent transcription, it does not inhibit translocation of NF-κB and its DNA 
binding ability. These findings illustrate the first human genetic clue for TRB3 and 
its relevance to chronic inflammatory diseases. 
  
TRB3 is involved with the binding of the kinase domain of AKT, a kinase which 
plays a key role in a range of cellular functions including cell division, apoptosis, 
and cellular activation. The physiological relevance of this interaction is supported 
by findings that TRB3 expression is induced in a normal liver following fasting, and 
that TRB3 levels are significantly higher in the liver of diabetic mice than in the liver 
of wild-type mice. TRB3 may serve as a molecular target for peroxisome 
proliferator-activated receptor alpha (PPAR-α), a protein which is activated by 
fasting (Koo et al., 2004). However, the findings of these results have conflicted 
with other experiments and these discrepancies may be based on over expression 
of either TRB3 messenger RNA or proteins (Lynedjian et al., 2004). These 
inconsistencies provide evidence that the relative level of TRB3 expression 
compared with its binding partners is critical in the metabolism of glucose. It is also 
significant to note that TRB3, in amounts comparable to those of diabetic mice, 
induced glucose intolerance and hyperglycemia (Du et al., 2003). Ethanol has also 
been found as an inducer of plasma TRB3 protein levels in other studies (He Ling 
et al., 2006). Based on data from the same investigation, ethanol-fed rats show 
decreased levels of membrane associated AKT, increased plasma AKT levels, and 
elevated TRB3 in the plasma.  When RNA interference (RNAi) suppressed TRB3 
expression, more than half of insulin stimulation was restored in the presence of 
ethanol.  This suggests that over expression of TRB3 in liver increases glucose 
production and that knockdown of TRB3 by RNAi improves glucose tolerance. 
Schwarzer and collegues showed that glucose or amino acid starvation induces 
TRB3 expression that is not dependent on AKT activity (Schwarzer et al., 2005). 
This study also exemplifies that overexpressed TRB3 protects cells from starvation-
mediated apoptosis in HeLa cells. In a separate study, a polymorphism in the 
human TRB3 was shown to impact on AKT activation in HepG2 cells that are 
associated with insulin resistance and cardiovascular risk (Prudente et al., 2005). 
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Figure 4. Simplified model of Fcer1-mediated signaling events.  
Cross-linking of FcεR1 -bound IgE with bi- or multivalent antigen activates Lyn 
and Fyn. Lyn in turn phosphorylates the ITAMS in FcεR1 and activates Syk. 
Lyn, Fyn and Syk phosphorylate many adaptor molecules and enzymes, 
thereby regulating the activation of the Ras-MAPK, PLC-γ and PI3K pathways 
leading to degranulation, lipid metabolism and gene transcription of protein 
mediators. 
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1.2. Chemokines, signaling and regulation 
 
Numerous studies have demonstrated that chemokines control the activation and 
recruitment of many immune cells, including mast cells, during an allergic 
response. Mast cells are able to migrate towards a diverse range of chemokines 
through chemokine receptors expressed on the mast cell surface.  The following 
sections discuss chemokines, signaling events and regulation of these events. 
 
1.2.1 Chemokine and chemokine receptors 
 
In the 1990’s chemokine research groups raced to discover novel chemokines and 
chemokine receptors. However, two fundamental observations about T cells 
suddenly made chemokines attractive to immunologists and virologists. The first 
observation showed that several chemokines inhibit the infection of CD4+ T cells by 
human immunodeficiency virus (HIV)-1 (Cocchi et al., 1995); the second profound 
observation was that T cells can express multiple chemokine receptors and their 
expression and responsiveness is regulated after differentiation or activation 
(Loetscher et al., 1996; Sallusto et al., 1997; Sallusto et al., 1998). Thereafter, the 
chemokine field expanded immensely, and fundamental questions about the 
trafficking of leukocytes that induce inflammation were answered in very rapid 
succession.  
 
Chemokines are a super family of low molecular weight (8-17 kilo Daltons (kDa)), 
secreted proteins (Borish et al., 2003; Alcami, 2003). Accumulating evidence now 
suggests that chemokines act as more than simple chemoattractant molecules in 
inflammation, and are important regulators in development, homeostasis and 
pathophysiological processes associated with viral infections, immune responses 
(Ono et al., 2003) and the mobilization of progenitors to the bone marrow (Pitchford 
et al., 2009). Chemokines are expressed in a range of cells including resident 
tissue cells, resident and recruited leukocytes, which include mast cells, 
macrophages, monocytes and endothelial cells. 
 
Chemokines are thought to have derived from 3 ancestral genes, and members of 
the chemokine superfamily are divided into four major groups based on the number 
and spacing of conserved N-terminal cysteine residues.  The CC chemokines (or β 
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chemokines) and CXC chemokines (also known as α chemokines) have four 
cysteine residues located in closely homologous positions within their amino acid 
sequence, and are the two most extensively characterised chemokine groups. In 
the CC chemokines the first two cysteine residues are adjacent, whereas for the 
CXC chemokines the first two cysteines are separated by a single amino acid 
(designated X). A third family, the C chemokines has only two cysteine residues 
and lacks the first and third cysteine residue and contains only one chemokine, 
lymphotactin. The final chemokine family, CX3C has three amino acids separating 
the first two cysteine residues and a lectin domain, which attaches it to the cell, and 
consists of the only chemokine Fractalkine. Over 50 different chemokines have 
been discovered to date and they carry out their functions via 19 chemokine 
receptors. Although there is a limited overall sequence homology between the 
chemokines they are grouped within a family because they have a similar 3-
dimensional structure, which is composed of a monomeric fold generated by a 
floppy N-terminus, which is essential for receptor activation, a C-terminal α helix 
and 3 internal β strands (Alexander et al., 2002).  
 
Chemokines are recognised by G- protein couple receptors (GPCRs), a large 
group of receptors that bind a diverse range of molecules, including chemokines, 
complement components, neurotransmitters and bioactive amines. GPCRs are 
seven transmembrane spanning receptors, which are coupled to heterotrimeric G-
proteins. These 40 kDa receptors approximately 350 amino acids in length possess 
an extracellular domain consisting of three extracellular loops and a short N-
terminus that act together to bind the chemokine ligand. The intracellular domain of 
the receptor is composed of three loops and a short C-terminus, which act together 
to transduce the chemokine signal via a conserved DRYLAV motif in the second 
intracellular loop. The C-terminus possesses several serine and threonine 
residues, which are phosphorylated during receptor occupancy. The lack of 
movement within the lipid bilayer is provided by the presence of a disulphide bride 
between extracellular loops one and two, and a pocket generated between the N-
terminal tail and extracellular loop 3 allows for the formation of a ligand-binding 
domain. 
 
Each chemokine family associates with a reciprocal family of receptors such that to 
date there are 11 CCR, 5 CXC receptors (CXCR), 1C receptor and 1 CX3CR 
receptor. The chemokine receptor family exhibits a high degree of redundancy, with 
 31 
ten of the chemokine receptors being able to bind two or more chemokines, 
thereby conferring an enormous versatility on the chemokine system. An example 
of this redundancy is shown by CCR1, which can bind chemokines Mip-1α, 
RANTES, MCP-2 and MCP-3. Several chemokines are also able to activate more 
than one chemokine receptor, such as RANTES, which can bind CCR1, CCR3 and 
CCR5. 
 
Chemokine receptor expression is unique to each leukocyte subtype and can vary 
according to the stage of differentiation and activation of the cell. Mast cells have 
the potential to express several chemokine receptors which include CCR1, CCR3, 
CCR4, CCR5, CXCR2 and CXCR4, but their precise receptor profiles can vary in 
response to their state of differentiation and which tissue they home and reside in 
(Ono et al., 2003). For example in BMMCs, CCR1, CCR2, CCR3, CCR4 and CCR5 
transcripts have been detected in SCF-treated cells, while mast cells isolated from 
various mouse strains suggest that CCR1, CCR2, CCR3 and CCR6 are expressed 
on activation of mast cells (Oliveira and Lukacs, 2001; Ono et al., 2003). 
 
The involvement of chemokine receptors in disease makes them ideal candidates 
for therapeutic intervention. The internalization and intracellular trafficking of 
chemokine receptors have important implications for the cellular responses elicited 
by chemokine receptors. In the absence of ligand chemokine receptors undergo a 
basal level of internalization, degradation or recycling. Ligand binding to GPCR can 
greatly enhance the internalization and hence trafficking of GPCR. Clathrin-
mediated pathway is the major pathway by which chemokine receptors are 
internalized, but some receptors may utilize caveolae-dependent internalization 
and lipid rafts routes. 
 
A major mechanism by which GPCR undergo ligand-induced internalization is 
through clathrin-mediated endocytosis (Vila-Coro et al., 1999; Venkatesan et al., 
2003). Ligand binding induces phosphorylation of Serine and Threonine residues in 
the intracellular loops and carboxyl-terminus of the chemokine receptor by G 
protein-coupled receptor kinases (GRKs) (Ferguson et al., 1998; Krupnick et al., 
1998). Phosphorylation results in 1) the uncoupling of the G protein subunits from 
the receptor and 2) receptor desensitisation in some cases. In addition, the 
phosphorylation of these residues are important for the recruitment of adaptor 
molecules that link the receptor to a lattice of clathrin that mediates receptor 
internalization. Two adaptor molecules that play important roles in chemokine 
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receptor internalization are adaptin 2 (AP-2) and β-arrestin. The involvement of 
receptors with these adaptor molecules results in recruitment of clathrin and 
formation of clathrin-coated pits which cleave off from the membrane via dynamin 
and become clathrin-coated vesicles  (Barlic et al., 1999; Droese et al., 2004; 
Orsini et al., 1999). Thereafter, the clathrin-coated vesicle is uncoated and the 
receptor-ligand complex enters the early endosomal compartment. The chemokine 
receptor can then 1) enter the perinuclear recycling compartment and traffic back to 
the plasma membrane to be re-exposed to its corresponding ligand 2) or it can 
enter the late endosomal compartment where it will be organised to the lysosomal 
compartment for degradation. 
 
1.2.2 Chemokine signaling through GPCR  
 
Chemokine receptor signaling constitutes a highly complex interplay of intracellular 
signaling events triggered by dimerisation of the chemokine receptor and the 
subsequent recruitment of Gi proteins, which upon dissociation act on a number of 
key effectors.  
 
Chemokine signal transduction was first studied using human neutrophils. The data 
suggested that IL-8 exhibited the same pattern of responses as other attractants 
such as the complement fragment C5a and N-formyl-methionyl peptides (fMLP). 
Bordetella pertussis toxin, which inactivates Gi proteins, 17-hydroxywortmannin 
(wortmannin), later found to block PI3K, and the PKC inhibitor staurosporin 
inhibited responses to IL-8 (Thelen, et al., 1988). Subsequent studies using such 
inhibitors showed that all chemokines act on the same class of receptors and 
induce a common signal transduction cascade.  
 
The effects of chemokines are mediated by GPCR, one of the largest families in 
the human genome, of which more than 800 sequences have been identified 
(Fredriksson et al., 2003). In the immune system GPCRs play a fundamental role in 
innate, adaptive and pathological responses, for example, in allergic diseases such 
as asthma characterised by chronic inflammation, chemokines secreted by lung 
resident cells e.g. bronchial epithelial cells and, maybe mast cells, recruit 
eosinophils and neutrophils (Gonzalo et al., 2007; Thomas et al., 2007). Over 60% 
of all pharmaceutical agents currently in use target GPCRs for the treatment of 
several diseases including allergic diseases such as asthma (Pierce et al., 2002).  
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The primary signal transducer used by GPCRs is the heterotrimeric G protein, 
which consists of α, β and γ subunits (Gilman 1987). In the absence of receptor 
ligand, these subunits co-exist as one complex in which the α subunit is bound to 
GDP. The α subunit consists of 4 major subfamilies, αi, αs, αq and α12/13, which 
are encoded by 20 α genes (Gutkind et al., 1998). Activation of the chemokine 
receptor by its ligand results in the dissociation of the receptor-bound heterotrimeric 
G protein into guanosine triphosphate (GTP)-bound αi subunit and βγ subunit. Each 
of these free activated subunits can now independently interact with distinct 
downstream effector molecules, inducing a diverse range of cellular responses 
(Figure 5), which include actin cytoskeletal rearrangements, cell movement and 
gene transcription (Marinissen et al., 2001; Marinissen and Gutkind, 2001). In 
addition, chemokine receptor signaling can also induce events such as mast cell 
degranulation.  
 
Gβγ is particularly important, as it activates two signaling pathways. One of these 
involves PLC and the other involves PI3K. PLC results in the generation of two 
messengers IP3 and DAG. As previously described IP3 further mobilises calcium 
from intracellular stores, which along with adenyl cyclase inhibition results in the 
calcium fluxes required for degranulation. DAG activates various isoforms of PKC, 
which activate a series of signal transduction events within the cell. PI3K is the 
other key effector activated by Gβγ (Curnock and Ward, 2003). Its activation results 
in the generation of lipid mediators which act as crucial secondary messengers for 
various downstream effectors including PKC, Rho GTPase and Ras pathways 
(Weiner et al., 2002). Chemokine ligand binding also activates the MAPK cascade, 
which activates various cytoskeletal elements.  
 
 
 
 
 
 34 
 
 
 
 
Figure 5. Simplified model of GPCR-mediated signaling events. 
Chemokine binding to GPCR induces dissociation of Gβγα complex into Gα and 
Gβγ subunits. These subunits are then free to activate various downstream 
effector molecules leading to cytoskeletal re-arrangements, chemotaxis and 
degranulation.  
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Cross talk between GPCR signaling pathways, such as those for chemokine 
receptors, has been widely demonstrated (Hur and Kim, 2002). Several studies, 
which have focused on the regulation of leukocyte trafficking, have shown that 
cross talk between chemokine receptors and non-GPCRs alters chemotaxis by 
modulating chemokine expression. An example of this is described by Fan and 
Malik (2003) who describe receptor cross-talk between TLR4 and CXCR2 in 
polymorphonuclear leukocytes.  Co-stimulation of TLR4 and CXCR2 receptors with 
MCP-1 and LPS, significantly reduced chemokine receptor internalisation resulting 
in the augmentation of a migratory response. Parker et al. (2004) found that 
stimulation of TLR2 and TLR4 in human monocytes resulted in down regulation of 
CCR1 and CCR2, with CCR1 being down regulated in an autocrine manner 
through the enhanced production of Mip-1α. In mast cells, CCR3 has been shown 
to rapidly locate to the cell surface from intracellular granules upon stimulation of 
FcεR1 by IgE/antigen (Price et al., 2003). In a study on RBL-2H3 cells similar 
stimulation of FcεR1 resulted in the up-regulation of the GPCR, Sphingosine-1-
phosphate (S1P), which is required for enhanced mast cell degranulation. Hence, 
the activation of non GPCRs, such as FcεR1 and the TLRs, have clearly been 
shown to have profound effects on chemokine receptor expression, and there is 
evidence to suggest that changes in receptor expression may potentially play a role 
in the co-stimulatory effect of Mip-1α on FcεR1 -mediated degranulation in mast 
cells. 
 
1.2.3 Regulation of GPCR signaling pathways: RGS family 
 
As previously mentioned GPCRs and G-proteins orchestrate a wide variety of 
signals and their activity is finely tuned by multiple regulatory systems.  A crucial 
regulatory step in the G-protein cycle is the deactivation of G-proteins by GTP 
hydrolysis, a process that is enhanced by GTPase activating proteins (GAPs). A 
family of proteins, which function as heterotrimeric G-protein GAPs were identified 
over 10 years ago in worms and mammals and termed Regulator of G-protein 
Signaling (RGS) proteins. RGS proteins function to accelerate the GTPase activity 
of the α subunit, accelerating the return of Gα to its inactive guanosine diphosphate 
(GDP)-bound form thereby inhibiting downstream activity (Figure 6).  
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Figure 6. RGS proteins accelerate GTPase activity of the α-subunit, 
thereby inhibiting downstream events. 
In its inactive state the α-subunit is bound to GDP. Upon stimulation (e.g. 
chemokine) conformational changes in the receptor induce the α subunit to 
release GDP and bind GTP. The binding of GTP causes the α-subunit to detach 
from the βγ-sub unit, thereby allowing them to independently interact with 
effector molecules associated with cell processes such as migration. G-protein 
signaling is terminated when the α-subunit hydrolyzes GTP to GDP, which 
causes re-association to the βγ-subunit. RGS proteins accelerate GTPase 
activity of the α-subunit, thereby inhibiting down stream signaling. 
 
 
 
 
 
 
 
 
 
 
GPCR Ligand 
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Each RGS protein contains a RGS box, which consists of a 120 amino acid domain 
that is responsible for GAP activity.  Based on RGS domain homology and 
accessory domains, these genes can be divided into eight sub-families: A or RZ; B 
or R4; C or R7; D or R12; E; RA: F or GEF; G or GRK and H or SNX. The 
combination of these domains ultimately creates highly regulated multi-functional 
proteins, capable of conducting complex signaling tasks. RGS proteins can up-
regulate GTPase activity up to 1000-fold (Posner et al., 1999). Moreover, RGS 
domains also serve as scaffolds by promoting rapid cycling of Gα subunits between 
active and inactive states (Willard et al., 2007; Zhong et al., 2003) or effector 
antagonists by competitively binding activated Gα subunits or effector enzymes 
(Roy et al., 2006; Schoeber et al., 2006). 
 
As previously mentioned FcεR1 mediated signaling in mast cells induces Syk 
activation, which in turn recruits and activates PI3K, PLCγ and MAPK. 
Accumulating evidence indicates PI3K plays an essential role in mast cell 
homeostasis and allergic responses (Fukao et al., 2002). Mast cells from mice 
expressing the inactive PI3K subunit p110δ have profoundly less antigen-induced 
degranulation (Ali et al., 2004). GPCRs may increase IgE mediated responses or 
induce mast cell activation alone.  Moreover, a study by Laffargue et al. (2002) 
demonstrated that PI3Kγ-deficient mast cells disrupt GPCR- mediated amplification 
of FcεR1-mediated degranulation, indicating that PI3Kγ is a requirement for GPCR 
signaling and is a modulator of the allergic signaling pathway. The ability of 
wortmannin, a non-specific PI3K inhibitor, to block C3a-induced expression of the 
chemokine, CCL2 in human mast cells suggests a role for PI3K in GPCR-mediated 
responses in mast cells (Venkatesha et al., 2005). For these reasons it is therefore 
not surprising that researchers have now started to investigate RGS proteins as 
regulators of mast cell- driven inflammation induced by GPCRs.  
 
Recent studies have unveiled RGS13 as a new signaling molecule, which may 
affect the intrinsic reactivity of mast cells to allergens. Bansal and co-workers 
(2008) established RGS13-deficient mice with Lac Z knock-in. Both immuno-
fluorescent and β-galactosidase staining of cultured BMMCs and tissues showed 
that RGS13 is expressed in murine mast cells. In addition they found that RGS13 
deficient mice had significantly increased IgE-mediated anaphylactic responses 
due to increased mast cell degranulation. Further experiments reconstituting 
RGS13–deficient BMMCs with RGS13 or over expression of RGS13 in wild type 
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BMMCs inhibited antigen-induced degranulation. This data suggests that the 
abnormality observed in RGS13 deficient mast cells was due to the absence of 
RGS13.  
 
In addition, Bansal and co-workers (2008) characterized how RGS13 affects 
GPCR-mediated functions of human mast cells in vitro. They examined human 
mast cell lines, HMC-1 and LAD2, depleted of RGS13 by siRNA or short hairpin 
RNA and HMC-1 cells over-expressing RGS13. The results demonstrated that 
RGS13 knockdown in LAD2 cells induced increased degranulation in response to 
S1P, but not to IgE-Ag or C3a. Compared to wild-type cells, cells stably expressing 
RGS13 short hairpin RNA had enhanced Ca2+ mobilization in response to 
adenosine, C5a, S1P (GPCR ligands), and stromal cell-derived factor-1 (SDF-1). In 
addition compared with control cells, AKT phosphorylation, chemotaxis, and IL-8 
secretion induced by CXCL12 were also up-regulated in short hairpin RGS13-
HMC-1 cells.  
 
1.3.  Regulation of actin cytoskeleton and chemotaxis 
 
Mast cells play a central and well-established role in mediating allergic disease, 
whilst chemokines control the activation and recruitment of immune cells during 
inflammation. The chemotaxis of mast cells to sites of inflammation and the 
subsequent release of pro-inflammatory mediators are crucial to eliciting allergic 
response. Over the years, by using several cell types including neutrophils and 
Dictyostelium discoideum, a large amount of evidence has contributed to the 
molecular basis of chemotaxis. However, to date there is limited evidence to 
understand the molecular mechanisms underlying mast cell chemotaxis. A 
continuing effort to better understand the molecular basis of mast cell migration 
during the allergic response will help identify alternative therapies. The following 
sections describe what is known about the actin cytoskeleton, chemotaxis and the 
vital components which regulate it. 
 
1.3.1 Actin cytoskeleton and Rho GTPases 
 
The actin cytoskeleton is a highly dynamic network, playing an essential role in 
numerous biological processes such as cell surface remodelling and motility. Actin 
filaments (composed of actin monomers), intermediate filaments and microtubules 
(composed of α and β tubulin) collectively known as the cytoskeleton, are 
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responsible for the mechanical properties and shapes of cells, which are often 
critical to their functions. Actin assembly provides a major force in cell motility, in 
particular by initiating protrusions such as filopodia (spiky protrusions) and 
lamellipodia (sheet-like protrusions) that propel the leading edge of the cell forward. 
Accumulating evidence over the past decade has provided a coherent model of 
how polymerisation of actin filaments can allow cells to migrate. While researchers 
have identified some of the major players in the formation of structures such as 
lamellipodia and filopodia, much remains to be elucidated about the mechanism of 
assembly and dynamics of these structures in actual physiological settings. 
 
Actin powers protrusions of a cell by polymerizing just under the plasma 
membrane. A cell has two options of actin filament geometry: bundled filaments 
leading to filopodial spikes or branched filaments leading lamellipodial sheet-like 
protrusions. Actin filaments are polar because the monomers in the filament all 
point in the same direction; the positive end (or ‘barbed’ end) grows more quickly 
than the negative end (or ‘pointed’ end). Capping proteins bind to the barbed ends 
to terminate elongation of the actin filaments. Once the actin filaments are 
established, they can elongate without help, but there is a strong barrier to initiating 
or ‘nucleating’ new filaments. Branched filaments found in lamellipodia are 
assembled by the actin related proteins (Arp) 2/3 complex. Arp 2/3 complex is a 
major nucleator of actin polymerisation. Arp 2/3 performs two actions 1) nucleates 
actin filaments from monomers and 2) binds pointed ends and caps them. This 
220kDa assembly consists of seven subunits: Arp2 and Arp3, being similar in 
structure and sequences to actin and the remaining five subunits, Arp C1-5, being 
unique and highly conserved in evolution (Machesky and Gould, 1999). Further 
studies also identified the ability of the Arp2/3 complex to direct formation of 
70°branches on the side of pre-existing filaments generating a dendritic array of 
filaments (Welch et al., 1997; Mullins et a., 1998, Pollard, 2007). These branches 
are identical to those observed in electron micrographs of the leading edge of 
rapidly motile cells (Svitkina and Borisy, 1998). 
 
Rho GTPases, Rac, Cdc42 and Rho are members of the Ras superfamily of GTP 
binding proteins which are pivotal and well characterised regulators of the actin 
cytokeleton. However, they also contribute to diverse cellular functions, including 
vesicular trafficking and cell cycle. In mammals, at present there are 20 Rho 
GTPases, all of which bind GTP and most of which exhibit GTPase activity. Each of 
these Rho GTPases acts as a binary switch, cycling between an active GTP-bound 
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form and an inactive GDP-bound state. In the GTP-active form they are able to 
interact with effector molecules to initiate a downstream signaling response, which 
mediates actin reorganization. Nucleotide binding status, which determines 
downstream signaling activity, is tightly controlled by the actions of three groups of 
proteins:  GEFs; GAPS and Rho guanine-nucleotide-dissociation (Rho-GDIs).  
GEFs increase the active GTP-bound conformation by stimulating release of GDP 
(Schmidt and Hall, 2002), while GAPs stimulate intrinsic GTPase activity, thereby 
promoting the inactive GDP-bound conformation (Bernards, 2003) and finally Rho-
GDIs, which prevent membrane targeting and interaction with downstream 
effectors by binding to the C-terminal prenyl group of many Rho GTPases 
(DerMardirossian and Bokoch, 2005). Rac, Rho and Cdc42 control signal 
transduction through distinct pathways that link membrane receptors to co-
ordination of the cytoskeleton and adhesion complexes (Figure 7). Signal 
integration and crosstalk exist between Rho GTPases and PI3K mediated signaling 
pathways, whereby both Rac and Rho are activated downstream of 
phosphoinositide signaling, and the activity of several GAPs and GEFs are 
regulated by PI(3,4,5)P3 binding (Bishop and Hall, 2000; Etienne-Manneville and 
Hall, 2002; Ridley, 2006). 
 
Rac 1 mediates the formation of lamellipodia (Ridley et al., 1992). These thin 
protrusive sheets can lift up and fold backwards at the leading edge, giving rise to 
membrane ruffles. Activation of Cdc42 produces microspikes including filopodia. 
These are finger-like projections consisting of actin filament bundles (Bishop and 
Hall, 2000), which act as sensors to explore the microenvironment of the cell, but 
are not considered essential for chemotaxis. Rho A regulates the generation of 
stress fibers and focal adhesions (Ridley and Hall, 1992).  
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Figure 7. The formation of lamellipodia and filopodia by RAC and Cdc42 
signaling pathways. 
The highly dynamic lamellipodium, at the leading edge of the cell is extended by 
ARP2/3. Rac activates actin polymerisation during lamellipodium formation 
through the WAVE complex, which in turn activates ARP2/3, and mDia2, which 
nucleates unbranched actin filaments. Filopodia are thin protrusions that 
contain parallel bundles of actin filaments that extend from the leading edge of 
the cell, which probably function as sensory probes. CDC42 induces actin 
polymerization by binding to WASP, IRSp53 to lnduce branched actin filaments 
using the ARP2/3 complex. CDC42 and Rac also induce actin polymerization 
by activation of mDia2. CDC42-mediated or Rac-mediated activation of the PAK 
phosphorylates LIMK, which phosphorylates and inhibits cofilin, thereby 
regulating actin-filament turnover. 
 
KEY: ARP2/3= actin-related protein-2/3. WASP= Wiskott–Aldrich syndrome 
protein. WAVE=WASP-family verprolin-homologous protein. mdia2= 
mammalian diaphanous-2. IRSp53= insulin-receptor substrate p53. PAK= p21-
activated kinase. LIMK= LIM kinase.   
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1.3.2 WASP: a component of actin assembly  
 
Wiskott–Aldrich syndrome protein (WASP) was the first identified member of a 
family of actin regulators, a key adaptor protein that connects multiple signaling 
pathways to filamentous actin (F-actin) polymerization, a process essential for 
chemotaxis. The WASP family consists of two principal subfamilies: WASP and 
WASP family verprolin homologous protein (WAVES). Although WASP expression 
is confined to haematopoietic cell lineages, neural WASP (N-WASP) and WAVE1, 
WAVE2 and WAVE3 are more widely expressed. The importance of WASP-
mediated cytoskeletal regulation in haematopoietic cells is shown by the human 
disease, Wiskott–Aldrich syndrome (WAS). These defects are caused by mutations 
in the WAS gene encoding WASP. Classical WAS is an X-linked primary 
immunodeficiency that is characterized by easy bruising and prolonged bleeding, 
eczema, low numbers of small platelets, and recurrent infections (Sullivan et al., 
1994). 
 
WASP and WAVES are the main activators of Arp2/3 complex (Millard et al., 2004). 
Upon activation these proteins induce numerous actin based structures, such as 
lamellipodia and filopodia. In addition to these structural roles, emerging data 
implicate other roles, which include cell-substrate adhesion (Ibarra et al., 2006) and 
cytokinesis (Pollitt and Insall, 2008). WASP is present throughout evolutionary 
history, and homologues have been identified in many eukaryotes from yeast to 
mammals. Mammals typically possess two WASPs, WASP and N-WASP, and 
three other WAVE proteins. Other members of the WASP family which have been 
identified are WASH (Linardopoulou et al., 2007), WASP homolog associated with 
actin, membranes, and microtubules (WHAMM) (Campellone et al., 2008) and JMY 
(Zuchero et al., 2009), however, at present very little is known about their 
physiological roles. 
 
The closest homologue to WASP is N-WASP. Both are structurally and functionally 
very similar, and in many in vitro assays one protein can be substituted for the 
other. WASP is hematopoietic-specific (Derry et al., 1994), whereas N-WASP is 
ubiquitously expressed (Miki et al., 1996). Both WASP and N-WASP are 
characterised by a conserved domain arrangement: Ena-Vasp homology domain 
(EVH1), also known as the WASP homology domain-1 (WH1), a proline-rich 
domain, a Cdc42/Rac GTPase binding domain (GBD), a G-actin binding verprolin 
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homology (V) domain, a cofilin homology(C) domain and a C-terminal acidic (A) 
segment. 
 
In resting cells, WASP and N-WASP exist in an auto-inhibited inactive 
conformation; this auto inhibition is released by the binding of Cdc42 and PI(4,5)P2 
(Kim et al., 2000). The C-terminus is responsible for binding to and activating the 
Arp 2/3 complex, it consists of one or two WH2 domains, which bind monomeric 
actin, followed by a short central region and acidic region which interacts with the 
Arp2/3 complex, resulting in actin nucleation (Higgs and Pollard, 1999). G-actin 
binds to the V domain (Higgs and Pollard, 2000). Binding of N-WASP to Cdc42 
induces a conformational change allowing its VCA domain to interact with the 
Arp2/3 compex resulting in actin assembly, and this is further enhanced by 
PI(4,5)P2 (Higgs and Pollard, 2000; Rohatgi et al., 1999). A proline-rich region 
provides potential sites for the binding of various SH3 domain containing proteins. 
Tyrosine phosphorylation of WASP increases its capacity to activate Arp 2/3 
complex without the need of Cdc42 or PI(4,5)P2. Moreover serine/threonine 
phosphorylation can induce actin polymerisation in vitro (Cory et al., 2003). 
Interaction between the WH1 domain with the WASP-interacting protein (WIP) is 
thought to suppress the activity of WASP or N-WASP (Ramesh et al., 1997). 
 
1.3.3 Cell migration, chemotaxis and cell polarity  
 
Cell migration is a highly complex orchestrated process that is crucial for a range of 
biological processes in animals, which include immune surveillance, wound healing 
and embryonic morphogenesis (Raja et al., 2007). Cell migration can be divided 
into distinct stages. Firstly, a cell must adhere to its surrounding environment and 
establish directionality. In the presence of a chemotatic agent, this requires that 
cells sense the direction of the chemical gradient in order to establish polarity. In 
the absence of chemoattractant, polarization maybe induced through changes in 
receptor occupancy (Lauffenburger and Horwitz, 1996). Once directionality is 
achieved, the leading edge of the cell composed of lamellipodia (and maybe 
filopodia) propels the cell forward. Adhesive contacts are formed at the front of the 
cell, along with simultaneous cell retraction, actin disassembly and detachment of 
adhesions at the rear of the cell. 
 
Researchers have extensively studied the underlying mechanisms of migration in 
vitro and in vivo, using a diverse range of cell types and model systems. These 
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include leukocytes which migrate during immune surveillance and accumulate at 
sites of inflammation, slower moving fibroblasts which migrate during wound 
healing, the body of a mouse, in which the development of an immune response 
and interactions of T and B cells can be monitored in real time and, more recently, 
following recruitment of lymphocytes to lymph nodes or movement of tumor cells in 
the whole animal using fluorescence imaging techniques (Miller et al., 2002; Sahai 
2007; Zinselmeyer et al., 2008). 
 
Chemotaxis, the directed movement of cells along an external gradient, is a critical 
cell biological response. These responses include the aggregation of Dictyostelium 
discoideum to form a multi-cellular organism, neurons finding their way in the 
developing nervous system and when leukocytes traffic between the vascular and 
lymphatic systems, and migrate from the blood toward sites of infection. In addition 
to these roles in normal physiology, inappropriate cell migration is the basis for 
many pathological conditions including cancer metastasis and chronic inflammatory 
diseases such as asthma and arthritis. 
 
Chemotaxis involves production and degradation of PI(3,4,5)P3 at the plasma 
membrane, generating a net accumulation at the leading edge of the cell. This 
ultimately drives actin polymerisation and directional cell movement, hence when 
cells undergo chemotaxis they must first acquire spatial asymmetry in order that 
generated forces within can be turned into productive forward movement. Abundant 
data indicate that both PI3Ks, their lipid products PI(3,4,5)P3 and Rho GTPases 
affect cell polarization, although their contributions appear to be highly dependent 
on cell type (Parent and Devreotes, 1999; Rickert et al., 2000; Chung et al., 2001; 
Ward, 2004). Interestingly, studies indicate cell polarization, and therefore 
chemotaxis is not a consequence of preferential localization of chemoattractant 
receptors at the leading edge, instead receptor localization remains uniformly 
distributed around the plasma membrane as demonstrated in neutrophils and 
Dictyostelium discoideum cells (Servant et al., 1999; Xiao et al., 1997).  
 
The generation of PI(3,4,5)P3 at the plasma membrane, provides docking sites for 
the recruitment of many pleckstrin homology (PH) domain containing signal 
transduction molecules involved in cytoskeletal organisation and cell survival. PH 
domains are protein modules of approximately 120 amino acids found in more than 
150 proteins, which bind phohospholipids with high affinity and specificity (Lemmon 
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et al., 2002). Tandem PH domain-containing protein 1 (Tapp-1) is specific for 
PI(4,5)P2, whereas other PH domains from AKT, Btk and Gab-2 have been shown 
to be highly specific for PI(3,4,5)P3   (Harriague and Bismuth G, 2002; Costello et 
al., 2002). Mutant PH domains are unable to bind PI(4,5)P2 or PI(3,4,5)P3  and do 
not translocate to the plasma membrane in response to PI3K activation (Funamoto 
et al., 2001). In unstimulated cells levels of PI(4,5)P2 and PI(3,4,5)P3  are almost 
undetectable, however levels rise rapidly within 10 seconds of stimulation with 
chemoattractant (Stephens et al., 1991).  
 
When Dictyostelium discoideum cells are exposed to a chemoattractant gradient 
PI3Ks bind to the membrane at the front, PI(3,4,5)P3 selectively accumulates at the 
leading edge, and new F-actin-filled pseudopodia are extended at corresponding 
sites (Chen et al., 2003). This role for PI(3,4,5)P3 in polarity and directional sensing 
has been demonstrated in other cell types such as Drosophila melanogaster 
hemocytes, human neutrophils and fibroblasts, neurons, and a variety of embryonic 
cells (Wang et al., 2002; Chadborn et al., 2006).  An invaluable tool in investigating 
the involvement of PI(3,4,5)P3  signaling in gradient sensing and polarity has been 
the use of green fluorescent protein (GFP) fused to the PH domains of proteins 
such as AKT, which bind preferentially to PI(3,4,5)P3  over PI(4,5)P2. As 
PI(3,4,5)P3  represents the major lipid products of class I PI3Ks, these probes have 
been utilised to investigate sites of cellular PI3K activity (Costello et al., 2002). The 
GFP–AKT-PH domain probe is uniformly distributed throughout un-stimulated 
Dictyostelium discoideum and fibroblasts, however after exposure to different 
chemoattractant stimuli the probe is recruited selectively to the membrane at the 
leading edge (Merlot and Firtel, 2003). In human neutrophils, the translocation of 
the probe from the cytoplasm to the plasma membrane when exposed to a uniform 
concentration of chemoattractant was rapid and transient, reaching a maxiumum 
accumulation by 30 seconds and decreasing over the ensuing two minutes 
(Servant et al., 2000), indicating that PI3K functions at the leading edge of the cell 
to mediate chemotaxis by using PI(3,4,5)P3 as a crucial secondary messenger.  
 
In leukocytes, both PI3Kγ and PI3Kδ isoforms have been implicated in asymmetric 
PI(3,4,5)P3  accumulation at the leading edge, for example, p110δ kinase-dead 
knock-in-macrophages or p110γ knockout neutrophils do not demonstrate 
PI(3,4,5)P3  accumulation and moreover are defective in polarization in response 
to colony stimulating factor (CSF)-1 and fMLP respectively (Sadhu et al., 2003; 
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Papakonstanti et al., 2007). Recent work indicates that the importance of PI3K in 
leukocyte chemotaxis is also dependent on the substrate on which cells are 
migrating. Ferguson et al., (2007) demonstrated that although accumulation of 
PI(3,4,5)P3 and F-actin at the leading edge of chemotactically stimulated p110γ−/− 
mouse neutrophils was perturbed, interestingly cells were able to chemotax 
normally on selected surfaces.  
 
1.3.4 Imaging cell migration 
 
When analysing cell migration, the major starting point is to characterise the 
behavior of cells, by taking images of shape change, persistence of movement and 
direction and the dynamics of actin structures such as the extension and retraction 
of lamellipodia, pseudopods, filopodia and membrane ruffling. These investigations 
have been conducted by making use of light microscopy methods, especially wide-
field microscopy in either Nomarski Interference Contrast or phase contrast 
settings. Images are recorded and collected by charge-coupled device (CCD) 
cameras as simple sections or Z-stacks. These time series images then have to be 
analysed using appropriate software. Alternatively, a vast amount of knowledge of 
the internal structure and organisation of cells comes from the investigation of fixed 
cells or tissue specimens, followed by detailed imaging using a combination of light, 
confocal and electron microscopic techniques. These studies have provided a 
through understanding of the fundamental cytoskeletal components and their 
architecture during cell migration. Moreover, in order to acquire a detailed 
understanding of the spatio-temporal control of the cytoskeleton, researchers have 
made use of GFP tagged cytoskeletal components possessing different spectral 
properties. The methods described above work well for investigating cell migration 
provided that there is high enough contrast in the images and that the data is such 
that the cells do not move out of the area of interest between data points. 
 
In 1888, Leber made the first observation of leukocyte chemotaxis in excised 
corneal tissues or rabbits; however, it was not until 30 years later that the first in 
vitro assays of chemotaxis were developed. These early assays assessed 
migration on coverslips or in capillary tubes. Although these systems established 
whether a substance was chemotatic, it was not possible to provide quantifiable 
data. In 1962, a quantitative method was developed by Boyden, who developed 
what is now known to most researchers as the Boyden chamber, a milestone in the 
study of chemotaxis, and moreover the basis of many chemotaxis assays. 
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In the Boyden system, a porous membrane separates 2 chambers. Cells are 
placed in one chamber, whilst the chemotatic agent is placed in another, allowing 
chemotaxis of the cells across the membrane. Various techniques can then be 
implemented to quantify the number of migrating cells, including microscopy and 
enzymatic techniques. This system offers many advantages, including ease of use, 
the ability to examine chemotaxis and the ability to quickly screen various 
compounds at many concentrations. However, the design of this system is limiting 
in that the speed of cell migration and the paths the cells adopt cannot be 
determined, real-time observations are not possible, and very sharp 
chemoattractant gradients are formed.  
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1.4 Hypothesis and aims of this thesis 
 
Former studies by Ono and co-workers (Toda et al., 2004; Miyazaki et al., 2005; 
Nifidra et al., 2010) found that co-engagement of FcεR1 and CCR1 resulted in 1) 
synergistically enhanced degranulation in ex vivo mast cells and RBL-CCR1 cells, 
2) inhibited Mip-1α induced chemotaxis of RBL-CCR1 cells, and 3) enhanced 
production of pro-inflammatory molecules, indicating that this response was 
facilitated by cross-talk between FcεR1 and CCR1-mediated signaling pathways. In 
addition, subsequent studies (Ono and Aye unpublished data) found that the gene 
expression of regulatory molecules RGS1 and TRB3 downstream of FcεR1 and 
CCR1 signaling, were significantly increased in RBL-CCR1 cells following FcεR1 
and CCR1 co-engagement. It has therefore been proposed that co-engagement of 
FcεR1 and CCR1 affects mast events other than degranulation and these data 
indicate cross-talk between CCR1 and FcεR1 signaling pathways. 
 
Based on current knowledge, the hypothesis of this thesis is that mast cell 
functions can be differentially regulated in response to co-stimulation by 
IgE/allergen and chemokine. 
 
To address this hypothesis, the specific aims of this thesis were as follows: - 
 
1. To further analyse whether and how simultaneous engagement of FcεRI 
and CCR1 may affect mast cell migration and elucidate the molecular 
mechanisms involved 
 
2. To analyse the roles of regulatory signaling molecules, RGS1 and TRB3 in 
mast cell degranulation, chemotaxis and mediator release. 
 
The data obtained from this thesis may contribute to our understanding of mast cell 
migration and arrest during an allergic response, which is key to effectively treating 
allergic diseases. 
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Chapter 2 
Materials and methods 
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2. Materials and Methods 
 
2.1 Induction of murine allergic conjunctivitis 
 
2.1.1 Mice 
For the present study eight-week-old female A/J mice (Harlan, United Kingdom 
(U.K)) or BALB C mice (Jackson Laboratory, United States of America (US)) were 
used for allergic conjunctivitis models 1 and 2 respectively. These preferred atopic 
strains of mice are routinely used to induce allergic models, including allergic 
conjunctivitis due to their preferential Th2 cell responsiveness to allergen 
(Gronberg et al., 2003).  
 
2.1.2 Murine models of allergic conjunctivitis 
 
2.1.2.1 Induction of murine allergic conjunctivitis model 1-A/J mice 
 
All procedures were conducted by myself with the aid of ophthalmologist Mr. Tom 
Flynn, in accordance with the UK government regulations for the care of 
experimental animals and with the ARVO Statement on the use of animals in 
ophthalmic and vision research. 
 
Allergic conjunctivitis was induced using the following protocol based on 
modification of a previously described method by Ohbayashi et al., 2007.   A/J mice 
were sensitized by intraperitoneal injection with 200µg of short ragweed pollen 
(SRW) (Greer Laboratories, Inc.) and 2mg of aluminum hydroxide (Alum) (Sigma, 
St. Louis, MO) in 400µl Phoshphate Buffer Saline (PBS) (Invitrogen) on days 0, 7 
and 14, and by treatment of eye drops containing 500µg SRW with 25µg Alum in 
5µl PBS on days 8 and 15. On day 27, the experimental challenge of 500µg SRW 
in PBS or PBS alone was administered topically to both eyes (Figure 8). 
Sensitisation over a 15-day period is required for the generation of systemic T-
helper 2 responses, and subsequent challenge with topical SRW induces severe 
allergic conjunctivitis.  
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Figure 8. Induction of murine allergic conjunctivitis model 1 using A/J 
mice.  
The mouse was sensitized over a 15-day period with short ragweed (SRW) 
pollen and Aluminium Hydroxide (Alum) injected intraperitoneally on days 0, 7 
and 14 and by eye drops on days 8 and 15. This was followed by experimental 
challenge with SRW on day 27 by eye drops. 
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Mice were divided into three groups as follows. 1) Naïve mice which were neither 
sensitized nor challenged, 2) sensitized/challenged mice, these were sensitized 
and challenged with SRW on day 27 and 3) sensitized/non-challenged mice, which 
were sensitized and challenged with PBS alone on day 27. Each group contained 
at least 5 eyes. 3, 6 and 24 hours after the experimental challenge and on 
diagnosis of allergic conjunctivitis (conducted by ophthalmologist, Mr. Tom Flynn) 
mice were sacrificed and whole eyes were enucleated from each group.  Each eye 
was embedded in optimal cutting temperature (OCT) compound (Sakura Finetek 
Europe) and was frozen on a liquid nitrogen-cooled duralumin plate. Specimens 
were stored at -70°C until for future use. Cryostat serial sections 10µm thick were 
cut and air-dried for 30 minutes. The sections were fixed by 30% methanol in 100% 
acetone for 10 minutes at 4°C. Toluidine Blue staining was conducted on 
conjunctival sections to identify mast cells and their location. In addition, 
enucleated eyes from each treatment (at least 5 eyes per group) were also 
processed by Dr. Peter Munro (UCL) for electron microscopy analysis. 
 
2.1.2.2 Induction of murine allergic conjunctivitis model 2- BALB/c mice 
 
All procedures were undertaken by Dr. Ohbayashi at Emory University, Atlanta, 
U.S. The protocol conformed to all regulations for laboratory animal research 
outlined by the Animal Welfare Act, NIH guidelines and the ARVO statement 
regarding the experimental use of animals. 
 
Briefly, BALB/c mice were sensitized by footpad injections with 50µg SRW and 
1mg Alum in 25µl PBS into both hind-footpads on day 0, 14 and 28, and by 
treatment of eye drops containing 1000ug SRW in 5ul PBS into each eye from days 
35-39. On day 42, the experimental challenge of 1000 µg SRW in 5ul PBS or PBS 
alone was administered topically to both eyes (Figure 9). 
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Figure 9. Induction of murine allergic conjunctivitis model 2 using BALB/c 
mice. 
The mouse was sensitized with short ragweed (SRW) pollen and Aluminium 
Hydroxide (Alum) injected into the footpads on days 0, 7 and 14 and by eye 
drops between days 35 and 39. This was followed by experimental challenge 
with SRW on day 42 by eye drops. 
 
 
 
 
 
 
 
 
 
 
 
0 28 
Day 
35 36 37 38 39 40 4 42  
Sensitisation by 
SRW and Alum 
Experimental 
challenge by 
SRW 
Footpad injections of SRW with Alum in PBS 
Eye drops of SRW with Alum in PBS 
Experimental challenge with SRW  
14 
 54 
Mice were divided into 2 groups as follows: 1) Naïve mice which were neither 
sensitized nor challenged and 2) sensitized/challengedmice, these were sensitized 
and challenged with SRW on day 42. Each group contained at least 5 eyes.  
 
30 minutes and 24 hours after the experimental challenge, and on diagnosis of 
allergic conjunctivitis mice were sacrificed and perfused transcardially with 4% 
paraformaldehyde (PFA). Whole eyes were enucleated from each group and fixed 
with 4% PFA for 24 hours at 4oC. The tissue was dehydrated in graded ethanols 
and embedded in paraffin resin. Cryostat serial sections 5µm thick were cut and 
sections stored at room temperature until further use. Thereafter, antigen retrival 
procedure and immunohistochemical analysis was carried out by my-self as 
described in section 2.10.1 -staining of murine conjunctival paraffin sections: 
Detection of mMCP-5 and CCR1. 
 . 
2.2 Cell line and cell culture 
 
2.2.1 RBL-CCR1 cell line 
 
For the present study a RBL cell line stably expressing the human chemokine 
receptor CCR1 (RBL-CCR1) was used.  These adherent cells express high affinity 
IgE receptors known as FcεR1, and have been used extensively to study FcεR1 
and the biochemical pathways for secretion in mast cells. RBL-CCR1 cells were 
kindly provided by Professor R. Richardson, JLC-Biomedical/Biotechnology 
Research Institute, North Carolina Central University, Durham, NC, USA. For 
plasmid map details please refer to Toda et al., 2004. 
 
2.2.2 RBL-CCR1 cell culture 
 
RBL-CCR1 cells were maintained as a monolayer in Dulbecco’s modified Eagle’s 
medium (DMEM) (Invitrogen) supplemented with 15% fetal bovine serum 
(FBS)(Sigma), 2 mM glutamine (Invitogen) and 1 mg/ml G418 (Invitrogen). Cells 
were maintained in a humidified cell incubator with 5% CO2 in air at 37oC. Cells 
were passaged once or twice weekly as required under standard sterile conditions 
as follows. 
 
Media was removed and cell monolayers were washed three times with sterile PBS 
at room temperature. Pre-warmed Trypsin (Invitrogen) was added to the flask and 
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incubated at 37oC with 5% CO2 for 5 minutes. Thereafter the flask was gently 
tapped in order to release the adherent cells and fresh DMEM containing 15% FBS 
was added to inactivate Trypsin. The resulting cell suspension was centrifuged for 
5 minutes at 1200 revolutions per minute (rpm). The supernatant was discarded 
(thereby removing any residual Trypsin), and re-suspended in fresh DMEM 
containing 15% FBS and 1mg/ml of G418, as a selection marker for CCR1 positive 
cells. 
 
Cyropreservation was carried out by re-suspending the cell pellet in 1.5mls of 
freezing mix containing 90% FBS and 10% Dimethyl Sulfoxide (DMSO) (Sigma). 
The cells were transferred to a cryovial and allowed to undergo freezing at -80°C 
for 24 hours. After which point, the frozen cells were transferred to liquid nitrogen at 
-150°C for long-term storage. 
 
2.2.3 GFP-AKT-RBL-CCR1 cell culture 
 
For the present study RBL cell line stably expressing the human chemokine 
receptor CCR1 and the PH domain of AKT tagged to GFP (GFP-AKT-RBL-CCR1) 
were kindly provided by Professor R. Richardson, JLC-Biomedical/Biotechnology 
Research Institute, North Carolina Central University, Durham, NC, USA. Professor 
Richardson has stated that the specific plasmid map details will be provided in the 
case of publications. This cell line was cultured and cryopreserved in the same 
manner as RBL-CCR1 cells using 1mg/ml of G418, as a selection marker as 
previously described.  
 
2.3. Transfection of RBL-CCR1 cells with either Rgs1 or TRB3 using 
Oligofectamine- RNA interference 
 
RBL-CCR1 cells for transfection were plated into 6-well plates with DMEM media 
(Invitrogen) and 15%FBS (Sigma) and allowed to grow until a confluency of 
approximately 90% was reached. Thereafter DMEM media (Invitrogen) was 
replaced with DMEM media without serum.  
 
To achieve transient knockdown of RGS1, antibiotic/serum free DMEM media 
(Invitrogen) and Oligofectamine (Invitrogen) was mixed with RGS1 Ambion Silencer 
Select Pre-designed siRNA ID number s132558 (Ambion) at a final concentration 
of 250nM. The mix was incubated at room temperature for 30 minutes and then 
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added to the cells. After 3 hours FBS was added to each well to reach a 
concentration of 10%). After 24 hours cells were validated for transfection efficiency 
by western blot (See section 2.13). Transient knockdown of TRB3 was achieved 
following the same protocol as RGS1 transient knockdown, with the exception that 
a final concentration of 150nM TRB3 siRNA, Ambion Silencer Select Pre-designed 
short interference RNA (siRNA) ID number s140931 (Ambion) was used. In 
addition RBL-CCR1 cells were also transfected with control siRNA, Ambion 
Silencer Select Pre-designed siRNA ID number 4390843 (Ambion) in the same 
manner as RGS1 and TRB3 transient knockdown. 
 
2.4 Degranulation assay 
 
Degranulation results in the release of chemical mediators, which include β-
hexosaminidase (Schwartz et al., 1979). The β-hexosaminidase assay has been 
widely used to monitor RBL degranulation. Current methods to quantify β-
hexosaminidase activity use colorimetric enzyme substrates. The present study 
used the substrate, p-nitrophenyl N-acetyl-beta-D-glucosamide, which generates 4-
p-nitrophenol when hydolysed by β-hexosaminidase. 
 
RBL-CCR1 cells which had been transfected with Rgs1, TRB3 or control siRNA 
(Ambion) were sensitised with or without 25 ng/ml anti-dinitrophenyl (DNP) IgE 
SPE 7  monoclonal antibody (MAb) overnight at 37oC with 5% CO2. After washing 
three times with x1 PBS, the cells were stimulated with 10 ng/ml dinitrophenyl 
human serum albumin (DNP-HSA) and/or 10ng/ml of recombinant human Mip-1α in 
DMEM containing 0.1% bovine serum albumin (BSA) for 30 minutes in a total 
volume of 200ul at 37oC with 5% CO2.  Following stimulation, 50ul of each 
condition supernatant was collected and added to the substrate p-nitrophenyl N-
acetyl-beta-D-glucosamide (Sigma) in 0.1M sodium citrate buffer (pH 4.5). After 
60 minutes at 37°C with 5% CO2, the reaction was quenched with 1M sodium 
carbonate (pH 10). Beta-hexaminidase activity was measured by the release of 4-
p-nitrophenol. This was determined using a spectrophotometer at an absorbance of 
405nm. Total beta-hexosaminidase activity was determined as previously 
described, with the exception that the cells were lysed with DMEM containing 0.1% 
Triton before addition of with p-nitrophenyl N-acetyl-beta-D-glucosamide in 0.1 M 
sodium citrate buffer (pH 4.5). Please note the remaining 150ul supernantant from 
each condition was left for 24 hours at 37°C with 5% CO2, and thereafter collected 
for mediator release analysis, which is described in section 2.5.  
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2.5 Mediator release assay 
 
Following the 24 hour degranulation assay (section 2.4), 100ul of each condition 
supernatant was placed in a sterile tube and centrifuged at 13,000 rpm at 4oC for 5 
minutes to pellet out any debris. The supernatant was carefully removed, taking 
care not to disturb the pellet and transferred to into a new sterile tube. Thereafter, 
the supernatant was centrifuged as before. Finally, the supernatant was carefully 
transferred into a cryovial, which was frozen at -80oC, and then later transferred 
into liquid nitrogen. Thereafter these samples were couriered on dry ice to Aushon 
Biosystems (US), where the Supernatants were assayed simultaneously for the 
presence of IL-4, IL-6, IL-10 MCP-1 and Mip-1α by using a multiplexing sandwich-
ELISA system.  
 
In brief, to quantitate cytokine and chemokine secretion, wells from a 96-well plate 
were spotted with capture antibodies specific for IL-4, IL-6, IL-10 MCP-1 and Mip-
1α, therefore allowing detection of multiple proteins in the same well. A volume of 
50µl culture supernatant was added and incubated with the addition of a cocktail of 
specific biotinylated detection antibodies. After this time a streptavidin- horseradish 
peroxidase (HRP) conjugate was added and the plate incubated. Detection of each 
analyte was achieved by using a chemiluminescent substrate solution and 
quantitated by using Search Light Array analysis software.  
 
2.6 Chemotaxis assay using transwell system 
 
This assay was performed using 24-well Transwell cell culture chambers with 
8.0µm pore size (Corning). RBL-CCR1 cells which had been transfected with Rgs1, 
TRB3 or negative control siRNA (Ambion), were sensitized with 25ng/ml anti-DNP 
IgE for 6 hours at 37°C with 5% CO2. After washing three times with x1 PBS, the 
sensitized cells (2x104cells) in 100 µl of DMEM containing 0.5% BSA were seeded 
in the upper compartment, and the lower compartment was filled with 600µl of the 
same medium containing 1ng/ml recombinant human Mip-1α and/or 10ng/ml DNP-
HSA. The cells were incubated for 100 minutes at 37°C with 5% CO2 followed by 
quantitation by hemocytometry. In brief, prior to the chemotaxis assay each 
transwell membrane (containing pores) was scratched to create a grid. Following 
the 100 minutes incubation period, the transwell membrane was fixed with 3.7% 
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PFA and then stained with Geimsa (Sigma) to identify mast cells. Mast cells 
attached to the bottom of each membrane and in the lower chamber of the 
transwell were counted using a hemocytometer. Figure 10 shows the setup of the 
transwell chemotaxis assay. 
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Figure 10.  A diagram depicting the transwell chemotaxis assay 
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2.7 Real time microscopy 
 
2.7.1 Chemotaxis pipette assay analysed by real time microscopy  
 
RBL-CCR1 cells were sensitised with or without 25 ng/ml anti-DNP IgE SPE 7 MAb 
(Sigma) and 2x104 cells were plated onto the centre of a Matek dish (with a glass 
cover slip insert) (Matek Corporation) overnight at 37oC with 5% CO2. Cells were 
washed three times with x1 PBS and were starved in Leibovitz-15 (L15) media 
(Invitrogen) containing 0.35% BSA (Sigma) in a heat chamber at 37oC for 1 hour 
before imaging. Cells were stimulated at 37oC, from a point source of LI5 media + 
0.35% BSA, containing PBS or 50 ng/ml recombinant human Mip-1α (R and D 
Systems) and/or 10ng/ml of antigen, DNP-HSA (Sigma) delivered with a Femotip II 
micropipette (Eppendorf). The Femotip II micropipette was lowered in focus into an 
area of the microscope's field of view with a micromanipulator (Eppendorf). The 
solution was dispersed from the Femotip by using a microinjection device 
(Eppendorf) at an optimized constant pressure of 15 hectopascal (hPA). When 
necessary, air bubbles were pushed out of the micropipette tip by applying a small 
pressure using a microinjection device. 
 
Cells were viewed on a Zeiss Axiovert 100M microscope using a 20x objective 
(Zeiss, UK). Phase Images of living cells were taken using a CCD camera coupled 
to an OpenLab-driven acquisition system (Improvision/Perkin Elmer) every 60 
seconds for one hour.  
 
2.7.2 Analysis of PI(3,4,5)P3 localisation in RBL-CCR1 cells in response to a 
Mip-1α  gradient using real time microscopy  
 
The PH domain of AKT tagged to GFP was used to detect PI(3,4,5)P3  localisation 
in RBL-CCR1 cells (GFP-AKT-RBL-CCR1). Stably expressing GFP-AKT-RBL-
CCR1 cells (kindly provided by Professor R. Richardson, JLC-
Biomedical/Biotechnology Research Institute, North Carolina Central University, 
Durham, NC, USA) were sensitised with or without 25 ng/ml anti-DNP IgE SPE 7 
MAb and 2x104 cells were plated onto the centre of Matek dish overnight at 37oC 
with 5% CO2. Cells were washed three times with x1 PBS and were starved in L15 
media containing 0.35% BSA in a heat chamber at 37oC for one hour before 
imaging. Cells were stimulated at 37oC, from a point source of LI5 media + 0.35% 
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BSA, containing PBS or 50ng/ml recombinant human Mip-1α and/or 10ng/ml DNP-
HSA delivered with a Femotip II micropipette (Eppendorf). Cells were viewed as 
previously described with the exception of a 40x and 63x oil objective (Zeiss, U.K). 
Fluorescent images of living GFP cells, acquired in the fluorescein isothiocyanate 
(FITC) channel, were taken using a CCD camera coupled to an OpenLab-driven 
acquisition system (Improvision/Perkin Elmer) every 60 seconds for one hour. 
 
2.8 Staining 
 
2.8.1 Phallotoxin 
  
Phalloidin is well established toxin for the detection of actin filaments and was used 
in the present study to detect F-actin in RBL-CCR1 cells 
 
2.8.1.1 Localisation of actin filaments in RBL-CCR1 cells 
 
RBL-CCR1 cells were sensitised with or without 25 ng/ml anti-DNP IgE SPE 7 MAb 
(Sigma) and 2x104 cells were plated onto the centre of Matek dish overnight at 
37oC with 5% CO2. After washing three times with x1 PBS, the cells were 
stimulated with 10 ng/ml DNP-HSA and/or 1ng/ml of recombinant human Mip-1α 
(R&D Systems) in Dulbecco’s modified Eagle’s medium containing 0.1% BSA at 
37oC with 5% CO2. The cells were washed three times with 1x PBS and fixed with 
4% Paraformaldehyde for 20 minutes at room temperature. After three successive 
washes with x1 PBS, cells were permeabilized with PBS containing 0.2% Triton X-
100 for 10 minutes at room temperature. Non-specific binding was blocked with 
PBS containing 0.5% BSA for one hour at room temperature. Thereafter, 
filamentous actin was detected by staining with appropriately diluted Rhodamine-
conjugated phalloidin in PBS (Molecular Probes, Invitrogen) for 30 minutes at room 
temperature in a humidified chamber. Finally, RBL-CCR1 cells were washed three 
times with x1 PBS and mounted in Vectorshield (Vector Labs). For phallodin details 
please see table 2 at the end of this chapter. 
 
Cells were viewed on a Zeiss 510 confocal microscope using a 40x oil objective 
(Zeiss). Fluorescent images of RBL–CCR1 cells, acquired in the rhodamine 
channel, were taken using a Zeiss-driven acquisition system. 
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2.8.2 Dyes 
 
Toluidine Blue is an aniline dye that is widely used to detect mast cells. Interaction 
of Toluidine Blue with mast cell granules causes the dye to undergo a 
metochromatic shift in colour from blue to deep purple.  
 
2.8.2.1 Identification of mast cells by Toluidine blue staining 
 
Frozen serial sections from allergic conjunctivitis mouse model 1 were washed 
three times in x1 PBS and incubated with 0.1% Toluidine Blue in 90% Ethanol for 
30 minutes at room temperature. Sections were washed five times in water and 
placed in a humidified chamber. Sections were viewed on an Olympus BX 
microscope using a 4x objective (Olympus Optical, UK). For counting purposes 
bright field images were taken using a CCD camera coupled to an Image Pro 
acquisition system. 
 
2.9. Immunocytochemistry  
 
2.9.1 Localisation of of WASP and CCR1 in RBL-CCR1 cells in response to a 
Mip-1α  gradient 
 
Chemotaxis pipette assay analysed by real time video phase microscopy was 
performed as described in section 2.3.1 with the exception that 1) cells were plated 
on Matek dishes with etched grid coverslips 2) non-sensitised CCR1-RBL cells 
were stimulated at 37oC from a point source of LI5 media + 0.35% BSA, containing 
PBS or 50ng/ml recombinant human Mip-1α delivered with a Femotip II 
micropipette and 3) phase images of living cells were taken with a 20x objective 
every 60 seconds for 20 minutes using a CCD camera coupled to an OpenLab-
driven acquisition system (Improvision/Perkin Elmer) . 
 
Thereafter the cells were washed three times with x1 PBS and fixed with 4% PFA 
(Sigma) for 20 minutes at room temperature. To remove any excess PFA, RBL-
CCR1 cells were washed three times with x1 PBS and then permeabilized with 
PBS containing 0.2% Triton X-100 for 10 minutes at room temperature. Non-
specific staining was blocked and F-actin staining was carried out simultaneously 
by incubating the cells with PBS containing 0.5% BSA and Alexa 647 conjugated 
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phalloidin (Molecular probes, Invitrogen) respectively, for one hour at room 
temperature in a humidified chamber.  CCR1 and WASP staining were conducted 
simultaneously as follows. Cells were incubated with primary antibodies mouse anti 
CCR1 (R and D systems) and rabbit anti WASP (Sigma) appropriately diluted in 
blocking agent at room temperature for 1 hour. In each experiment a parallel 
secondary antibody staining (no primary antibody) was included to control for 
background staining of the antibody. After 3 successive washes with x1 PBS, 
specific binding of primary antibodies appropriately diluted in PBS was detected by 
incubating with secondary antibodies, mouse anti rabbit Alexa 545 (Molecular 
probes, Invitrogen) and goat anti rabbit Alexa 488 (Molecular probes, Invitrogen) 
respectively for 1 hour at room temperature in a humidified chamber. Cells were 
washed three times in x1 PBS and mounted in 3.7% glycerol. For phallodin and 
antibody details please see table 2 at the end of this chapter. 
 
Cells were viewed on a Zeiss Axiovert 100M microscope using a 40x oil objective 
(Zeiss, UK). Fluorescent images of fixed cells, acquired in the FITC, rhodamine and 
Cy 5 channel, were taken using a CCD camera coupled to an OpenLab-driven 
acquisition system (Improvision/Perkin Elmer). 
 
2.10 Immunohistochemistry 
 
2.10.1 Staining of murine conjunctival paraffin sections: Detection of mMCP-5 
and CCR1 
 
Dr. Mark Obayashi provided paraffin sections 5µm thick of conjuctival tissue 
(enucleated eyes cut longitudinally) from allergic conjunctivitis murine model 2 
using BALB/c mice. Prior to immunohistochemical staining, these sections were 
deparaffinised with a series of xylene and ethanol washes as follows. Each section 
was placed in 4 containers, 5 minutes each in 100% xylene followed by 5 minutes 
each in 4 containers of 100% ethanol. Thereafter the sections were dipped 10 
times each in 95%, 90%, 80%, 70% and 50% ethanol. Finally the sections were 
dipped 10 times in water. This was repeated once more before the immuno-
staining procedure.  
 
Primary antibody anti mMCP-5, kindly provided by Dr. Rick Stevens, Harvard 
University, Boston, MA, USA, detects conjuctival mast cells characterised by the 
expression of mMCP-5. The use of this antibody required an antigen retrival 
 64 
procedure that was conducted prior to immunostaining as follows. Slides were 
placed in a beaker containing x1 Cytomation retrival (Dako) solution at room 
temperature for 5 minutes. The beaker was then placed in a water bath at 95oC for 
20 minutes, after which point was removed and allowed to reach room 
temperature.  This procedure aims to improve staining by modifying the molecular 
conformation of ‘target’ proteins through an exposure of slide-mounted specimen 
material to a heated buffer solution.  
 
The slides were washed three times in x1 PBS and the section circled with a wax 
pen (Dako). To reduce background auto-fluorescence the sections were then 
treated with Image T (Dako) for 30 minutes in a humidified chamber.  Non-specific 
staining was blocked with PBS containing 5% normal goat serum and 1% BSA for 
1 hour at room temperature in a humidified chamber. Mast cells were detected by 
incubating with anti-mMCP-5 antibody appropriately diluted in blocking agent 
overnight at 4oC in a humidified chamber. After three successive washes with x1 
PBS the sections were incubated with secondary antibody goat anti rabbit Alexa 
555 (Molecular probes, Invitrogen) appropriately dilute in 1x PBS for 1 hour at room 
temperature in a humidified chamber. After washing three times with x1 PBS 
sections were incubated with primary antibody mouse anti CCR1 appropriately 
diluted in blocking solution for 1 hour at room temperature in a humidified chamber. 
Thereafter sections were washed three times with x1 PBS and incubated with 
secondary antibody goat anti mouse Alexa 488 appropriately diluted in PBS for 1 
hour at room temperature in a humidified chamber. Sections were washed three 
times with x1 PBS and mounted in Vectorshield mounting agent (Vector Labs). In 
each experiment a parallel secondary antibody staining (no primary antibody) was 
included to control for background staining of the antibody. For antibody details 
please see table 2 at the end of this chapter. 
 
For counting purposes sections were viewed on an Olympus BX microscope using 
a 40x oil objective (Olympus Optical, UK). Fluorescent images acquired in the FITC 
and rhodamine channel, were taken using a CDD camera coupled to an Image Pro 
acquisition system. 
 
2.10.2 Staining of conjunctival frozen sections: Detection of WASP and actin  
 
Frozen sections from allergic conjunctivitis mouse model 1 were washed three 
times in x1 PBS and then treated with sodium borohydride (Sigma) to reduce 
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background autofluorescence. Non-specific staining was blocked and F-actin 
detection was carried out simultaneously by incubating with PBS containing 0.5% 
BSA and rhodamine-conjugated phalloidin respectively, for one hour at room 
temperature in a humidified chamber. WASP staining was detected by incubating 
the sections with a primary antibody, rabbit anti WASP (Sigma) diluted in blocking 
agent overnight at 4oC in a humidified chamber. Thereafter the sections were 
washed three times in x1 PBS and incubated with secondary antibody goat anti 
rabbit Alexa 488 (Molecular probes, Invitrogen) appropriately diluted in PBS for 1 
hour at room temperature. Sections were washed three times with x1 PBS and 
mounted in Vectorshield mounting agent (Vector Labs). In each experiment a 
parallel secondary antibody staining (no primary antibody) was included to control 
for background staining of the antibody. For phallodin and antibody details please 
see table 2 at the end of this chapter. 
 
Sections were viewed on a Leica confocal SP2 microscope using a 63x oil 
objective. Fluorescent images acquired in the FITC, rhodamine channel, were 
taken using a Leica-driven acquisition system. 
 
2.11 Analysis of Microscopy 
 
2.11.1 Quantification of Migration   
 
On completion of real time movies, the outline of each cell was manually traced for 
each time point using Open Labs Software. This software automatically generated 
a centre point or centroid for each cell (Figure 11).  
 
The centroid is the average of the x and y coordinates of all of the pixels in the 
trace. These coordinates were converted into micro metres at the beginning of 
each manual trace, and imported into Image J chemotaxis and migration tool 
software, where a migration plot was generated. From this migration plot several 
parameters were calculated, including accumulated distance, Euclidean distance, 
velocity and directionality (Figure 12). 
 
The accumulated distance is the cell path from the initial time point (ti) to the final 
time point (tf), where as the Euclidean distance is the straight line distance from ti 
to tf (Figure 13).  The directionality of the cell was calculated by the formula: 
Euclidean distance/ accumulated distance. 
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Figure 11. Open Lab snapshots showing the outline of each cell at 
timepoints t1 (A) and t2 (B) with its corresponding centroid x. 
 
 67 
                
 
                          
              
                               
                                
 
 
Figure 12. Image J snapshots showing a migration plot with its 
corresponding parameters. Cell traces were arranged to show their 
origins at x=y=0.  
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Figure 13. Accumulated and Euclidean distance, where ti represents initial 
time and tf, final time.  
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2.11.2 Quantification of Toluidine Blue positive murine conjunctival mast 
cells 
 
Following Toluidine Blue staining of mast cells, all images were analyzed by the 
Image J program. Toluidine Blue positive mast cells were counted in the forniceal 
region of the conjunctivia marked G and AG (Figure 14) to a stromal depth of 
200µm and 500µm respectively parallel to the basement membrane of the surface 
epithelium. Regions, G and AG, were of an equal size and this was determined 
using the Image J program. The results were expressed as the mean count of cells 
± standard error mean (SEM) per mm2.  
 
 
2.11.3 Quantification of mMCP5 and CCR1 positive murine conjunctival mast 
cells 
 
Following immunohistochemistry staining of mMCP-5 and CCR1, all images were 
analyzed by Image Pro acquisition software system using a FITC channel to detect 
mMCP-5 and a TRTCI channel to detect CCR1. Thereafter, mMCP-5 and CCR1 
positive mast cells were counted using a grid (0.1 mm2). The grid was placed 100 
µm parallel to the basement membrane of the surface epithelium in the area 
marked G. (Figure 15). The number of immunopositive cells were determined and 
results were expressed as the mean count of cells ± SEM per 0.1 mm2. 
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Figure 14. Schematic representation of the conjunctivia showing the location of the 
chemokine gradient, G, and the location away from the chemokine gradient, AG, 
the areas in which mast cells were counted. 
 
 
 
 
 
 
 
 
Figure 15. Schematic representation of the conjunctivia showing the location of the 
chemokine gradient, G, the area in which mast cells were counted.  
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2.12 RT-PCR 
 
2.12.1 RNA isolation 
 
Total RNA was extracted from cells using the RNeasy kit (Qiagen cat.74104) as 
per the manufacturer’s instructions. Briefly, cells grown on 6- well plates (< 1x107) 
were lysed directly by adding 350ul lysis buffer containing β mercapto-ethanol 
(10µl/ml, Sigma-Aldrich). The resulting suspension was vortexed for 1 minute and 
immediately stored at -80oC for future use or subjected to RNA isolation. The 
samples were then applied to the RNeasy Mini spin column, contaminants washed 
away, and RNA eluted in 20-30µl of RNAse free water. The concentration of RNA 
was determined using a spectrophotometer. RNA samples were stored at -80oC 
and thawed on ice before use. 
  
2.12.2 Reverse Transcription (RT) 
 
RNA was reverse transcribed into cDNA using the QuantiTect Reverse 
Transcription Kit (Qiagen cat 205311), which comprises elimination of genomic 
DNA and reverse transcription. Briefly, 1µg of purified RNA sample was incubated 
in gDNA Wipeout buffer for 2 minutes at 42oC to eliminate any genomic DNA 
contamination. Thereafter, the reverse transcription reaction was performed (as per 
kit instructions) in a final volume of 20µl containing a master mix of RNA, 
Quantiscript Reverse Transcriptase, RNase inhibitor, dNTPs and Mg2+ mix, oligo-dT 
and RNase free water.  The mixture was incubated at 42oC for 15 minutes, 95oC for 
5 minutes (to inactivate the Quantiscript Reverse Transcriptase) and 4oC for 5 
minutes in a thermalcycler. Following first strand synthesis reaction, a portion of the 
reverse transcription reaction was immediately transferred into another tube for the 
3 Real Time Quantitative PCR (qPCR) reaction. 
 
2.12.3 qPCR 
 
Real time quantification of DNA was carried out using the QuantiTect SYBR green 
PCR kit (Qiagen cat 204143) as per manufacturers instructions. Primer sequences 
were obtained from Applied Biosystems and reconstituted to a concentration of 
50µM in buffer. Briefly, the amplification and detection was performed in a final 
reaction volume of 25µl containing 2x SYBR Green master mix, (master mix 
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contained intercalating SYBR Green I dye that fluoresces when bound to ds DNA, 
Taq DNA polymerase, KCL, (NH4)2SO4 and ROX dye), 0.5µM of primer, 50ng 
copy DNA (cDNA) and RNase water. The mixture was incubated at 94°C for 15 
seconds, 55oC for 30 seconds, 72oC for 30 seconds for 40 cycles and for 95oC for 
15 seconds, 60oC for 30 seconds and 95oC for 15 seconds for 1 cycle. An 
annealing temperature of 52°C was used for all primers. All data were normalized 
to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression (Applied 
Biosystems). 
 
 
2.12.4 Analysis of qPCR 
 
Cycle threshold (Ct) values were recorded and the data was normalised by running 
each sample against GAPDH, as a housekeeping gene, with the relative gene 
expression calculated using the ∆∆Ct method as described below: 
∆= change 
∆Ct = Ct target gene - Ct housekeeping gene 
  ∆∆Ct = ∆Ct sample - ∆Ct unstimulated 
   
2.13 Western Blotting  
 
2.13.1 Protein Isolation  
 
Following experimental conditions, cytoplasmic and nuclear proteins were 
extracted from cells by using Mammalian Protein Extraction Reagent (M-PER) 
(Thermo Scientific) as follows. Adherent cells were washed three times with x1 cold 
PBS. 50µl of cold M-PER containing a protease inhibitor cocktail (Cat no: P8340, 
Sigma-Aldrich)-10 µl per ml of lysis buffer, Dithiothreitol (DTT) 0.5 mM, Phenyl 
Methyl Sulfonyl Fluoride (PMSF) 1mM and Sodium Orthovanadate 3mM was 
added to adherent cells and scraped rapidly. The resulting cell lysate was pipetted 
thoroughly and transferred to a microfuge tube. The samples were centrifuged 
twice at 14,000rpm for 10 minutes to pellet the cell debris and the supernatant 
containing the proteins of interest was collected. 
 
Protein concentration was estimated using a Pierce bicinchoninic acid (BCA) 
Protein Assay Kit (Thermo Scientific). This method relies the reduction of Cu2+ to 
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Cu1+ by protein in an alkaline medium. The resulting purple-colored reaction 
product is detected by a reagent containing BCA. 
 
In a 96 well plate 10ul of protein or standard sample (diluted 1:4 in PBS) was 
added to 200µl of BCA reagent. The samples were mixed thoroughly on a plate 
shaker for 30 seconds and incubated at 37oC for 15 minutes. The absorbance of 
the resulting purple solution was then measured at 562nm using a 
spectrophotometer.  To ensure equal loading of protein onto the electrophoresis gel 
protein volumes were adjusted according to relative absorbance readings. To 
ensure for further normalisation of amount of protein loaded, a loading control of β-
actin (Abcam) was also used in each experiment. All protein samples were stored 
at -80oC for future use. 
 
2.13.2 Protein Gel Electrophoresis and transfer 
 
The NuPAGE gels and buffer systems from Invitrogen were used for protein gel 
electrphoresis . In this study 10% Bis-Tris gels (NP0315, Invitrogen) were used in 
combination with the MOPS SDS running buffer (NP0001, Invitrogen, UK) for 
resolution of proteins with a molecular weight between 20 and 60 kDa. All gels 
were of 1.5mm thickness containing 15 wells, capable of holding 30µl of solution 
and prepared as follows. 
 
30 µl of loading sample was prepared with 9 µl of loading buffer (LDS 4X),3 µl of 
reducing agent (10X),  and a maximum of 18 µl of protein sample. As previously 
mentioned, in order to load equal amounts of protein, this volume of 18 µl was 
adjusted based on the absorption readings (from BCA assay) and the remaining 
volume made up with water. To denature the protein the loading samples were 
boiled at 80oC for 10 minutes. The pre-casted gels were washed in distilled water 
and fitted into the XCell SureLock™ Mini-Cell mini vertical electrophoresis system 
(Invitrogen). Thereafter, the chamber was locked to generate a watertight 
compartment for the gel and the electrodes. Into this compartment, working 
concentration running buffer and working concentration MOPS running buffer (for 
bis-tris gels Cat no: NP0001 with antioxidant (500 µl/ 200mls buffer) was added. 
The protein ladder and samples were loaded into the gels and were run at 180V for 
50 minutes.  
Before protein transfer, Poly VinyliDene Fluoride (PVDF) membranes (Hybond-P) 
were pre-treated with methanol for 5 minutes, washed in distilled water and 
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equilibrated in working concentration transfer buffer (Invitogen). Protein transfer 
was conducted at 35V for 90 minutes using the XCell SureLock™ Mini-Cell mini 
transfer set up (Invitrogen). 
 
2.13.3 Immunoblotting 
 
Membranes were blocked in tris-buffered saline  (TBS) +0.1% Tween-20 with 5% 
BSA at room temperature for 1 hour. Primary antibodies were diluted in blocking 
buffer and incubated overnight at 4oC. The membrane was washed 3 times in TBS 
+ 0.1% Tween-20 for 15 minutes at room temperature and incubated with 
secondary antibody conjugated to HRP (Jackson Laboratories) for 1 hour at room 
temperature. After three successive washes in TBS + 0.1% Tween-20 for 15 
minutes and twice with TBS, the blot was visualised with enhanced luminol-based 
chemiluminescent (ECL) advanced detection kit (Thermo scientific). For antibody 
details please see table 2 at the end of this chapter. 
 
 
2.14 Statistical analysis of results 
 
For the present study all statistics were determined using the student T-test, which 
assesses whether the means of two groups are statistically different from each 
other when measuring one variable. 
 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 76 
Chapter 3. 
The effect of FcεRI and CCR1 co-engagement on RBL-CCR1 cell motility 
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3. The effect of FcεRI and CCR1 co-engagement on RBL-CCR1 cell motility 
 
3.1 Introduction and hypothesis 
 
Mip-1α was first observed as a histamine releasing factor in mouse peritoneal mast 
cells (Alam et al., 1992), though these in vitro experiments showed that Mip-1α was 
a markedly less effective histamine releasing factor than IgE/antigen. The role of 
Mip-1α in mast cell physiology in vivo is less well defined having been implicated in 
various mast cell functions including activation, differentiation and homing (Ono et 
al., 2003). Miyazaki and co-workers (2005) observed the rapid expression of Mip-
1α in resident mononuclear cells following allergen challenge in a murine allergic 
conjunctivitis model. Subsequent studies by Toda and co-workers (2004) 
demonstrated that co-stimulation of RBL-CCR1 cells in vitro by Mip-1α and 
IgE/antigen synergistically enhanced degranulation and inhibited Mip-1α mediated 
chemotaxis. This data suggests that while CCR1 and FcεRI engagement is 
essential for optimal activation and degranulation of mast cells, it also affects other 
mast cell events such as chemotaxis. 
 
As displayed by several cell types, the migration of cells towards chemoattractants 
during biological processes requires the reorganisation of the actin cytoskeleton, 
along with defined localisation patterns for cell motility components such as 
PI(3,4,5)P3 and chemokine receptors. Mast cells accumulate at sites of 
inflammation during an allergic response, however, at present, the mechanisms 
underlying mast cell migration in vitro and in vivo are poorly understood. A 
continued effort to further elucidate the mechanisms involved during mast cell 
migration will help identify alternative anti-inflammatory therapies. 
 
Based on current knowledge, I hypothesise that CCR1 engagement by Mip-1α and 
simultaneous engagement of CCR1 and FcεR1 by Mip-1α and IgE/antigen 
respectively, in RBL-CCR1 cells in vitro, can alter cell morphology, actin 
cytoskeleton reorganisation and the localisation of cell motility components 
pertinent for cell migration.  
 
To address this hypothesis, the specific aims of this chapter were as follows: - 
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1. To analyse actin reorganisation in RBL-CCR1 cells following co-stimulation 
with Mip-1α and IgE/antigen.  
2. To analyse by real time microscopy the behaviour and morphology of RBL-
CCR1 cells migrating towards a Mip-1α gradient and test the effects of IgE 
receptor cross-linking. 
3. To analyse the localisation of PI(3,4,5)P3, CCR1 and actin in RBL-CCR1 
cells migrating towards Mip-1α gradient. 
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3.2 Results 
 
3.2.1 Actin reorganisation in RBL-CCR1 cells induced by homogeneous co-
stimulation by Mip-1α  and IgE/antigen 
 
The actin cytoskeleton is a highly dynamic network, and rearrangement of the actin 
cytoskeleton is a crucial component of cell motility. Membrane ruffling and 
lamellipodia formation as a result of actin polymerisation are fundamental 
components of the cytoskeleton rearrangements required for cell movement. In a 
previous study, Toda et al (2004) showed that FcεRI engagement has an inhibitory 
effect on Mip-1α-induced chemotaxis, suggesting that co-stimulation with antigen 
and Mip-1α affect reorganisation of actin cytoskeleton of RBL-CCR1 cells. In order 
to examine the effects of co-stimulation of CCR1 and FcεRI by Mip-1α and 
IgE/antigen respectively on actin reorganisation in RBL-CCR1 cells, RBL-
CCR1cells were stimulated with 1ng/ml of Mip-1α (optimal condition for chemotaxis 
established by Toda et al., 2004) and 10ng/ml of DNP-HSA (antigen), thereafter 
actin filaments were visualized with TRITC-conjugated phallodin. The data are 
representative of 4 separate experiments with more than 40 cells analysed in each.  
 
Unstimulated RBL-CCR1 cells are pod shaped elongated cells with strong, evenly 
distributed actin expression (Figure 16A). RBL-CCR1 cells homogeneously 
stimulated with 1ng/ml of Mip-1α dramatically induced actin rich membrane ruffles 
within one minute (Figure 16B). Moreover, cells stimulated with 1 ng/ml of Mip-1α 
for five minutes showed further large distinct actin rich membrane ruffles (as 
indicated by white arrow), a flattened morphology adopting a polarized phenotype 
with actin rich lamellipodia (as indicated by yellow arrow) at the leading edge of the 
cell (Figure 16C). Interestingly, cells sensitized with IgE mAb and co-stimulated 
with Mip-1α and IgE/antigen for one minute and five minutes exhibited few or no 
membrane ruffles (Figures 16D and 16E respectively) compared with Mip-1α 
stimulated cells. Cells sensitized with IgE alone for five minutes exhibited intense 
cortical actin and few membrane ruffles compared with Mip-1α stimulated cells 
(Figure 16F).  
 
These results indicate that FcεR1 engagement alters actin cytoskeleton 
reorganisation of RBL-2H3 cells. It inhibits pronounced Mip-1α induced membrane 
ruffling response and thereby contributes to the inhibition of Mip-1α induced 
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chemotaxis of RBL-CCR1 cells.  
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Figure 16. Rhodamine phalloidin-stained RBL-CCR1 cells showing F-actin 
distribution (red) and decreased membrane ruffling following stimulation 
with Mip-1α and co-stimulation with Mip-1α + IgE/Antigen. (A) Unstimulated 
RBL-CCR1. RBL-CCR1 cells were stimulated with Mip1a for (B) 1 minute or (C) 
5 minutes; or Mip-1α + IgE/antigen (D) 1 minute or (E) 5 minutes; and (F) IgE 
for 5 minutes. Mip-1α  stimulated RBL-CCR1 cells exhibit extensive membrane 
ruffling ( as indicated by white arrow) and lamellipodia ( as indicated by yellow 
arrow) as compared to co-stimulated cells. The data are representative of 4 
separate experiments with more than 40 cells analysed in each experiment. 
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3.2.2 Behavioural responses of RBL-CCR1 Cells to gradients of Mip-1α  and 
IgE/antigen co-stimulation using real time microscopy 
 
Chemotaxis is the directional movement of cells within a chemokine gradient. Actin 
polymerisation and membrane ruffling occur at the leading edge of chemotactic 
cells, resulting in cell polarisation and facilitating appropriate directional movement 
up a chemotactic gradient. In order to acquire a detailed understanding of the 
mechanisms involved in mast cell chemotaxis, the initial starting point for many 
investigations of cell motility is to characterise the behaviour of cells.  
 
Toda et al., (2004) demonstrated using a chemotaxis transwell system (standard 
Boyden chamber) that Mip-1α induced RBL-CCR1 chemotaxis and inhibition of 
Mip-1α induced chemotaxis was a result of FcεR1 and CCR1 co-engagement. 
However, the standard Boyden chamber only determines an end point of cell 
motility and does not allow for the observation of cell movement to characterize the 
motility pattern. Therefore, a series of experiments were conducted to characterise 
the behaviour of RBL- CCR1 cells towards a micropipette (creating a gradient), 
containing either DMEM media supplemented with PBS; Mip-1α; both Mip-1α and 
antigen (in this case RBL-CCR1 cells were sensitized with IgE MAb); antigen; Mip-
1α and antigen and Mip-1α  (however in this case RBL-CCR1 cells were sensitized 
with IgE MAb). For each experiment 10-15 cells per condition were recorded every 
minute for one hour using real time microscopy. Following this recording, the 
results were analysed in Image J using the chemotaxis tool that give migrational 
plot, directionality, Euclidean distance, accumulated distance and velocity for each 
condition. The data are representative of five separate movies for each condition 
with at least 10-15 cells analysed in each movie.  
 
In the experiment shown in Figure 17, a micropipette (as indicated by a yellow *) 
filled with DMEM plus PBS (DMEM/PBS) is positioned within a field of RBL-CCR1 
cells. Figures 17A-E are representative of 5 independent time-lapse videos where 
the red arrow shows the movement of a representative cell towards DMEM/PBS 
over a period of 1 hour Figure 17A shows at the onset of the experiment RBL-
CCR1 cells are elongated pod shaped cells. Cells exposed to the micropipette 
gradient for five minutes (Figure 17B), ten minutes (Figure 17C), 30 minutes 
(Figure 17D) and 60 minutes (Figure 17E) were unresponsive, displaying no 
membrane ruffling or cell polarization. Figure 17F shows a migrational plot 
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representing the pathway undertaken by each RBL-2H3 cell in response to the 
micropipette gradient in one hour, where the x and y axis represent the distance in 
um. The plot indicates the cells remain stationary, the cells seem to ‘wiggle’ on the 
spot in response to DMEM/PBS gradient and their endpoint surrounding the x-y 
intercept, thereby inferring limited motility. A movie of the experiment described in 
this figure is available on CD1 movie file name, DMEMMedia.  
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Figure 17. RBL-CCR1 cells do not migrate towards PBS/DMEM. 
Time-lapse video microscopy frames of RBL-CCR1 motility towards a 
micropipette tip (*) containing PBS/DMEM media alone at timepoints (A) 0, (B) 5 
minutes, (C) 10 minutes, (D) 30 minutes, (E) 60 minutes. Figures 2A-E are 
representative of 5 independent time-lapse videos where the red arrow shows 
the movement of a representative cell towards PBS/DMEM over a period of 1 
hour.  (F) RBL-CCR1 cell migrational plot depicting the path of each cell every 
minute for a period of 1hour towards a micropipette tip containing media alone. 
Cell traces were arranged to show their origins at x=y=0. Migration plot shown 
in Figure 2F is representative of 5 independent experiments 
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In the experiment shown in Figure 18, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α is positioned within a field of RBL-2H3 cells. Figures 
18A-E are representative of 5 independent time-lapse videos where the red arrow 
shows the movement of a representative cell towards Mip-1α over a period of 1 
hour.  The cells appeared unresponsive and elongated in shape at the onset 
(Figure 18A), however within five minutes RBL-2H3 cells showed intense 
membrane ruffling (Figure 18B) when exposed to the micropipette Mip-1α gradient. 
By ten minutes, RBL-CCR1 cells displayed large membrane ruffles at their leading 
edge, formed lamellipodia and were polarised (Figure 18C). By 30 minutes (Figure 
18D) and 60 minutes (Figure 18E) RBL-2H3 cells maintained a polarized 
phenotype and were able to chemotax toward the micropipette Mip-1α gradient. 
The migrational plot in Figure 18F indicates RBL-CCR1 cells moved from 0-20+ um 
in response to a Mip-1α gradient for one hour. A movie of the experiment described 
in this figure is available on CD1 movie file name, Mip1a.  
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Figure 18. RBL-CCR1 cells chemotax towards Mip-1α. 
Time-lapse video microscopy frames of RBL-CCR1 motility towards a 
micropipette tip (*) containing Mip-1α at timepoints (A) 0 ,(B) 5 minutes, (C) 10 
minutes, (D) 30 minutes, (E) 60 minutes. Figures 2A-E are representative of 5 
independent time-lapse videos where the red arrow shows the movement of a 
representative cell towards Mip-1α over a period of 1 hour.  (F) RBL-CCR1 cell 
migration plot depicting the path of each cell every minute for a period of 1hour 
towards a micropipette tip containing Mip-1α alone. Cell traces were arranged 
to show their origins at x=y=0. Migration plot shown in Figure 2F is 
representative of 5 independent experiments 
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In the experiment shown in Figure 19, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α and 10ng/ml of antigen is positioned within a field of 
RBL-CCR1 cells sensitized with IgE MAb. Figures 19A-E are representative of 5 
independent time-lapse videos where the red arrow shows the movement of a 
representative IgE sensitised cell towards Mip-1α and antigen over a period of 1 
hour. The cells appeared unresponsive and elongated in shape at the onset (Figure 
19A). By five minutes, RBL-CCR1 cells remained unresponsive towards the Mip-1α 
and antigen micropipette gradient (Figure 19B). Moreover, further exposure at ten 
minutes (Figure 19C), 30 minutes (Figure 19D) and 60 minutes (Figure 19E) 
rendered the cells inactive, with no obvious morphological changes, cell 
polarization or chemotaxis. Figure 19F shows a migrational plot representing the 
pathway undertaken by each RBL-CCR1 cell sensitized with IgE MAb in response 
to the micropipette Mip-1α and antigen gradient in one hour. The pathway of the 
cells end mostly at the intercept of the x and y-axis thereby showing limited 
movement. A movie of the experiment described in this figure is available on CD1 
movie file name, Mip1a and IgEAntigen.  
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Figure 19. RBL-CCR1 cells pre-sensitised with IgE do not chemotax 
towards Mip-1α and antigen. 
Time-lapse video microscopy frames of IgE sensitised RBL-CCR1 motility 
towards a micropipette tip (*) containing Mip-1α and antigen at timepoints (A) 0 
,(B) 5 minutes, (C) 10 minutes, (D) 30 minutes, (E) 60 minutes. Figures 2A-E 
are representative of 5 independent time-lapse videos where the red arrow 
shows the movement of a representative IgE pre-sensitised cell towards Mip-1α 
and antigen over a period of 1 hour. (F) RBL-CCR1 cell migration plot depicting 
the path of each cell every minute for a period of 1hour towards a micropipette 
tip containing Mip-1α and antigen alone. Cell traces were arranged to show 
their origins at x=y=0. Migration plot shown in Figure 2F is representative of 5 
independent experiments 
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In the experiment shown in Figure 20, a micropipette (*) filled with 10ng/ml of 
antigen is positioned within a field of RBL-CCR1 cells. The cells appeared 
unresponsive and elongated in shape at the onset (Figure 20A). At five minutes 
exposure RBL-CCR1 cells showed no obvious morphological changes towards the 
micropipette antigen gradient (Figure 20B). Further exposure to the micropipette 
antigen gradient at ten minutes (Figure 20C), 30 minutes (Figure 20D) and 60 
minutes (Figure 20E) did not induce membrane ruffles or cell polarization. Figure 
20F shows a migrational plot representing the pathway undertaken by each RBL-
CCR1 cell in response to the micropipette antigen gradient in one hour. RBL-CCR1 
cells endpoints surround the x-y intercept, thereby showing limited motility towards 
the micropipette antigen gradient. A movie of the experiment described in this 
figure is available on CD1 movie file name, Antigen.  
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Figure 20. RBL-CCR1 cells do not migrate towards antigen. 
Time-lapse video microscopy frames of RBL-CCR1 motilty towards a 
micropipette tip (*) containing antigen at timepoints (A) 0, (B) 5 minutes, (C) 10 
minutes, (D) 30 minutes, (E) 60 minutes. (F) RBL-CCR1 cell migration plot 
depicting the path of each cell every minute for a period of 1hour towards a 
micropipette tip containing antigen alone. Cell traces were arranged to show 
their origins at x=y=0. Migration plot shown in Figure 2F is representative of 5 
independent experiments 
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In the experiment shown in Figure 21, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α and 10ng/ml of antigen is positioned within a field of 
RBL-CCR1 cells. The cells appeared unresponsive and elongated in shape at the 
onset (Figure 21A). However, within five minutes exposure to the micropipette Mip-
1α and antigen gradient the cells dramatically induced large membrane ruffles 
(Figure 21B). Further exposure to the micropipette Mip-1α and antigen gradient at 
ten minutes (Figure 21C), 30 minutes (Figure 21D) and 60 minutes (Figure 21E) 
induced large distinct membrane ruffles, lamellipodia formation, cell polarization 
and chemotaxis of these cells towards the gradient. Figure 21F shows a 
migrational plot representing the pathway undertaken by each RBL-CCR1 cell in 
response to the micropipette Mip-1α and antigen gradient in one hour. The cells 
are able to chemotax upto 40um towards the Mip-1α and antigen gradient. A movie 
of the experiment described in this figure is available on CD1 movie file name, Mip-
1a and antigen. 
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Figure 21. RBL-CCR1 chemotax towards Mip-1α and antigen. 
Time-lapse video microscopy frames of RBL-CCR1 motilty towards a 
micropipette tip (*) containing Mip-1α and antigen at timepoints (A) 0, (B) 5 
minutes, (C) 10 minutes, (D) 30 minutes, (E) 60 minutes.(F) RBL-CCR1 cell 
migration plot depicting the path of each cell every minute for a period of 1hour 
towards a micropipette tip containing Mip-1α and antigen alone. Cell traces 
were arranged to show their origins at x=y=0. Migration plot shown in Figure 2F 
is representative of 5 independent experiments 
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In the experiment shown in Figure 22, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α is positioned within a field of RBL-CCR1 cells 
sensitised with IgE MAb. The cells appeared unresponsive and elongated in shape 
at the onset (Figure 22A).  However, within five minutes RBL-CCR1 cells showed a 
varied membrane ruffling response (Figure 22B) when exposed to the micropipette 
Mip-1α gradient. At ten minutes (Figure 22C) 30 minutes (Figure 22D) and 60 
minutes (Figure 22E) exposure to the micropipette Mip-1α gradient most, but not all 
cells were able to form lamellipodia and chemotax towards the gradient. Figure 22F 
shows a migrational plot representing the pathway undertaken by each RBL-CCR1 
cell sensitised with IgE MAb in response to the micropipette Mip-1α gradient in one 
hour. RBL-CCR1 cells were able to chemotax towards the Mip-1α gradient, 
however their motility and morphological response was variable. A movie of the 
experiment described in this figure is available on CD1 movie file name, Mip-1a 
plus IgE.  
 
These results indicate that RBL-CCR1 cells induce large membrane ruffles and are 
able to chemotax towards a Mip-1α gradient. However, co-engagement of FcεR1 
and CCR1 have profound effects on cell morphology and inhibit chemotaxis.  
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Figure 22. RBL-CCR1 sensitised with IgE chemotax towards Mip-1α. 
Time-lapse video microscopy frames of RBL-CCR1 motilty towards a 
micropipette tip (*) containing Mip-1α at timepoints (A) 0, (B) 5 minutes, (C) 10 
minutes, (D) 30 minutes, (E) 60 minutes. (F) RBL-CCR1 cell migration plot 
depicting the path of each cell every minute for a period of 1hour towards a 
micropipette tip containing Mip-1α. Cell traces were arranged to show their 
origins at x=y=0. Migration plot shown in Figure 2F is representative of 5 
independent experiments 
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Figures 23A-E  and table 3 show the analysis of cell motility parameters by Image J 
following each movie. The parameters analysed were: 
 
1) Directionality- a value for the directionality of motion and is calculated using the 
following equation 
 
          Directionality =  Euclidean distance/ accumulated distance 
                                  
 
2) Euclidean distance- the distance travelled from initial time (ti) to final time (tf). 
Figure 12 in chapter 2 materials and methods .  
 
3) Accumulated distance- the straight line distance from intial time (ti) to final time 
(tf). See Figure 12 in chapter 2 materials and methods .  
 
 
4) Velocity - speed 
 
In Figure 23A, in the presence of a Mip-1α gradient the directionality of RBL-CCR1 
cells was significantly up-regulated in comparison to DMEM/PBS gradient.  
Interestingly, there was a significant decrease in directionality of IgE sensitised 
RBL-CCR1 cells in response to a Mip-1α and antigen gradient in comparison to 
RBL-CCR1 cells exposed to a DMEM /PBS gradient. In Figure 23B the Euclidean 
distance of RBL-CCR1 cells in response to a Mip-1α was significantly greater that 
that observed by DMEM /PBS gradient. However, there was a significant decrease 
in directionality of IgE sensitised RBL-CCR1 cells in response to a Mip-1α and 
antigen gradient in comparison to RBL-CCR1 cells exposed to a DMEM/PBS 
gradient. In Figure 23C and 23D the accumulated distance and velocity 
respectively of RBL-CCR1 cells were not affected by a Mip-1α gradient or any 
other conditions applied. These results indicate that a Mip-1α gradient stimulates 
RBL-CCR1 cell polarisation (directionality) and this effect is not inhibited by antigen 
or IgE alone, but by the combination of Mip-1α and IgE plus antigen. Although, Mip-
1α or any other combinations do not affect cell speed, Mip-1α polarises RBL-CCR1 
cells which is the reason why it increases chemotaxis. 
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Figure 23. Motilty parameters of RBL-CCR1 cells. 
Motility parameters were determined using Image J. Figures 8A-D show the (A) 
Directionality, (B) Euclidean distance, (C) Accumulated distance and (D) velocity 
of RBL-CCR1 cells. The data represent the Mean +/- standard error mean 
(SEM) of five experiments where *, p <0.001, using the student T-test. 
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 Media 
alone 
Mip-
1α  
alone 
Mip1α+IgE/Antigen Antigen 
alone 
Mip-1α  
+ 
Antigen 
Mip-1α  
+ IgE 
Directionality  
0.042 
+/- 
0.004 
SEM 
 
 
0.138 
+/- 
0.018 
SEM 
 
 
0.032 
+/- 
0.003 SEM 
 
 
 
0.032 
+/- 
0.003 
SEM 
 
 
0.158 
+/- 
0.014 
SEM 
 
 
0.1025 
+/- 
0.009 
SEM 
 
Euclidean 
distance 
(um) 
 
4.578 
+/- 
1.153 
SEM 
 
 
11.878 
+/- 
1.423 
SEM 
 
 
4.398 
+/- 
0.673 SEM 
 
 
4.366 
+/- 
0.684 
SEM 
 
 
18.916 
+/- 
1.057 
SEM 
 
 
11.757 
+/- 
1.428 
SEM 
 
Accumulated 
distance 
(um) 
 
104.584 
+/- 
21.199 
SEM 
 
 
95.37 
+/- 
13.792 
SEM 
 
 
132.186 
+/- 
8.411 SEM 
 
 
130.6 
+/- 
10.279 
SEM 
 
 
127.424 
+/- 
10.909 
SEM 
 
 
113.252 
+/- 
5.940 
SEM 
 
Velocity 
(um/minute) 
 
1.588 
+/- 
0.471 
SEM 
 
 
1.62 
+/- 
0.231 
SEM 
 
 
2.24 
+/- 
0.142 SEM 
 
 
2.028 
+/- 
0.313 
SEM 
 
 
2.16 
+/- 
0.183 
SEM 
 
 
1.92 
+/- 
0.101 
SEM 
 
Table 3. Summary of cellular effects (motility parameters) from the  
pipette assays of RBL-CCR1 cells  
 
 
. 
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3.2.3 Localisation of PI(3,4,5) P3 in RBL-CCR1 cells in response to a Mip-1α   
gradient 
 
The lipid product PI(3,4,5)P3, is a well known candidate for establishing cell 
polarity. The PH-AKT-GFP probe accumulates within seconds at the leading edge 
of polarised neutrophils responding to a chemoattractant (Servant et al., 2000). 
This asymmetric localisation activates Rho GTPases, which ultimately drives actin 
polymerization inducing subcellular processes such as lamellipodia, pseudopods, 
filopodia, membrane ruffling, and subsequently chemotaxis. Although the 
asymmetric localization of PI(3,4,5)P3 at the leading edge has been reported in 
many cells types, it is not known whether PI(3,4,5)P3 plays a role in mast cell 
polarization and chemotaxis. 
 
The objective of these experiments was to examine the localisation of PI(3,4,5)P3 
in RBL-CCR1 cells in response to a Mip-1α gradient, and thereby determine 
whether directed cell movement in mast cells is via a PI(3,4,5)P3 mediated 
pathway.  RBL-CCR1 cells stably expressing PH-AKT-GFP probe were exposed to 
a micropipette containing 50ng/ml of Mip-1α. For each experiment a minimum of 
three cells were recorded every five seconds for ten minutes using real time 
fluorescent microscopy. The data are representative of two separate experiments 
with at least two cells analysed in each movie.  
 
As shown in Figure 24A, unstimulated RBL-CCR1 are pod shaped elongated cells, 
in which PI(3,4,5)P3 was localised throughout the cytoplasm and nucleus. Cell a 
stimulated with 50ng/ml of Mip-1α for five seconds showed a flattened morphology 
with PI(3,4,5)P3 localised around the cell membrane( as indicated by the white 
arrow) (Figure 24B) and further stimulation with Mip-1α for ten seconds showed 
increased PI(3,4,5)P3 localisation around the cell membrane (Figure 24C). By one 
minute, cell a continued to show a flattened morphology with intense membrane 
ruffles, PI(3,4,5)P3 localised to, and was highly concentrated on the membrane 
ruffles at the leading edge ( as indicated by the red arrow) (Figure 24D). By two 
minutes cells began to polarise, PI(3,4,5)P3 remained localised around the cell 
membrane (Figure 24E). At five minutes stimulation RBL-CCR1 cells showed a 
polarised phenotype, with a large distinct membrane ruffle and lamellipodia. 
Interestingly PI(3,4,5)P3 re-localised to the edge of the lamellipodia nearest the 
Mip-1α gradient (Figure 24F). Moreover, at seven minutes stimulation PI(3,4,5)P3 
 99 
expression was no longer observed within the large lamellipodia, but was now 
observed at the cell membrane (Figure 24G).  
 
Unfortunately, as RBL-CCR1 cells no longer stably expressed the PH-AKT-GFP 
probe it was not possible to quantitate the localisation of PI(3,4,5)P3 in these 
experiments, nor examine how the localisation of PI(3,4,5)P3 was affected by co-
stimulation of CCR1 and FcεR1 by Mip-1α and IgE/Ag respectively. As it was not 
possible to detect PI(3,4,5)P3 in RBL-CCR1 Cells using a specific PI(3,4,5)P3 
antibody it was decided that the role of WASP, also a mediator of cell polarisation 
would be examined instead of PI(3,4,5)P3 for subsequent experiments.  
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Figure 24. Localisation of PI(3,4,5)P3 at the leading edge of RBL-
CCR1cells in response to a Mip-1α gradient.The PH domain of AKT tagged 
to GFP was used to detect PIP3 localisation in RBL-CCR1 cells. Stably 
expressing GFP-AKT-RBL-CCR1cells were exposed to a micropipette (*) 
containing Mip-1α at time points (A) 0 (B) ) 5 seconds (C) 10 seconds (D) 1 
minute (E) ) 2 minutes  (F) ) 5 minutes  (G) 7 minutes. The white arrow shows 
localisation of PIP3 at the cell membrane at 5 seconds, while the red arrow 
shows the localisation of PIP3 at the leading edge at 5 minutes in one RBL-
CCR1 cell in response to Mip-1α. Figures 23A-H are representative of two 
independent experiments. 
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3.2.4 Localisation of CCR1, actin and WASP in RBL-CCR1 cells in response 
to a Mip-1α  gradient 
 
A mechanism for the spatial organisation of chemokine receptors on the leukocyte 
cell surface following chemokine stimulation that would allow for the detection of, 
and subsequent chemotaxis towards a chemokine gradient remains unclear. Both 
symmetrical and asymmetrical distributions of chemokine receptors have been 
observed on the cell surface following chemokine receptor stimulation (Servant et 
al., 1999; Gomez-Mouton et al., 2004). Moreover, distinct localisation of CCR1 on 
membrane ruffles in RBL-2H3 cells following stimulation with Mip-1α has been 
reported (Beer et al., 2007). WASP has been implicated in several biological 
processes that involve actin cytoskeletal organisation. Myers et al., (2005) 
previously showed localization of WASP at the leading edge of chemotaxing 
Dictyostelium cells, however to date, the localisation of WASP at the leading edge 
of chemotaxing mast cells responding to Mip-1α is yet to be elucidated.   
 
The objective of these experiments was to examine the localisation of CCR1, actin 
and WASP in response to a Mip-1α gradient in RBL-CCR1 cells. RBL-CCR1 cells 
were exposed to a micropipette containing either 50ng/ml of Mip-1α for 5, 10 and 
20 minutes, or with DMEM/PBS for 20 minutes. RBL-CCR1 cells were fixed with 
PFA and stained for CCR1, actin and WASP. For each experiment a minimum of 
10-15 cells were recorded every minute for 20 minutes using real time microscopy. 
The data are representative of five separate experiments with at least 10-15 cells 
analysed in each.  
 
In the experiment shown in Figure 25, a micropipette (as indicated by a yellow *) 
filled with DMEM media plus PBS was positioned within a field of RBL-CCR1 cells 
for a the duration of 20 minutes. Figure 25A shows RBL-CCR1 cells are elongated 
pod shaped cells at the onset of the experiment. Cells exposed to DMEM/PBS 
micropipette showed a flattened morphology and were unresponsive, displaying no 
membrane ruffling or cell polarization (Figure 25B-E). Cells displayed CCR1 
expression at the cell membrane (Figure 25B) and diffuse actin expression (Figure 
25C). WASP was expressed throughout the cytoplasm and cell surface of the cells 
(Figure 25D). Figure 25E shows the co –localisation of CCR1 (red), actin (blue) and 
WASP (green), where the periphery of the cells were yellow (co-localisation of 
CCR1 and actin) and the cell body aqua (co-localisation of actin and WASP). 
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Figure 25. In response to a pipette of PBS/DMEM for 20 minutes CCR1 
localises at the cell membrane, whilst actin and WASP remain throughout 
the cytoplasm of RBL-CCR1 cells. (A) Time-lapse video microscopy frames of 
RBL-CCR1 motility towards a micropipette tip (*) containing PBS/DMEM media. 
Images were recorded every minute for 20 minutes, cells were then fixed and 
stained for (B) CCR1, (C) Actin and (D) WASP. (E) co-localisation of 
CCR1(red), actin( blue), WASP (green). The figures shown are representative 
of five independent experiments.  
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In the experiment shown in Figure 26, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α is positioned within a field of RBL-CCR1 cells for the 
duration of 5 minutes. Figure 26A shows at the onset of the experiment RBL-CCR1 
cells are elongated pod shaped cells. Cells exposed to the Mip-1α gradient 
displayed distinct polarised membrane ruffles and lamellipodia (Figure 25B-E). 
CCR1 (Figure 26B), actin (Figure 26C) and WASP (Figure 26D) were localised and 
enriched in the polarised membrane ruffles and lamellipodia that occurred on the 
side of the pipette. In addition, WASP localised to the nucleus. Figure 26E shows 
the co –localisation of CCR1 (red), actin (blue) and WASP (green). 
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Figure 26. In response to a pipette of Mip-1α for 5 minutes. CCR1, actin 
and WASP localise in the polarised membrane ruffles and lamellipodia of 
RBL-CCR1 cells. (A) Time-lapse video microscopy frames of RBL-CCR1 
motility towards a micropipette tip ( *) containing Mip-1α. Images were recorded 
every minute for 5 minutes, cells were then fixed and stained for (B) CCR1, (C) 
Actin and (D) WASP. (E) co-localisation of CCR1(red), actin( blue), WASP 
(green).The figures shown are representative of five independent experiments.  
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In the experiment shown in Figure 27, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α is positioned within a field of RBL-CCR1 cells for the 
duration of 10 minutes. Figure 27A shows at the onset of the experiment RBL-
CCR1 cells are elongated pod shaped cells. Cells exposed to the Mip-1α gradient 
for ten minutes displayed intense polarised membrane ruffles and lamellipodia 
(Figure 27B-E). CCR1 began to internalise (Figure 27B), actin continued to localise 
in the polarised membrane ruffles (Figure 27C) and WASP was no longer 
concentrated at the polarized membrane ruffles but remained in the nucleus 
(Figure 27D). Figure 27E shows the co –localisation of CCR1 (red), actin (blue) and 
WASP (green). 
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Figure 27. In response to a pipette of Mip-1α for 10 minutes, CCR1 begins 
to internalise. Actin remains localised in the polarised membrane ruffles 
and lamellipodia, whilst WASP now re locates from the polarised 
membrane ruffles to the cytoplasm and nucleus of RBL-CCR1 cells.  
(A) Time-lapse video microscopy frames of RBL-CCR1 motility towards a 
micropipette tip ( *) containing Mip-1α. Images were recorded every minute for 
10 minutes, cells were then fixed and stained for (B) CCR1, (C) Actin and (D) 
WASP. (E) Co-localisation of CCR1(red), actin( blue), WASP (green).  
The figures shown are representative of five independent experiments.  
 
 107 
In the experiment shown in Figure 28, a micropipette (as indicated by a yellow *) 
filled with 50ng/ml of Mip-1α is positioned within a field of RBL-CCR1 cells for the 
duration of 20 minutes. Figure 28A shows at the onset of the experiment RBL-
CCR1 cells are elongated pod shaped cells. Cells exposed to the Mip-1α gradient 
for 20 minutes showed a flattened morphology with reduced membrane ruffles 
(Figure 28B-E). CCR1 expression was no longer internalised but was now at the 
cell membrane (Figure 28B) while actin expression was diffuse throughout the 
cytoplasm (Figure 28C). WASP was no longer concentrated at the polarized 
membrane ruffles, but was localised within the nucleus (Figure 28D). Figure 28E 
shows the co –localisation of CCR1 (red), actin (blue) and WASP (green), in which 
CCR1, actin and WASP expression was comparable to that observed in response 
to a DMEM/PBS gradient. 
 
 
 
 
 
 
 
 
 
 
 108 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. In response to a pipette of Mip-1α for 20 minutes. CCR1 
localises at the cell membrane. Actin begins to re-localise from the 
polarised membranes to the cytoplasm, whilst WASP localises throughout 
the cytoplasm and nucleus of RBL-CCR1 cells. (A) Time-lapse video 
microscopy frames of RBL-CCR1 motility towards a micropipette tip ( *) 
containing Mip-1α. Images were recorded every minute for 20 minutes, cells 
were then fixed and stained for (B) CCR1, (C) Actin and (D) WASP. (E) Co-
localisation of CCR1(red), actin( blue), WASP (green). The figures shown are 
representative of five independent experiments.  
 
 
 
 
 
 
 
 
20um 
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3.3 Discussion 
 
The ability of mast cells to chemotax towards sites of inflammation and parasitic 
infection, and the subsequent release of pro-inflammatory mediators is crucial 
process in allergic inflammation. A former study by Toda et al., (2004), 
demonstrated that engagement of FcεR1 and CCR1 receptor synergistically 
enhanced degranulation in mast cells and also exhibited profound effects on 
chemotaxis and cell morphology, indicating cross-talk between FcεR1 and CCR1 
signalling pathways. In addition, the PI3K inhibitor, Wortmannin significantly 
inhibited synergistic degranulation of RBL-CCR1 cells suggesting that this pathway 
is mediated via PI3K. In this light the aim of this chapter was to further define the 
effects of FcεR1 and CCR1 engagement on cell motility. 
 
Actin reorganisation in RBL-CCR1 cells induced by homogeneous co-
stimulation by Mip-1α and IgE/antigen 
 
A crucial component of cell motility towards chemoattractants requires the 
reorganisation of the actin cytoskeleton, induction of membrane ruffling and cell 
polarisation. FcεRI engagement has an inhibitory effect on Mip-1α-induced 
chemotaxis (Toda et al., 2004), indicating that co-stimulation with Mip-1α and 
IgE/antigen affect reorganisation of actin cytoskeleton of RBL-CCR1 cells. 
Therefore, on this basis the first objective was to analyse the effects of co-
stimulation by Mip-1α and IgE/antigen on actin reorganisation in RBL-CCR1 cells. 
The data from this study demonstrates that Mip-1α stimulation rapidly induced 
profound membrane ruffles and cell polarisation. However, co-stimulation with Mip-
1α and IgE/antigen decreased the membrane ruffling response of RBL-CCR1 cells. 
This data suggests that engagement by FcεR1 inhibits the reorganisation of the 
actin cytoskeleton. Moreover, this may also explain the inhibitory effect on Mip-1α 
induced chemotaxis of RBL-CCR1 cells in response to co-stimulation. Toda at 
al.,(2004)  demonstrated that Mip-1α -mediated chemotaxis of RBL-CCR1 cells 
requires activation of the Rho pathway. Moreover they showed that costimulation 
with Mip-1α and IgE/antigen enhanced Rac and Cdc42 activation but decreased 
ROCK activation in RBL-CCR1 cells. Decreased ROCK activation may also be a 
mechanism by which FcεR1 engagement inhibits actin reorganisation and hence 
Mip-1α -mediated chemotaxis of RBL-CCR1 cells. 
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Behavioural responses of RBL-CCR1 Cells to gradients of Mip-1α and 
IgE/antigen co-stimulation using real time microscopy 
 
Since the beginning of the 21st century it has been possible to characterise the 
dynamic behaviour of immune cells using time lapse video microscopy (Cantrell et 
al., 2002; Mempel et al., 2004; Looney et al., 2011; Sergé et al., 2011). However, 
how RBL-CCR1 cell shape changes relate to actual motility is at present poorly 
understood. In order to analyse the effects of co-stimulation on RBL-CCR1 
morphology and motility, a series of experiments using time-lapse video 
microscopy were conducted to observe the behaviour and other cell motility 
parameters such as: directionality, Euclidean distance, accumulated distance and 
velocity of RBL- CCR1 cells in response to Mip-1α and IgE/antigen or Mip-1α 
alone.  
 
The current model of cell motility is frequently described as a multistep process, in 
which, F-actin polymerization at the front of the cell pushes out a membrane 
protrusion such as lamellipodia that subsequently becomes anchored to an 
extracellular substrate by transmembrane receptors of the integrin family. Integrins 
are dynamically coupled to the actin cytoskeleton and translate the internal force 
that is generated when myosin II contracts the actin network. The data from my 
study demonstrates that RBL-CCR1 cells, induce actin polymerization and 
chemotax towards a Mip-1α gradient and this response is inhibited by CCR1 and 
FcεR1 co-stimulation. Although the leading edges of RBL-CCR1 cells remained 
dynamic and protruded with normal speed towards Mip-1α gradient, RBL-CCR1 
cells were unable to move their trailing edges, nevertheless, Mip-1α gradient was 
still able to polarize the RBL-CCR1 cell population. Does the trailing edge 
contraction contribute to overall RBL-CCR1 cell body locomotion? This functional 
dissociation between front and back of Mip-1α stimulated RBL-CCR1 cells 
demonstrates that the leading edge migrates independently and without a need for 
receptor-mediated coupling of contractile forces to the extracellular matrix. 
However, to further validate this explanation future studies should analyse the 
response of RBL-CCR1 cells towards a Mip-1α gradient and CCR1 and FcεR1 co-
stimulation in the presence of extracellular matrix proteins such as Collagen Type1 
and Type IV, and the role of integrins during this process.  Previous studies using 
fibroblasts and leukocytes moving on 2D substrates, demonstrate that myosin 
contraction at the back of the cell is required to disassemble receptor binding-sites 
and subsequently retract the membrane (Palecek et al., 1996; Lauffenburger and 
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Horwitz, 1996; Hogg et al., 2003; Morin et al., 2008). However, contrary to this, 
Lammermann et al., (2008) did not observe membrane tethers in myosin II-
inhibited leukocytes migrating in 3D gels. Moreover, chemotactic dendritic cells 
mechanically adapt to the adhesive properties of their substrate by switching 
between integrin-mediated and integrin-independent locomotion (Renkawitz et al., 
2009). Another explanation for the lack of moving distance displayed by RBL-CCR1 
cells (in real time microscopy) possibly relates to the functional role and biology of 
mast cells, in that within an inflamed tissue, maybe it is not necessary for mast cells 
to move large distances to function, it could be that mast cells only need to 
chemotax short distances before exhibiting effector function. This data would fit in 
with findings by Toda and co-workers (2004), where we show that although RBL-
CCR1 cells are able to chemotax towards Mip-1a using a Boyden chamber assay, 
these cells transmigrate through a very thin porus membrane, thereby moving very 
small distances. 
 
Leukocytes are dispersed throughout the body and have the potential to infiltrate 
any type of tissue. They frequently exhibit cell migration velocities that are up to 
100 times faster than mesenchymal and epithelial cell types (Friedl, P. et al., 2004; 
Pittet & Mempel, 2008). At present there is no data indicating the relative velocity of 
mast cells during an allergic response, however, it would be expected, that mast 
cells would move extremely quickly as the first line of defence towards a 
chemokine gradient and a roaming pathogen or allergen, and then stop and 
accumulate. The data in this study shows that RBL-CCR1 cells respond within 
seconds to a Mip-1α gradient, however, surprisingly, there were no significant 
changes in velocity when Mip-1α mediated chemotaxis was inhibited by Mip-1α and 
IgE/antigen. This data indicates that while Mip-1α does not affect cell speed, Mip-
1α polarises RBL-CCR1 cells, which is the reason why it increases chemotaxis. 
Renkawitz et al., (2009) demonstrated that dendritic cells that lacked all integrin 
heterodimers induced velocities of up to 20 µm min–1 in 100% of cells, whereas 
only 8% of wild-type cells had maximum flow rates of 5 µm min–1. They showed 
that accelerated velocities was balanced by an increased actin polymerization rate, 
therefore, cell shape and velocity remained constant on alternating substrates. With 
this information at hand, it is not known at present, whether integrin depletion would 
affect RBL-CCR1 velocity in the presence of Mip-1α or co-stimulation by Mip-1α 
and IgE/antigen. 
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Localisation of PI(3,4,5)P3  in RBL-CCR1 cells in response to a Mip-1α  
gradient 
 
The accumulation of PI(3,4,5)P3 , as a result of PI3K activity, along the leading 
edge of a chemotaxing cell (Funamoto et al., 2001; Huang et al., 2003; Merlot and 
Firtel, 2003; Sasaki et al., 2004) has been proposed to be an indispensable 
signaling event that is required for cells to undergo chemotaxis towards 
chemoattractants. Although PI(3,4,5)P3  has been demonstrated to be a central 
component in the chemotaxis of some cell types, it is not clear whether PI(3,4,5)P3  
accumulation, and hence the PI3K pathway is a universal pathway for chemotaxis, 
or a pathway only used by certain cell types and chemoattractants. On this basis, 
the aim of these experiments was to examine the localisation of PI(3,4,5)P3  in 
RBL-CCR1 cells (using RBL-CCR1 cells stably expressing PH-AKT-GFP probe) in 
response to a Mip-1α  gradient, and thereby determine whether directed cell 
movement in mast cells is PI(3,4,5)P3  dependent. This study shows that 
PI(3,4,5)P3  is rapidly localized along the leading edge of RBL-CCR1 cells in 
response to a Mip-1α  gradient. Unfortunately, as RBL-CCR1 cells no longer stably 
expressed the PH-AKT-GFP probe it was not possible to quantitate PI(3,4,5)P3  
accumulation at the leading edge, nor examine the localisation of PI(3,4,5)P3  by 
co-stimulation of CCR1 and FcεR1 engagement, and hence this data needs to be 
interpreted with caution. Nevertheless, PI(3,4,5)P3  accumulation along the leading 
edge of RBL-CCR1 cells indicates one potential mechanism of mast cell 
polarization and Mip-1α -mediated chemotaxis. In addition, previous data showing 
inhibition of RBL-CCR1 degranulation by the non-specific PI3K inhibitor, 
Wortmannin, indicates that this effect is PI3K mediated. 
 
Localisation of CCR1, actin and WASP in RBL-CCR1 cells in response to a 
Mip-1α gradient 
 
The formation of membrane ruffles and lammelipodia as a result of actin 
polymerisation are fundamental components of the cytoskeleton rearrangements 
required for cell motility and chemotaxis. Following chemokine stimulation, at 
present there are two chemokine receptor localisation patterns, an asymmetrical 
and symmetrical distribution observed on the cell surface  (Servant et al., 1999; 
Gomez-Mouton et al., 2004). Our finding that CCR1 localises on the membrane 
ruffles of RBL-CCR1 stimulated with chemotatic concentrations of Mip-1α  (Beer et 
al., 2007) suggests the possibility by which RBL-CCR1 might localise or up 
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regulate their chemokine receptors on the surface of membrane ruffles in order to 
detect a chemokine gradient.  WASP family members function as scaffold proteins, 
transducing a wide range of signals from proteins or membranes to mediate 
dynamic changes in the actin cytoskeleton. Cdc42 appears to control actin 
polymerization through the interaction with WASP, (Aspenstrom et al., 1996; 
Symons et al., 1996; Insall and Machesky, 2009; Monypenny et al., 2011), an 
activator of the actin nucleating Arp2/3 complex (Machesky and Gould, 1999).  
 
Given the unstable nature of the GFP-AKT-RBL-CCR1 cell line it was not possible 
to conduct further analysis of PI(3,4,5)P3  localisation in response to a Mip-1α  
gradient in these cells. Hence, the next question to ask was whether WASP was 
targeted to sites of new actin polymerization and the leading edge of chemotaxing 
RBL-CCR1 cells in response to a Mip-1α gradient. In light of this information the 
objective of these experiments was to investigate CCR1, WASP and actin 
localisation in cells fixed at varying time points following stimulation with a Mip-1α 
gradient. This would allow one to investigate the spatiotemporal distribution of the 
receptor over the course of initial stimulation, polarisation and chemotaxis. My 
findings show that upon stimulation by a gradient of Mip-1α, CCR1 co-localised to 
sites of new actin polymerisation- the polarised membrane ruffles and lamellipodia 
that occurred on the side of the pipette. Interestingly, WASP localisation was also 
observed, along with CCR1 at the polarized membrane ruffles.  With regards to this 
data, actin polymerisation of RBL-CCR1 cells in the presence of a Mip-1α gradient 
is mediated by WASP and the localisation of CCR1 on membrane ruffles at the 
leading edge of RBL-CCR1 may facilitate the accurate detection of a chemokine 
gradient and allow for subsequent chemotaxis along it. Prolonged exposure of Mip-
1α gradient to RBL-CCR1 induces CCR1 internalisation and exclusion of WASP 
from the polarised actin rich ruffles and nucleus, suggesting a transient role of 
WASP during this process. 
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Chapter 4. 
The effect of FcεRI and chemokine co-engagement on mast cell motility in 
murine allergic conjunctivitis 
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4. The effect of FcεRI and chemokine co-engagement on mast cell motility in 
murine allergic conjunctivitis 
 
4.1 Introduction and hypothesis 
 
During an allergic response directed migration is essential at several stages such 
as: mast cell progenitor movement from the bone marrow, recruitment through 
venules into the tissue and migration within the tissue. Reduction of mast cell 
accumulation at sites of inflammation would subsequently reduce mast cell 
activation at these sites.  At present, how mast cells migrate in vitro and in vivo is 
very poorly understood compared to other cell types.  Nevertheless, compiling 
together in vitro and in vivo observations will contribute to our understanding of 
mast cell migration, and thereby identify potential therapeutic agents. Chapter 3 of 
this thesis demonstrated that in vitro, RBL-CCR1 cells chemotax towards Mip-1α, 
exhibiting profound membrane ruffles and actin cytoskeleton re-organisation.  In 
addition, Mip-1α mediated RBL-CCR1 chemotaxis demonstrated specific 
localisation of actin, CCR1 and WASP at the leading edge (edge nearest to 
chemokine gradient) of polarised cells, correlating with the localisation dynamics 
and morphological changes demonstrated in other chemotaxing cell types. 
 
Based on current knowledge, I hypothesise that in vivo conjunctival murine mast 
cells can chemotax towards chemokine, with morphological changes and 
localisation of actin, CCR1 and WASP at the leading edge of polarised mast cells 
following allergen challenge. 
 
To address this hypothesis, the specific aims of this chapter are as follows: - 
 
1. To establish a model of murine allergic conjunctivitis so as to mimic ocular 
allergic diseases. 
2. To analyse the morphology of mast cells in an inflamed (chemokine gradient 
present) and non-inflamed (no chemokine gradient present) murine conjunctiva.  
3. To determine the kinetics of mast cell accumulation in an inflamed 
(chemokine gradient present) and non-inflamed (no chemokine gradient present) 
murine conjunctiva.  
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4. To investigate the localisation of WASP, CCR1 and actin in mast cells in an 
inflamed conjunctiva (chemokine gradient present) and non-inflamed conjunctiva 
(no chemokine gradient present). 
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4.2 Results 
 
4.2.1 Murine models of allergic conjunctivitis 
 
In the present study A/J and BALB/c mice were used to induce models of allergic 
conjunctivitis as these strains readily induce Th2 responses and are routinely used 
to mimic ocular allergic disease in man. 
 
With the aid of an ophthalmologist, Mr. Tom Flynn (London), it was possible to 
establish a murine model of allergic conjunctivitis using A/J mice. In brief, the 
mouse was sensitised over a 15-day period with SRW and Alum. This was followed 
by experimental allergen challenge with SRW pollen by eye drops thereby inducing 
an inflammatory response (which would include a chemokine gradient and the 
release of pro-inflammatory mediators) and subsequent allergic conjunctivitis. The 
SRW sensitised-challenged mice showed the following symptoms; conjunctival 
oedema; lid oedema; redness; tearing; squinting, which reflect distinctive 
characteristics of the inflammatory response, and are employed as the evaluation 
criteria when scoring murine allergic conjunctivitis. In comparison, the sensitised 
non-challenged and non-sensitised, non-challenged mice did not display any of the 
above symptoms. (Figure 29).  
 
Thereafter, eyes were enucleated from A/J mice and processed as either resin 
sections to analyse morphological changes in conjunctival mast cells by electron 
microscopy or cryostat serial sections to analyse kinetics of conjunctival mast cell 
accumulation and the localisation of actin, CCR1 and WASP in these cells. 
Unfortunately these experiments using A/J mice could not be completed at UCL 
(London), due to my extended 1.5 year absence for medical reasons and my  
supervisor Professor Ono leaving for the United States of America (U.S). Therefore 
all animal work had to be terminated. As a result, I completed the remaining aims of 
this chapter in Professor Ono’s new laboratory in the U.S, where Dr. Obayashi 
(Professor Ono’s post-doctoral scientist) established a murine model of allergic 
conjunctivitis, using BALB/c mice instead of A/J mice. Thereafter, the eyes were 
enucleated from BALB/c mice and processed as paraffin sections, which were used 
in subsequent experiments to address the same aims as those implemented for A/J 
mice.  
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Please note that although two different models were used in this study both 
successfully induced allergic conjunctivitis. In addition, other differences between 
these models were the time points of final SRW challenge and the method utilised 
for mast cell identification. 
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Figure 29. Symptoms of murine allergic conjunctivitis. A/J mice indicating  
(A) severe allergic conjunctivitis with short ragweed pollen (B) non-diseased eye 
with control PBS. The diseased eyes in comparison to non-diseased eyes 
displayed the following sypmtoms; conjunctival edema; lid edema; redness; 
tearing; squinting,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
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4.2.2 Behavioural and morphological responses of murine conjunctival mast 
cells in inflamed conjunctiva. 
 
In order to fully understand the mechanisms of mast cell chemotaxis, the initial 
starting point is to characterise the behaviour and morphology of the cells in vitro. 
Chapter 3 of this thesis examined the morphological responses of RBL-CCR1 cells 
in response to Mip-1α and IgE/antigen co-stimulation in vitro using real time 
microscopy. In light of this the objective of these experiments was to characterise 
by electron microscopy the morphological responses of mast cells in SRW 
sensitised-challenged, sensitised non-challenged or non-sensitised non-challenged 
conjunctiva in vivo using an A/J murine model of allergic conjunctivitis. The figures 
are representative of five separate experiments with at least 3-5 eyes analysed in 
each.  
 
Figure 30A shows an electron micrograph representing  mast cells from sensitised 
non-challenged or non-sensitised non-challenged conjunctiva of A/J mice. The 
mast cells are pod shaped elongated cells comprising numerous tightly packed 
black histamine containing granules. In contrast, conjunctival mast cells from the 
A/J murine model of allergic conjunctivitis three hours post sensitised-challenged 
with SRW, appeared stretched in shape with numerous branching filopodia 
extending from the cell membrane. The black histamine containing granules were 
no longer tightly packed within the cell cytoplasm. Some granules were clearly 
being exuded from the cell, a recognised feature indicating activation and 
degranulation, which is characteristic of the early phase response. (Figure 30B). At 
nine hours post sensitised-challenged with SRW, conjunctival mast cells were 
comparable in morphology to that observed at three hours post sensitised- 
challenged. However, in addition other inflammatory cells were also present such 
as neutrophils, which would be characteristic of the late phase response (Figure 
30C). 
 
Unfortunately, it was not possible to examine by electron microscopy the 
morphological responses of conjunctival mast cells from the BALB/c murine model 
of allergic conjunctivitis  (model established in the U.S.A) as the eyes from these 
mice were processed as paraffin sections for immunohistochemistry analysis alone.
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Figure 30. Morphology of murine conjunctival mast cells in naïve and post 
allergen challenged conjunctiva. Electron micrographs displaying images of 
representative mast cells (red arrow) from the conjunctivia  (A) of a naïve 
mouse (B )3 hours post allergen challenge indicative of the early phase 
response, where yellow arrows indicates filapodia (C) 9 hours post allergen 
challenge indicative of the late-phase response. The figures are representative 
of five separate experiments with at least 3-5 eyes analysed in each 
experiment.    
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4.2.3 Kinetic analysis of murine conjunctival mast cells accumulation within 
an inflamed conjunctiva.  
 
Numerous studies have demonstrated that mast cells chemotax towards 
chemokines, accumulating at sites of inflammation during an inflammatory 
response. Miyazaki and co-workers (2005) previously demonstrated that a gradient 
of Mip-1α was localized mainly to mononuclear cells within the forniceal area of an 
inflamed murine conjunctiva following allergen challenge with SRW. In light of this 
information a series of experiments were conducted to determine at various time 
points the number of mast cells in SRW sensitised-challenged, sensitised non-
challenged or non-sensitised non challenged conjunctiva in vivo using an A/J 
murine model of allergic conjunctivitis. The data are representative of five separate 
experiments per condition with at least 3-5 eyes analysed in each condition. 
 
Following treatment eyes were enucleated from A/J mice and processed as 
cryostat serial sections. Thereafter each section was stained with Toluidine Blue to 
identify mast cells which appeared purple in colour. Mast cells were counted: 1) in 
the forniceal region of the conjunctiva, a potential area of a chemokine gradient, 
this area was represented by the letter G and 2) and a region of similar size away 
from the forniceal area and no potential gradient, this area was represented by the 
letter AG. (Figure 31A).  
 
In Figure 31B, an up-regulation in conjunctival mast cell accumulation was 
observed in areas away from the gradient in non-sensitised non-challenged mice 
as compared to those conjunctival mast cells observed in areas near the gradient, 
and those in areas near and away from the gradient in sensitised non-challenged 
mice. However, three hours post SRW sensitised-challenged mice exhibited a 
dramatic increase in conjunctival mast cell accumulation in areas near and away 
from the gradient when compared with conjunctival mast cells from non-sensitised 
non-challenged mice, respectively. Six hours post SRW, sensitised-challenged 
mice exhibited a downregulation in conjunctival mast cell accumulation in areas 
near the gradient. In addition, a further downregulation of conjunctival mast cells 
was observed in areas away from the gradient. At 24 hours post SRW sensitised-
challenged mice, the number of conjunctival mast cells accumulated in areas near 
and away from the gradient was comparable to that observed in areas near and 
away from the gradient respectively in six hours post SRW sensitised- challenged 
mice.  
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Figure 31. Kinetic analysis of mast cell accumulation within the inflamed 
mouse conjunctiva induced by allergic conjuctivitis model 1-using A/J 
mice. (A) Schematic representation of the conjunctivia showing the location of 
the chemokine gradient, G, and the location away from the chemokine gradient, 
AG. (B) Mast cells were counted in equivalent size areas in the vicinity of the 
gradient versus away from the gradient and the data represented as a graph.  
The data represent the mean +/- standard error mean (SEM) of five 
experiments per condition with at least 3-5 eyes analysed in each.   
Figure A is adapted from Miyazaki et al., 2005 
Key: S-NC= Sensited non-challenged mice 
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Paraffin sections from the BALB/c murine model of allergic conjunctivitis were 
stained with anti-mMCP-5 antibody to identify conjunctival mast cells (characterized 
by the expression of the chymase mMCP-5) and counter stained with anti-CCR1 
antibody to identify CCR1 positive mast cells. CCR1 positive mast cells were 
counted in the forniceal area, a potential area of a chemokine gradient (Figure 
32A). Unfortunately due to the compromised architecture of processed tissue it was 
not possible to identify and count conjunctival mast cells away from the forniceal 
area, a potential area of no chemokine gradient. 
Figure 32B shows an upregulation in CCR1 positive conjunctival mast cells in the 
forniceal region in 30 minutes post SRW sensitised-challenged mice as compared 
to conjunctival mast cell accumulation observed at 30 minutes in non-sensitised 
non-challenged mice. In addition, a decrease in conjunctival mast cell accumulation 
was observed in the forniceal region of 24 hours post SRW sensitised-challenged 
mice compared to mast cell accumulation observed 30 minutes post SRW 
sensitised-challenged mice. Please note that unfortunately, as this model was 
induced in the U.S. the time points employed post SRW allergen challenge were 
different to those in the A/J murine model of allergic conjunctivitis.  
 
Although two different models were used to analyse mast cell accumulation within 
an inflamed conjunctiva both models showed the same effect in that following SRW 
challenge in sensitised mice, an increase in mast cells can be seen in the forniceal 
region of the conjunctiva. 
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Figure 32. Kinetic analysis of mast cell accumulation within the inflamed 
mouse conjunctiva induced by allergic conjuctivitis model 2- using 
BALB/c mice. (A) Schematic representation of the conjunctivia showing the 
location of the chemokine gradient, G, in the forniceal region. (B) Mast cells 
were counted by using a grid in the vicinity of the gradient, and the data 
represented as a graph. The data represent the Mean +/- standard error mean 
(SEM) of five experiments per condition with at least 3-5 eyes analysed in each.   
Figure A is adapted from Miyazaki et al., 2005. 
Key: SC= Sensited challenged mice, NS-NC=Non-sensitised, non-challenged 
mice. 
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4.2.4 Localisation of CCR1, actin and WASP in conjunctival mast cells within 
an inflamed murine conjunctiva.  
 
Previous reports have demonstrated that actin, CCR1 and WASP have individually 
and in concert shown an important role in cytoskeletal re-organisation, cell polarity 
and chemotaxis. Chapter 3 of this thesis analysed the localisation of actin, CCR1 
and WASP in RBL-CCR1 cells in response to a Mip-1α gradient, and showed that 
these components were enriched at the leading edge of these cells in vitro, which 
would be indicative of chemotaxing cells. In light of this information, the objective of 
these experiments by using a model of allergic conjunctivitis was to examine the 
morphology and localisation of actin, CCR1 and WASP following SRW allergen in 
sensitised mice, and thereby determine whether these observations correlate with 
the observations for RBL-CCR1 cells and other migrating cell types. 
 
Cryostat serial sections from the eyes of an allergic conjunctivitis model using A/J 
mice were stained with Toluidine Blue to identify the mast cells and their location, 
whilst the serial section was stained for actin and WASP. Thereafter purple positive 
mast cells were numbered and were co-localised to those mast cells in the serial 
section, which was stained for actin and WASP. 
 
Figure 33 shows the presence of purple positive mast cells in a SRW sensitised-
challenged conjunctiva of A/J mice. In the SRW sensitised-challenged conjunctiva 
of A/J mice, actin localises throughout the cytoplasm of mast cell number 1 with 
increased actin expression observed at only one end of the cell (Figure 34A), whilst 
WASP also displays an asymmetric localisation within the cell (Figure 34B).  Mast 
cell number 2 also shows actin and WASP expression within the cell, however it is 
difficult to see the exact distribution at this magnification of x 63 (Figure 34A and 
34B). Figure 34C shows the co-localisation of actin and WASP in mast cells 1 and 
2.  
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Figure 33. Conjunctival mast cells (purple) 1 and 2 (pink arrows) in the 
vicinity of a chemokine gradient, G, in SRW sensitised-challenged mice. 
 
 
60um 
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34. (A) Actin (red) and (B) WASP (green) localisation in murine 
conjunctival mast cells 1 and 2 (indicated by purple arrows) in the vicinity 
of a chemokine gradient, from a serial section of tissue shown in figure 33 
in SRW sensitised-challenged mice. (C) Co-localisation (yellow) of actin 
(red) and WASP (green) in murine conjunctival mast cells in SRW 
sensitised-challenged mice.  
 
 
 
 
 
 
20um 
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Allergic conjunctivitis models using BALB/c mice established in the US were 
processed in paraffin which allowed identification of mast cells by anti-mMCP-5 
antibody and CCR1 by anti-CCR1 antibody. It was possible to identify CCR1 
positive mast cells by epi-fluorescence.  
 
CCR1 positive cells present in non-sensitised non- challenged conjunctiva at 30 
minutes were identified with anti–CCR1 antibody (Figure 35A) and mast cells by 
anti-mMCP-5 antibody (Figure 35B). Figure 35C shows the co-localisation of 
positive CCR1 mast cells in yellow/orange present in non-sensitised non- 
challenged conjunctiva at 30 minutes. In SRW sensitized-challenged conjunctiva at 
30 minutes anti –CCR1 antibody identified CCR1 positive cells (Figure 36A), whilst 
mast cells were identified by anti-mMCP-5 antibody (Figure 36B). Figure 36C 
shows the co-localisation of positive CCR1 mast cells in yellow/orange in SRW 
sensitised-challenged conjunctiva at 30 minutes.  
 
Although it was possible to identify CCR1 positive mast cells by epi-fluorescence 
microscopy, unfortunately due to time constraints in the US it was not possible to 
examine the localisation of CCR1 and actin within these cells using confocal 
microscopy. Also, it was not possible to bring the tissue sections to UCL to be 
analysed by confocal microscopy.   
 
In addition to CCR1 and mast cell staining, after many attempts it was not possible 
to identify a source of WASP antibody, which could be used in paraffin sections. 
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Figure 35. (A) CCR1 (green) and (B) positive mast cell (red) expression in the 
vicinity of a chemokine gradient (forniceal region), in non-sensitised non-
challenged murine conjunctiva. (E) co-localisation (yellow/orange) of CCR1 
(green) positive mast cells (red) in the vicinity of a chemokine gradient (forniceal 
region), in non-sensitised non-challenged murine conjunctiva. This figure is 
representative of five separate experiments with at least 3-5 eyes analysed in 
each.  
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Figure 36. (A) CCR1 (green) and (B) positive mast cell (red) expression in the 
vicinity of a chemokine gradient (forniceal region), in sensitised-challenged 
murine conjunctiva. (C) co-localisation (yellow/orange) of CCR1 (green) positive 
mast cells (red) in the vicinity of a chemokine gradient (forniceal region), in 
sensitised-challenged murine conjunctiva. This figure is representative of five 
separate experiments with at least 3-5 eyes analysed in each.  
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4.3 Discussion 
 
The eye is among the first organs to encounter environmental allergens, and as a 
result is a common target of inflammatory responses. Allergic eye diseases are 
often concomitant with other allergic diseases such as atopic dermatitis and 
asthma. Present drug treatment for ocular allergy targets the key mechanisms 
involved in the development of disease, however most of these agents are 
associated with significant adverse side affects.  In order to establish new 
therapeutic approaches further investigations into the molecular basis are required.  
 
Many eukaryotic cells undergo directed cell movement, otherwise known as 
chemotaxis towards a soluble ligand. This process is necessary for many biological 
functions, including the migration of macrophages during wound healing 
(Devreotes and Zigmond, 1988; Martinez-Quiles et al., 2001) and the aggregation 
of Dictyostelium cells to form a multicellular organism (Parent and Devreotes, 1999; 
Chung et al., 2001). Chemotaxis requires a defined cell polarity in which 
components of the cytoskeleton such as actin, WASP and CCR are differentially 
localized at the leading edge of a migrating cell as well as its retracting posterior 
(Firtel and Chung, 2000; Chung et al., 2000). 
 
Chapter 3 of this thesis demonstrated that during Mip-1α-induced RBL-CCR1 
chemotaxis, specific localisation of actin, CCR1 and WASP was enriched in 
polarised cells, which has been corroborated by other studies of other cell types. In 
addition, the morphology and chemotaxis of these cells were dramatically inhibited 
upon Mip-1α and IgE/antigen co-stimulation.  In light of this information, the aim of 
this chapter was to examine the morphology and localisation of actin, CCR1 and 
WASP in conjunctival murine mast cells following SRW allergen challenge. 
 
Murine models of allergic conjunctivitis 
 
Allergic conjunctivitis is IgE-mediated hypersensitivity reaction to aeroallergens 
such as short ragweed or grass pollen after they come into contact with the 
conjunctival surface. Many different animal models of ocular allergy have been 
established thus far, however it is vital to recognise that within ocular allergies, 
different disease entities exist and that only some of these can be mimicked by 
animal models.  In the present study a murine model of allergic conjunctivitis was 
used to mimic ocular allergic disease in man. Both A/J and BALB/c mice 
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successfully induced allergic conjunctivitis displaying symptoms commonly present 
such as: conjunctival edema; lid edema; redness; tearing; and squinting. These 
symptoms reflect the distinctive categories of the inflammatory response and are 
employed as the evaluation criteria when scoring murine allergic conjunctivitis. 
 
Behavioural and morphological responses of murine conjunctival mast cells 
in inflamed conjunctivia. 
 
In chapter 3 of this thesis, RBL-CCR1 cells in vitro demonstrated profound 
morphological changes, including extensive membrane ruffling in response to a 
gradient of Mip-1α alone and abolished membrane ruffling upon of Mip-1α and 
IgE/antigen stimulation. In light of this, the objective of the experiments in this 
chapter was to characterise the morphological responses of mast cells in SRW 
sensitised-challenged conjunctiva. 
 
Reports have shown chemokine stimulation induces actin polymerisation and the 
formation of filopodia and lamellipodia at the edge of the cell membrane closest to 
the chemokine gradient and that these are essential steps during chemotaxis 
(Berzat et al., 2010; Van Haastert et al., 2010; Roussos et al., 2011; Wang et al., 
2011). In the present study, three and nine hours in post SRW sensitised- 
challenged mice, conjunctival mast cells appeared polarised and displayed 
numerous filopodia from the cell membrane compared to sensitised non-challenged 
or non-sensitised non-challenged mice, in which, mast cells remain elongated in 
shape and displayed no processes from the cell membrane.  This would fit in with 
data from chapter 3, which showed that RBL-CCR1 cells exposed to a Mip-1α 
gradient, induced extensive membrane ruffling and also adopted a polarised cell 
phenotype. RBL-CCR1 cells pre-treated with IgE and exposed to a gradient of Mip-
1α and antigen inhibited membrane ruffling (Chapter 3), hence, we can assume 
that in the presence of allergen and chemokine in the murine allergic conjunctivitis 
model, mast cells should not display any membrane ruffling. However, this is not 
the case in vivo, and a likely explanation is that morphological changes of RBL-
CCR1 cells in the presence of chemokine and antigen is transient and rapid in vitro. 
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Kinetic analysis of murine conjunctival mast cells accumulation within an 
inflamed conjunctiva.  
 
In the present study a series of experiments were conducted to analyse mast cell 
accumulation within the inflamed conjunctiva in two different models of murine 
allergic conjunctivitis. In the present study the A/J murine model of allergic 
conjunctivitis showed an increase in Toluidine Blue stained mast cells in the 
forniceal area in three hours post SRW sensitized-challenged mice compared to a 
non-sensitised non-challenged and sensitized non-challenged mice, thereby 
suggesting that the increase in conjunctival mast cells is in response to a 
chemokine gradient generated in the forniceal region. However, six hours post 
SRW, sensitized-challenged mice, exhibit a decrease in conjunctival mast cell 
numbers compared to three hours post SRW, suggesting that the chemokine 
gradient no longer exists.  
 
In the present study, mast cells from the BALB/c murine model of allergic 
conjunctivitis were identified by anti-mMCP-5 antibody and counter stained with 
anti-CCR1 antibody to identify CCR1. The chemokine receptor CCR1 can bind 
several chemokines including Mip-1α, RANTES, MCP-2 and MCP-3 (Ochi et al., 
1999; Humbles et al., 2002). Using the BALB/c murine model of allergic 
conjunctivitis an increase in CCR1 positive mast cells were observed in the 
forniceal region of 30 minutes post SRW sensitised-challenged mice compared to 
non-sensitised non-challenged mice. This data suggests that the increased CCR1 
positive mast cell number could be in response to a Mip-1α chemokine gradient 
generated in the forniceal region. This would also correlate with a previous study by 
Miyazaki and co-workers (2005) who demonstrated that a gradient of Mip-1α was 
localized mainly to mononuclear cells within the forniceal region of an inflamed 
murine conjuctiva. In addition, this observation would also correlate with data from 
chapter 3 and studies by Toda et al (2004) demonstrating that RBL-CCR1 mast 
cells can chemotax towards a Mip-1α chemokine gradient within a time frame of 30 
minutes (real time microscopy pipette assay) to three hours (transwell chamber 
assay). However, in 24 hours post SRW sensitised-challenged mice there is a 
decrease in mast cell number in the forniceal region compared to non-sensitised 
non-challenged mice. An explanation for this is that the chemokine gradient no 
longer exists within the forniceal region as this time point could be representative of 
the late phase response. To validate whether this time point is representative of the 
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late phase, one could stain for immune cells which are characteristic of the late 
phase response, such as T cells or eosinophils. However, it is important to note 
that both models showed the same effect in that following SRW challenge in 
sensitised mice, an increase in mast cells can be seen in the forniceal region of the 
conjunctivia. 
 
Reports have shown that progenitor mast cells are capable of homing from the 
circulation into the tissue (Abonia et al., 2006; Hallgren et al., 2007). Although, 
there is an increase in mast cell number in the forniceal area of an inflamed 
conjunctiva it is not possible to establish whether resident mast cells have migrated 
within the tissue towards the chemokine gradient, or whether these are progenitor 
mast cells homing into the tissue from circulation. Future studies should validate 
this by analysing the number of progenitor mast cells versus mature mast cells in 
the forniceal region. In addition, this data fits with previous clinical findings that 
demonstrated during the pollen season, the median mast cell numbers in the 
conjunctiva increased by 61% in seasonal allergic conjunctivitis patients compared 
to normal patients and remained increased in allergic patients out of season 
(Kumagai et al., 2006). In addition, murine models of antigen induced Th2 
pulmonary inflammation demonstrate a significant increase in airway mast cells, in 
comparison to non-sensitised non-challenged mice which have few mast cells 
(Ikeda et al., 2003) 
 
Localisation of actin, WASP and CCR1 in conjunctival mast cells within an 
inflamed murine conjunctiva.  
 
Local mast cell hyperplasia, a prominent feature of the allergic response, is likely to 
involve mast cell progenitor recruitment and migration of mature mast cells within 
the inflamed tissue. Therefore, the therapeutic targeting of the mechanisms that 
regulate mast cell migration during inflammation may possibly reduce the mast cell 
accumulation to the affected tissues and ease the subsequent effect of mast cell 
activation in these locations. At present there are no therapeutic agents that 
specifically target mast cell migration. However, a reduction of tissue resident mast 
cells has been demonstrated in murine allergic models that are genetically deficient 
in PI3K (Ali et al., 2004; Koyasu et al., 2005) 
 
The objective of these experiments was to examine the specific localisation of 
actin, CCR1 and WASP in murine conjunctival mast cells using an A/J and BALB/c 
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murine models of allergic conjunctivitis and thereby determine whether these 
observations mimic RBL-CCR1 cells and other chemotaxing cell types. 
 
Myers and co-workers (2005) reported that WASP played an essential role in 
organizing polarized F-actin assembly in chemotaxing cells in vitro, and was 
preferentially localized at the leading edge and uropod of chemotaxing cells in vitro. 
Recently, a WASP biosensor was constructed to report WASP activation and 
localisation in vivo, demonstrating localization of WASP in actin protrusions at the 
cell pheriphery of macrophages and neutrophils following CSF-1 stimulation 
(Cammer et al., 2009). In addition, actin displays an asymmetric localization pattern 
in chemotaxing neutrophils and monocytes in vivo following Mip-1α stimulation 
(Khandoga et al., 2009). Although there are reports demonstrating the expression 
and potential roles of actin and WASP in several cell types during migration in vivo 
and in vitro (Tharp et al., 2006; Colditz et al., 2007; Lammermann et al., 2008;), at 
present there are no studies examining the localisation of WASP, actin or CCR1 in 
chemotaxing mast cells in vivo. Consistent with hematopoietic cells, conjunctival 
mast cells observed in this study express WASP (Guinamard et al., 1998; Mani et 
al., 2009). In SRW sensitized-challenged mice, it was possible to see an 
asymmetric distribution of WASP and actin in conjunctival A/J murine mast cells at 
a x63 magnification, however more cells need to be analysed to validate this. 
Unfortunately it was not possible to compare the localisation of WASP and actin in 
sensitised non-challenged and non-sensitised non-challenged conjunctivas as it 
was technically difficult to co-localise Toludine Blue positive mast cells with the 
corresponding actin and Wasp stained serial sections. However, this can be 
overcome if a suitable WASP antibody can be identified for use in paraffin sections. 
Future experiments could use this antibody along with mMCP-5, which successfully 
identified mast cells in paraffin sections. In light of current knowledge in vivo and 
observations for actin and WASP in RBL-CCR1 cells in vitro, it is possible that mast 
cells in vivo may show the same localization patterns during chemotaxis. 
 
Both asymmetrical and symmetrical CCR localisation patterns have been 
demonstrated on the cell surface in vitro  (Servant et al., 1999; Gomez-Moulton et 
al., 2004; Schröppel et al., 2004; Fifadara et al., 2010). Although differential 
expression of chemokine receptors has been observed in monocyte 
subpopulations in vivo  (Saederup et al., 2010), to date, there are no reports 
demonstrating chemokine receptor localisation patterns on the cell surface in vivo. 
Although using paraffin sections it was possible to observe CCR1 positive 
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conjunctival mast cells in SRW sensitised challenged and non-challenged non-
sensitised BALB/c mice, unfortunately at this magnification it was not possible to 
examine the exact localisation of CCR1 within these cells. To validate the exact 
localisation of WASP, actin and CCR1, future experiments must analyse WASP, 
actin and CCR1 stained tissue, and observe cells using a x63 magnification along 
with X, Y and Z –stacks at 0.5 um step size use generate a 3-dimensional image of 
these cells. This would enable the whole cell to be visualised and possibly the 
exact location of each component within the cell. 
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Chapter 5. 
The role of RGS1 in mast cell degranulation, mediator release and 
chemotaxis 
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5. The role of RGS1 in mast cell degranulation, mediator release and 
chemotaxis 
 
5.1 Introduction and hypothesis 
 
Previous studies demonstrate signaling from the FcεR1 receptor following allergen 
mediated cross-linking results in two phenomena: 1) arrested chemotaxis towards 
a chemokine gradient (Toda et al., 2004) and 2) enhanced production of pro-
inflammatory molecules when CCR1 and FcεR1 receptors are dually engaged 
(Nifidra et al., 2010). Moreover, in a recent study by Aye and Ono (unpublished 
data) the gene expression for several genes including RGS1 and TRB 3, were up-
regulated after stimulating IgE sensitised RBL-CCR1 cells with Mip1-α. Further 
expression of RGS1 and TRB3 were observed by co-stimulation by Mip1-α and 
IgE/antigen respectively. The possibility that RGS1 and TRB3 might also function 
as signaling molecules in mast cell processes requires further elucidation. 
 
Based on current knowledge, I hypothesise that the signaling molecule RGS1, 
downstream of FcεR1 signaling, can regulate mast cell degranulation, chemotaxis 
and mediator release. 
 
To address this hypothesis, the specific aims of this chapter were as follows:  
 
1. Using RNA interference to characterise how RGS1 affects RBL-CCR1 
degranulation, in which RBL-CCR1 cells are co-stimulated with Mip1-α and 
IgE/antigen and appropriate controls. In addition, examine the functionality 
of CCR1 on RBL-CCR1 degranulation by using the CCR1 antagonist met-
RANTES. 
 
2. Using RNA interference analyse how RGS1 affects cytokine and chemokine 
release from RBL-CCR1 cells following degranulation, in which RBL-CCR1 
cells are co-stimulated with Mip1-α and IgE/antigen and appropriate 
controls. 
 
3. Using RNA interference analyse how RGS1 affects gene expression of IL-6, 
IL-13 and CCL7 
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4. Using RNA interference analyse how RGS1 affects RBL-CCR1 chemotaxis, 
in which RBL-CCR1 cells are co-stimulated with Mip1-α and IgE/antigen and 
appropriate controls.  
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5.2 Results 
 
5.2.1 Depletion of endogenous RGS1 in RBL-CCR1 cells by RNA interference. 
 
In the first instance, RNA interference was used to deplete RGS1 content in RBL-
CCR1 cells and thereby determine how RGS1 controls RBL-CCR1 degranulation, 
mediator release and chemotaxis. Western Blotting in Figure 37 confirmed that 
RGS1 protein was reduced in RBL-CCR1 cells expressing RGS1 siRNA compared 
with cells expressing the control RGS1 siRNA. The data are representative of more 
than 10 separate experiments.  
 
Figure 37. Reduction of endogenous RGS1 in RBL-CCR1 cells by RNA 
interference. 
RBL-CCR1 cells were transfected with either RGS1 siRNA or control siRNA. 
Lysates were prepared and RGS1 expression was evaluated by western blot using 
anti-RGS1 Ab. Anti-actin was used to further assess protein loading. Data are 
representative of 10 experiments. 
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5.2.2. Effect of RGS1 on RBL-CCR1 degranulation 
 
The objective of these experiments was to initially examine the effect of RGS1 on 
RBL-CCR1 degranulation, in which RBL-CCR1 cells were co-stimulated with Mip1-
α and IgE/antigen. Simultaneously, the functionality of CCR1 on RBL-CCR1 
degranulation and its interaction with RGS1 during this response was also 
examined using the CCR1 antagonist met-RANTES. Degranulation of RBL-CCR1 
was determined by measuring the release of the granule protein beta-
hexosaminidase. The data are representative of 3 separate experiments, in which 
each condition was analysed in triplicate per experiment.  
 
As shown in Figure 38, Mip1-α stimulated RBL-CCR1 cells treated with control 
siRNA caused a significant increase in degranulation compared to non-sensitised 
RBL-CCR1 cells treated with control siRNA. However, Mip1-α stimulated RBL-
CCR1 cells treated with RGS1 siRNA induced a significant increase in 
degranulation in comparison to Mip1-α stimulated RBL-CCR1 cells treated with 
control siRNA. Interestingly, co-stimulation with Mip1-α and IgE/antigen induced a 
significant increase in degranulation in RBL-CCR1 cells treated with RGS1 siRNA 
compared to co-stimulated RBL-CCR1 cells treated with control siRNA , and RGS1 
siRNA treated cells stimulated with either Mip1-α  or IgE/antigen. However, by 
using met-RANTES on RGS1 and control siRNA treated cells under co-stimulation 
conditions degranulation observed was significantly decreased. 
 
These results suggest that CCR1 and FcεRI cooperatively mediate optimal 
degranulation and this event can be significantly increased when RBL-CCR1 cells 
are treated with RGS1 siRNA. Moreover, by using the CCR1 antagonist met-
RANTES, degranulation levels are significantly reduced in RGS1 siRNA treated 
cells thereby indicating CCR1 mediated functions. 
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Figure 38. Co-stimulation by Mip1-α and IgE/antigen enhanced 
degranulation of RGS1 siRNA treated RBL-CCR1 cells. After sensitization 
with IgE, RBL-CCR1 cells were stimulated with antigen and Mip1-α or with 
Mip1-α alone with or without CCR1 antagonist met-RANTES. The data 
represent the Mean +/- standard error mean (SEM) of five experiments where *, 
p <0.001, using the student T-test. KEY: Rgs1 siRNA= RGS1siRNA. NC siRNA= 
control siRNA.   
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5.2.3 Effect of RGS1 on RBL-CCR1 mediator release of cytokines and 
chemokines 
  
The objective of these experiments was to examine the effect of RGS1 on mediator 
release from RBL-CCR1 cells co-stimulated with Mip1-α and IgE/antigen 24 hours 
post degranulation. The mediators that were analysed from each cell supernatant 
were 1L-4, IL-6, IL-10, MCP-1 and Mip1-α. The data are representative of 3 
separate experiments, in which each condition was analysed in triplicate per 
experiment 
 
Figure 39 shows the secretion levels of chemokines and cytokines in response to 
co-stimulation by Mip1-α and IgE/antigen respectively, compared with stimulation 
by IgE/antigen alone. IL-4, IL-6 and MCP-1 were all secreted at significantly higher 
levels from co-stimulated RBL-CCR1 cells treated with RGS1 siRNA compared to 
co-stimulated cells treated with control siRNA. No significant changes were 
observed in IL-10 and Mip1-α secretion under these conditions. 
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Figure 39. Co-stimulation by Mip-1α and IgE/antigen enhanced mediator 
release of IL-4, IL-6 and MCP-1 from RGS1 siRNA treated RBL-CCR1 cells.  
After sensitization with IgE, RBL-CCR1 cells were co-stimulated with antigen 
and Mip1-α or with Mip1-α alone. 24 hours post degranulation, supernatants 
were collected and analysed for chemokines and cytokine secretion. The data 
represent the Mean +/- standard error mean (SEM) of five experiments where *, 
p <0.001, using the student T-test. 
KEY: Rgs1 siRNA= RGS1siRNA.  NC siRNA= control siRNA.   
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5.2.4 Gene expression of Inflammatory mediators IL-6, IL-13 and CCL7 in 
RBL-CCR1 cells 
 
The objective of these experiments was to examine gene expression of IL-6, IL-13 
and CCL7. The data are representative of 3 separate experiments, in which each 
condition was analysed in triplicate per experiment.  
 
Figure 40 shows the relative gene expression of (A) IL-6 (B) IL-13 and (C) CCL7. 
Cross-linking with IgE and antigen showed no statistically significant differences in 
IL-6, IL-13 and CCL7 gene expression compared to non-sensitised and IgE 
sensitized RBL-CCR1 cells 
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Figure 40. Gene expression of inflammatory mediators following 
IgE/Antigen stimulation of RBL-CCR1 cells.  
(A) IL-6, (B) IL-13 and (C) CCL7 mRNA are expressed by RBL-CCR1 cells, and 
the levels vary with stimulation. Triplicate samples were collected from 
unstimulated cells or from cells stimulated with or without IgE for 30 min at 37C. 
Realtime mRNA detection was performed using an Applied Bioscience 
thermocycler 7500. Expression was quantified using the Delta-delta CT 
calculation method and represented relative expression. Expression levels were 
normalized to that of GAPDH. The data are representative of three independent 
experiments. 
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5.2.5 Effect of RGS1 on the gene expression of inflammatory mediators IL-6, 
IL-13 and CCL7 in RBL-CCR1 cells 
 
Figure 41 shows effect of RGS1 on (A) IL-6, (B) IL-13 and (C) CCL7 gene 
expression. This data is derived from one experiment, in which each condition was 
analysed in triplicate. Upon cross-linking, IL-6, IL-13 and CCL7 gene expression 
seem to be up-regulated in RBL-CCR1 cells, however, as the error bars are large 
and data is from 1 experiment only it should be viewed with caution. 
 
 149 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41. Effect of RGS1 on gene expression of inflammatory mediators 
following IgE/Antigen stimulation of RBL-CCR1 cells. (A) IL-6, (B) IL-13 and 
(C) CCL7 mRNA are expressed by RBL-CCR1 cells, and the levels vary with 
stimulation. Triplicate samples were collected from resting cells or from cells 
stimulated with or without IgE for 30 min at 37C. Real time mRNA detection was 
performed using an Applied Bioscience thermocycler 7500. Expression was 
quantified using the Delta-delta CT calculation method and represented relative 
expression. Expression levels were normalized to that of GAPDH. The data 
shown is from one experiment only. 
 
 150 
5.2.6 Effect of RGS1 on RBL-CCR1 chemotaxis  
 
The objective of these experiments by using a transwell chemotaxis system was to 
examine the effect of RGS1 on RBL-CCR1 chemotaxis, in which RBL-CCR1 cells 
were co-stimulated with Mip1-α and IgE/antigen. The data are representative of 3 
separate experiments, in which each condition was analysed in triplicate per 
experiment. 
 
Figure 42 shows the chemotaxis of RBL-CCR1 cells in response to co-stimulation 
of CCR1 and FcεR1 by Mip1-α and IgE/antigen respectively, compared with 
stimulation by Mip1-α alone. RGS1 siRNA treated RBL-CCR1 cells demonstrated a 
significant increase in chemotaxis upon Mip1-α stimulation compared to control 
siRNA treated cells stimulated by Mip1-α. Interestingly, upon RGS1 siRNA 
treatment co-stimulated RBL-CCR1 cells showed a significant increase in 
chemotaxis as compared to co-stimulated control siRNA treated cells. 
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Figure 42. Co-stimulation by Mip1-α and IgE/antigen enhanced chemotaxis 
of RGS1 siRNA treated RBL-CCR1 cells. 
After sensitization with IgE, RBL-CCR1 cells were co-stimulated with Mip1-α 
and antigen or with Mip1-α. The data represent the Mean +/- standard error 
mean (SEM) of three experiments where *, p <0.01, using the student T-test. 
KEY: Rgs1 siRNA= RGS1siRNA. NC siRNA= control siRNA. 
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5.3 Discussion 
 
Previous reports demonstrate that cross-talk between CCR1 and FcεR1 signaling 
pathways in RBL-CCR1 cells results in two phenomena: enhanced degranulation 
and arrested chemotaxis towards a chemokine gradient (Toda et al., 2004). 
Unpublished data by Aye and Ono showed that RGS1 was up-regulated after 
stimulating IgE sensitised RBL-CCR1 cells with Mip1-α. Interestingly further up-
regulation of RGS1 was observed by co-stimulation by Mip-1α. Therefore, the 
overall objective of this study was to establish whether RGS1 might also function 
as a signaling molecule in degranulation, mediator release and chemotaxis of RBL-
CCR1 cells, in which RBL-CCR1 cells were co-stimulated with Mip1-α and 
IgE/antigen. The findings from my work are the first to show that RGS1 negatively 
regulates biological responses such as degranulation, mediator release and 
chemotaxis of RBL-CCR1 cells in response to CCR1 and FcεR1 co- stimulation.  
 
The first aim of this study was analyse the role of RGS1 in RBL-CCR1 
degranulation, in which RBL-CCR1 cells were co-stimulated with Mip1-α and 
IgE/antigen. In addition to these experiments, the CCR1 antagonist met-RANTES 
was employed to examine the functionality of CCR1 on RBL-CCR1 degranulation. 
Upon co-stimulation with Mip1-α and IgE/antigen, RGS1 siRNA cells significantly 
enhanced degranulation as compared to co-stimulated control RBL-CCR1 cells. 
RGS proteins mediate binding to Gα subunits and GAP activity. RGS GAP activity 
accelerates the transformation of Gα to its inactive form, thereby promoting 
termination of GPCR signaling pathways.  
 
Previous data showed that synergistic degranulation by CCR1 and FcεR1 is 
mediated by a PI3K pathway. In the present study, siRNA treatment of RGS1 
would further promote CCR1 chemokine signaling, and along with FcεR1 
engagement this would explain the increased degranulation levels observed in 
RGS1 siRNA RBL-CCR1 cells. Recent studies demonstrate that another member 
of the RGS family, RGS13, was up-regulated after FcεR1 aggregation in human 
and murine mast cells. Moreover, and surprisingly, RGS13-/- mice induced 
increased IgE-mediated anaphylactic responses due to increase mast cell 
degranulation (Bansal et al., 2008). Thus, together these data suggest that RGS1 
may regulate the intrinsic response of mast cells to environmental allergens 
through its inhibition of IgE/antigen mediated PI3K activity. Abnormalities in RGS1 
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expression could contribute to the pathogenesis of diseases, such as anaphylaxis 
and mastocytosis, associated with increased mast cell responsiveness. In the 
present study CCR1 activity was blocked by using the CCR1 antagonist met-
RANTES, this resulted in decreased    RBL-CCR1 degranulation. Thus, it would be 
appropriate to hypothesize that a certain level of signaling from CCR1 is important 
for RBL-CCR1 activation. 
 
Having analysed the effect of RGS1 on RBL-CCR1 degranulation, subsequent 
experiments from this study aimed to analyse the effect of RGS1 on chemokine 
and cytokine secretion from RBL-CCR1 following degranulation, in which RBL-
CCR1 cells are co-stimulated with Mip1-α and IgE/antigen. The panel of 
chemokines and cytokines analysed were IL-4, IL-6, IL-10, MCP-1 and Mip-1α. The 
work from this study demonstrated that IL-4, IL-6 and MCP-1 were secreted at 
significantly higher levels from RGS1 siRNA treated RBL-CCR1 cells following co-
stimulation of CCR1 and FceRI compared with FcεR1 alone or control cells.  This 
data is consistent with other reports demonstrating that activation of mast cells can 
release several cytokines including IL-4, IL-6, which have significant effects in the 
mucosa, including the induction of adhesion molecules and chemokines that 
contribute the recruitment of inflammatory cells characteristic of the late-phase 
response (Anderson, 2001; Cook et al., 1998; Fifadara et al., 2009). MCP-1 is 
secreted in the ocular allergic disease VKC and produced by mast cells, epithelial 
cells, fibroblasts and macrophages (Kumagai et al., 2006; Leonardi et al., 2006; 
Leonardi et al., 2003). The data from the present study shows an increase in 
secreted levels of MCP-1 from Mip1-α and IgE/antigen co-stimulated RBL-CCR1 
cells treated with RGS1 siRNA. Together, this data suggests that RGS1 regulates 
chemokine and cytokine secretion, most probably by driving the GPCR-CCR1 
signaling pathway forward. However, the exact mechanism by which RGS1 plays a 
role in chemokine and cytokine secretion, and other events such as   mast cell 
differentiation, homing, survival and ability to recruit other inflammatory cells 
requires further elucidation. 
 
To date several members of the RGS family have been implicated in regulating 
immune cell migration; chemotaxis induced by CXCL12 was greater in short hairpin 
RGS13-HMC-1 cells compared with control (Bansal et al., 2008 a); RGS 2 and 
RGS16 overexpression inhibits chemotatic responses of lymphocyte cell lines in 
vitro (Bowman et al., 1998); RGS1 deficient B-cells chemotaxed to a greater extent 
after exposure to the chemokines CXCL13 and CXCL12 (Shi et al., 2002). 
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However, the role of RGS1 on mast cell motility is yet to be reported. Hence, the 
next aim of this study was to analyse whether RGS1 affects RBL-CCR1 
chemotaxis, in which RBL-CCR1 cells were co-stimulated with Mip1-α and 
IgE/antigen. Data from the present study shows that RGS1 siRNA RBL-CCR1 cells 
pre-sensitised with IgE induced significantly greater levels of chemotaxis towards a 
gradient of Mip1-α and antigen as compared to co-stimulated control IgE pre-
sensitised cells. This data suggests that 1) RGS 1 is a negative regulator of RBL-
CCR1 chemotaxis and 2) by depleting RGS1, CCR1-GPCR pathway is accelerated 
thereby further increasing Mip1-α mediated chemotaxis. 
 155 
Chapter 6 
The role of TRB 3 in mast cell degranulation, mediator release and 
chemotaxis 
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6. The role of TRB 3 in mast cell degranulation, mediator release and 
chemotaxis 
 
6.1 Introduction and hypothesis 
 
Tribbles have been described as a family of proteins with potent signaling 
regulatory functions.  They have been shown to interact with and modulate the 
activity of several MAPK activator MAPKK proteins (Kiss-Toth et al, 2004; Kiss-
Toth et al, 2006). This suggests that TRB3 may also stimulate pro-inflammatory 
cytokines to activate a MAPK response when gene expression levels are high as 
well as play an important role in the allergic response. In addition, as previously 
described in Chapter 5, Aye and Ono (unpublished data) demonstrated the gene 
expression of TRB3 was further up-regulated after stimulating IgE sensitised RBL-
CCR1 cells with Mip1-α and IgE/antigen.  
 
Based on current knowledge, I hypothesise that TRB3, downstream of FcεR1 
signaling, can regulate mast cell degranulation, chemotaxis and mediator release. 
 
To address this hypothesis, the specific aims of this chapter were as follows: - 
 
1. Using RNA interference to characterise how TRB3 affects RBL-CCR1 
degranulation, in which RBL-CCR1 cells are co-stimulated with Mip1-α and 
IgE/antigen and appropriate controls.  
 
2. Using RNA interference analyse how TRB3 affects cytokine and chemokine 
release from RBL-CCR1 cells following degranulation, in which RBL-CCR1 
cells are co-stimulated with Mip1-α and IgE/antigen and appropriate 
controls. 
 
3. Using RNA interference analyse how TRB3 affects RBL-CCR1 chemotaxis, 
in which RBL-CCR1 cells are co-stimulated with Mip1-α and IgE/antigen and 
appropriate controls.  
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6.2 Results 
 
6.2.1 Depletion of endogenous TRB3 in RBL-CCR1 cells by RNA interference. 
 
RNA interference was employed to deplete TRB3 content in RBL-CCR1 cells and 
therefore determine how TRB3 may affect RBL-CCR1 in processes such as 
degranulation, mediator release and chemotaxis. Western Blotting in Figure 43 
confirmed that TRB3 protein was reduced in RBL-CCR1 cells expressing TRB3 
siRNA compared with cells expressing the control TRB3 siRNA. The data are 
representative of more than 10 separate experiments.  
 
 
Figure 43. Reduction of endogenous TRB3 in RBL-CCR1 cells by RNA 
interference.  
RBL-CCR1 cells were transfected with either TRB3 siRNA or control siRNA. 
Lysates were prepared and TRB3 expression was evaluated by western blot with  
anti-TRB3 Ab. Anti-actin was used to further assess protein loading. Data are 
representative of 10 experiments. 
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6.2.2 Effect of TRB3 on RBL-CCR1 degranulation 
 
The objective of these experiments was to examine the effect of TRB3 on RBL-
CCR1 degranulation, in which RBL-CCR1 cells were co-stimulated with Mip1-α and 
IgE/antigen and appropriate controls. Degranulation of RBL-CCR1 was determined 
by measuring the release of the granule protein beta-hexosaminidase. The data 
are representative of 3 separate experiments, in which each condition was 
analysed in triplicate per experiment.  
 
As shown in Figure 44, TRB3 siRNA treated RBL-CCR1 cells co-stimulated with 
Mip1-α and IgE/antigen displayed a significant increase in degranulation compared 
to co-stimulated cells treated with either control siRNA; IgE/antigen stimulated cells 
treated with TRB3 siRNA or; TRB3 siRNA treated cells stimulated with Mip1-α. 
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Figure 44. Co-stimulation by Mip1-α and IgE/antigen enhanced 
degranulation of TRB3 siRNA treated RBL-CCR1 cells. 
After sensitization with IgE, RBL-CCR1 cells were stimulated with antigen and 
Mip1-α or with Mip1-α alone. The data represent the Mean +/- standard error 
mean (SEM) of three experiments where *, p <0.01, using the student T-test. 
KEY: TRB 3 siRNA= TRB3 siRNA. NC siRNA= control siRNA. 
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6.2.3 Effect of TRB3 on RBL-CCR1 mediator release of cytokines and 
chemokines 
  
The objective of these experiments was to examine the effect of TRB3 on mediator 
release from RBL-CCR1 cells co-stimulated with Mip1-α and IgE/antigen 24 hours 
post degranulation. The chemokines and cytokines that were analysed from each 
cell supernatant were 1L-4, IL-6, IL-10, MCP-1 and Mip1-α. The data are 
representative of 3 separate experiments, in which each condition was analysed in 
triplicate per experiment.  
 
As shown Figure 45, the expression of 1L-4, IL-6, IL-10, MCP-1 and Mip1-α in 
response to co-stimulation of CCR1 and FcεRI by Mip1-α and IgE/antigen 
respectively, compared with stimulation by IgE/antigen alone. Co-stimulated RBL-
CCR1 cells treated with TRB3 siRNA secreted significantly high levels of IL-10 and 
MCP-1 compared to control siRNA treated co-stimulated RBL-CCR1 cells. In 
addition, RBL-CCR1 cells treated with TRB3 siRNA secreted significantly low levels 
of IL-4 and IL-6 in response to co-stimulation by Mip1-α and IgE/antigen compared 
to co-stimulated control siRNA treated cells. 
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Figure 45. Co-stimulation with Mip-1α and IgE/antigen enhanced mediator 
release of IL-10, and MCP-1 from TRB 3 siRNA treated RBL-CCR1 cells.  
RBL-CCR1 cells were stimulated with Mip1-α and antigen (cells sensitised with 
IgE) or with Mip1-α alone. 24 hours post degranulation, supernatants were 
collected and analysed for chemokines and cytokine secretion. The data 
represent the Mean +/- standard error mean (SEM) of three experiments where 
*, p <0.01, using the student T-test. 
KEY: Rgs1 siRNA= RGS1siRNA.  NC siRNA= control siRNA.   
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6.2.4 Effect of TRB3 on RBL-CCR1 chemotaxis  
 
The objective of these experiments by using a transwell chemotaxis system was to 
examine the effect of TRB3 on RBL-CCR1 chemotaxis, in which RBL-CCR1 cells 
were co-stimulated with Mip-a and IgE/antigen. The data are representative of 3 
separate experiments, in which each condition was analysed in triplicate per 
experiment.  
 
As shown In Figure 46, shows the chemotaxis of RBL-CCR1 cells in response to 
co-stimulation by Mip1-α and IgE/antigen compared to stimulation by Mip1-α alone. 
Interestingly TRB3 siRNA treated RBL-CCR1 cells co-stimulated with Mip1a and 
IgE/antigen showed a significant increase in chemotaxis compared to co-stimulated 
contol siRNA treated cells. 
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Figure 46. Co-stimulation by Mip1-α and IgE/antigen enhanced chemotaxis 
of TRB3 siRNA treated RBL-CCR1 cells. 
RBL-CCR1 cells were stimulated with Mip1-α and antigen (cells sensitised with 
IgE) or with Mip1-α. The data represent the Mean +/- standard error mean 
(SEM) of three experiments where *, p <0.001, using the student T-test. 
KEY: TRB 3 siRNA= TRB 3 siRNA. NC siRNA= control siRNA. 
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6.3 Discussion 
 
As previously mentioned, the gene expression of two genes, RGS1 and TRB3 were 
up-regulated after co-stimulation by Mip1-α and IgE/antigen (Aye and Ono, 
unpublished data). Tribbles have been described as a family of proteins with potent 
signaling regulatory functions, in which they interact with and modulate the activity 
of signal transduction pathways, including the PI3K (Iynedjian, 2005; Du et al., 
2003) and MAPK (Kiss-Toth et al., 2004; Hegedus et al., 2007) systems. On this 
basis, the overall aim of the present study was to analyse whether TRB3 may 
regulate degranulation, mediator release and chemotaxis of RBL-CCR1 cells, in 
which RBL-CCR1 cells are co-stimulated with Mip1-α and IgE/antigen. The findings 
from this study are the first to demonstrate that TRB3 indeed plays a negative 
regulatory role on RBL-CCR1 degranulation, mediator release and chemotaxis in 
response to CCR1 and FcεRI co- stimulation.  
 
Co-stimulation by Mip1-α and IgE/antigen synergistically enhances degranulation of 
RBL-CCR1 cells, and this effect is mediated via a PI3K pathway (Toda et al., 
2004). The signal transduction molecule, AKT, is transported to the cell membrane 
upon PI3K activation and is a fundamental component in cytoskeletal re-
organisation, intracellular signaling and cell survival (Lemmon et al., 2002; Costello 
et al., 2002). Du et al., (2003) demonstrated in hepatic cells that TRB3 is a 
pseudokinase that binds AKT and inhibits phosphorylation of AKT, which is 
required for AKT to be active. This has been confirmed by other similar cell types 
(Naiki et al., 2007; Matsushima et al., 2006), including chondrocytes (Cravero et al., 
2009). The first objective of this study was to determine whether TRB3 affects RBL-
CCR1 degranulation, in which RBL-CCR1 cells were co-stimulated with Mip1-α and 
IgE/antigen. My findings demonstrated that upon co-stimulation with Mip1-α and 
IgE/antigen TRB3 siRNA RBL-CCR1 cells induced a significant increase in 
degranulation compared to co-stimulated cells treated with either control or 
IgE/antigen stimulated cells treated with TRB3 siRNA. This data suggests that 
TRB3 is a negative regulator of RBL-CCR1 degranulation, and moreover, through 
co-stimulation by CCR1 and FcεRI, TRB3 drives a signal cascade, possibly by 
inhibiting AKT that regulates the level of degranulation that is important in the 
allergic response. Future studies could analyse the interaction of TRB3 and AKT 
phosphorylation during CCR1 and FcεRI engagement on RBL-CCR1 cells.  
 
TRB3 plays an important role in the regulation of several cytokines and 
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chemokines. It has been documented that TRB3 acts as a negative regulator of 
NF-κβ, a known regulator of IL-6 production (Grogan et al., 2001). Down regulation 
of TRB2 enhances IL-8 production both in THP-1 cells and in human primary 
monocytes via a MAPK signalling pathway (Eder et al., 2008). In addition, Smith et 
al., (2011) demonstrated that knockdown of TRIB3 by siRNA interference up-
regulated TLR2-mediated NF-κB activation and chemokine induction in response to 
Helicobacter pylori (H. pylori) LPS. IL-4 has also been associated with the allergic 
response by promoting the production of IgE, and chemokine and mucus 
production at the site of allergic inflammation (Kelly-Welch at al., 2003; Ownby, 
D.R. et al., 2001).  
 
Following on from the regulatory role of TRB3 on RBL-CCR1 degranulation, 
subsequent experiments from this study aimed to investigate the effects of TRB3 
on other mast cell processes such as mediator release following RBL-CCR1 
degranulation, in which RBL-CCR1 cells were co-stimulated with Mip1-α and 
IgE/antigen. The findings from the present study demonstrated that upon co-
stimulation by Mip1-α and IgE/antigen, RBL-CCR1 cells treated with TRB3 siRNA 
secreted significantly high levels of IL-10 and MCP-1 but significantly low levels of 
IL-4 and IL-6 compared to TRB3 siRNA treated cells stimulated with IgE/antigen 
alone. Surprisingly, the findings from this investigation demonstrate that a lack of 
TRB3 in RBL-CCR1 cells decreases levels of IL-4 and IL-6 (which does not 
correlate with previous reports for IL-6), thereby indicating that TRB3 does not 
serve as a negative regulator for these particular cytokines. It is possible that TRB3 
is a positive regulator of NF-κβ, hence, future studies should validate this by 
analysing the interaction of TRB3 and NF-κβ following CCR1 and FcεRI 
engagement of RBL-CCR1 cells. MCP-1 is considered an important chemokine in 
immune interactions because it recruits monocytes to an area where it will promote 
an inflammatory response.  However, MCP-1 is not a very potent chemoattractant 
for mast cells and is associated with the recruitment of lymphocytes and 
eosinophils (Taub et al., 1995). Data obtained from the present study demonstrated 
that MCP-1 was significantly increased through TRB3 siRNA treatment following 
CCR1 and FcεRI engagement, which indicates that TRB3 is a negative regulator 
for this chemokine. Hence, the negative regulatory effect of TRB3 on MCP-1 could 
potentially affect the recruitment of various immune cells such as monocytes and 
lymphocytes during an inflammatory response. Anti-inflammatory mediators, such 
as IL-10 antagonise the activities of Th1 cytokines (Lester et al., 1995; Romagnani 
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et al., 2000). The data from my study demonstrated that IL-10 secretion was also 
was significantly increased through TRB3 siRNA treatment following CCR1 and 
FcεRI engagement of RBL-CCR1 cells. This data indicates that TRB3 is not only a 
negative regulator of MCP-1, but also for the anti-inflammatory cytokine IL-10.  
 
The chemotaxis of cells to sites of inflammation in response to pathogenic stimuli 
or cytokines/chemokines is regulated via a PI3K signalling pathway. This study, 
along with the findings of Toda et al., (2004) demonstrated that co-stimulation by 
Mip1-α and IgE/antigen exhibited profound effects on RBL-CCR1 actin cytokeleton 
and thereby, inhibited Mip1-α induced chemotaxis. As previously mentioned TRB3 
3 inhibits AKT phosphorylation in many cell types (Du et al., 2003; Cravero et al., 
2009), which in turn could potentially effect downstream signalling of the PI3K 
pathway and the chemotaxis process. Therefore it is of crucial importance to the 
physiological resolution of inflammation to have effective control mechanisms in 
place, which control mast cell responses. To date there are no reports 
demonstrating a regulatory role of TRB3 on mast cell chemotaxis.  The final aim of 
the present study was to examine the effect of TRB3 on RBL-CCR1 chemotaxis, in 
which RBL-CCR1 cells were co-stimulated with Mip1-α and IgE/antigen. The 
findings from this study demonstrate that TRB3 siRNA treated RBL-CCR1 cells co-
stimulated with Mip1a and IgE/antigen showed a significant increase in chemotaxis 
compared to co-stimulated contol siRNA treated cells, but a significant decrease in 
chemotaxis compared to Mip1-α stimulated TRB3 siRNA treated cells. The results 
from this investigation indicate that while TRB3 is a negative regulator of IgE 
sensitized RBL-CCR1 chemotaxis towards Mip1-α and antigen, it serves as a 
positive regulator of RBL-CCR1 chemotaxis towards Mip1-α. It was not possible in 
the present study to further elucidate the exact molecular signalling components 
involved in this process following Mip1-α and FcεRI engagement, however, it is 
possible that TRB3 mediates its affects on chemotaxis by either modulating PI3K 
activation/AKT phosphorylation and/or MAPK systems, hence future studies should 
aim to test this. 
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Chapter 7 
General discussion and future work 
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7. General discussion and future work 
 
Allergic diseases affect 25% of the general population and costs associated with 
these diseases dominate public health budgets. At present therapeutic approaches 
target key mechanisms involved in the development of the clinical disease, these 
include: histamine with histamine receptor antagonists, mast cells with mast cell 
stabilisers, inflammation with corticosteroids, and finally severe inflammation with 
immuno-modulators (Verhagen et al., 2005; Leonardi et al., 2008, Frew, 2011). 
However, all of these agents pose side affects, whilst some such as corticosteroids 
give rise to adverse side affects such as glaucoma and cataracts. Hence, to 
establish novel therapeutic strategies, further insights to better understand the 
molecular basis of the allergic response are required. 
 
Previous studies demonstrated that CCR1 and FcεR1 engagement following 
allergen mediated cross-linking resulted in three phenomena 1) enhanced 
synergistic degranulation in RBL-CCR1 cells and ex vivo murine conjunctival cells, 
2) arrest of Mip-1α induced chemotaxis of RBL-CCR1 cells (Toda et al., 2004; 
Miyazaki et al., 2005) and 3) gene expression up-regulation of RGS1 and TRB3 in 
RBL-CCR1 cells (Aye and Ono, unpublished data). Considering the role of mast 
cells an allergic inflammation the previous findings I have just discussed are 
consistent with the biology of the response. In that mast cells would migrate toward 
a chemoattractant gradient at sites of inflammation, but stop and accumulate where 
the concentration of allergen is high. Meanwhile the degranuation of mast cells at 
sites of inflammation is enhanced by co-stimuation with Mip-1α and allergen at the 
sites where cells accumulate thereby focusing the inflammatory response. 
 
The chemotaxis of mast cells to sites of inflammation and the subsequent release 
of mediators such as histamine and cytokines/chemokines upon degranulation are 
crucial to eliciting allergic inflammation. Unlike many other cell types such as 
neutrophils, fibroblasts, T-cells and Dictyostelium there is as yet very little evidence 
to understand mast cell chemotaxis at this level. The data presented in this study 
illuminate the role of WASP, CCR1 and actin polymerisation as mechanisms 
underlying Mip-1α induced RBL-CCR1 chemotaxis. Moreover, CCR1 and FcεR1 
engagement inhibits RBL-CCR1 actin reorganisation and other cell motility 
parameters such as directionality, which are required for Mip-1α induced 
chemotaxis. In addition, by using siRNA the present study is the first to show that 
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RGS1 and TRB3 serve as negative regulators of RBL-CCR1 chemotaxis upon 
CCR1 and FcεR1 engagement.  
 
Immune cells such as neutrophils and dendritic cells are highly motile. They can 
detect the presence of chemoattractant signals, and guide their movement in the 
direction of the concentration gradient of these signals. This process known as 
chemotaxis, has a role in diverse functions such as immune surveillance, wound 
healing and tissue homoeostasis (Baggiolini, 1998; Norman and Hickey, 2005; 
Thelen and Stein, 2008; Zinselmeyer et al., 2008; Beltman et al., 2009; Velazquez 
and Teran, 2010). The mechanisms involved in cell motility have been extensively 
studied in vitro and in vivo, using a variety of different model systems and cell 
types. Chemotaxis can be divided into discrete stages. First, cells must adhere to 
their surrounding environment. When the cell response is chemotactic, chemotaxis 
requires that cells sense the direction of the chemical gradient in order to establish 
polarity. Polarization might improve chemotaxis by enhancing the persistence of 
movement towards the source. Once directionality is established, forward 
movement is driven by protrusion of a leading edge composed of lamellipodia 
which is periodically induced at points on the cell membrane. This is accompanied 
by simultaneous cell retraction, actin reorganization and detachment of adhesions 
at the cell rear. An array of proteins are required for efficient cell chemotaxis, 
ranging from actin-binding proteins, such as the Arp2/3 complex which are 
activated by adaptor proteins such as WASP; PI3Ks; PI(3,4,5)P3  and  GTP-
binding proteins of the Rho family, Rac, Cdc42, and Rho (Machesky & Insall, 1998; 
Vanhaesebroeck et al., 2005; Villalonga and Ridley, 2006; Oak et al., 2007; Costa 
et al., 2007: Cain and Ridley, 2009).  
 
The data presented here are the first to show by real time microscopy that CCR1 
and FcεR1 engagement exhibits profound effects on RBL-CCR1 morphology: 
decreased membrane ruffling and inhibition of Mip-1α induced chemotaxis of RBL-
CCR1 cells. The Rho family, Rac, Cdc42, and Rho control chemotaxis by 
mediating the reorganization of the actin cytoskeleton. Toda at al., (2004) 
demonstrated that Mip-1α -mediated chemotaxis of RBL-CCR1 cells was inhibited 
by Rho kinase (ROCK) inhibitor, Y-27632. Meanwhile, co-stimulation by Mip-1α 
and IgE/antigen enhanced Rac and Cdc42 activation but decreased ROCK 
activation in RBL-CCR1 cells compared with cells stimulated with Mip-1α alone. In 
addition to these findings, this study has demonstrated that Mip-1α induced 
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chemotaxis of RBL-CCR1 cells stimulates new sites of actin polymerization at the 
leading edge of polarized cells, along with WASP and CCR1 co-localisation at 
these sites, indicating that these events are necessary for the detection of, and 
subsequent chemotaxis of RBL-CCR1 towards a Mip-1α gradient. In vitro studies 
demonstrate the Arp2/3 complex, which binds to the sides of pre-existing filaments 
and induces the formation of branches, thereby mediates actin polymerization. 
Activation of Arp2/3 is induced by the WASP/ Cdc42 pathway (Millard et al., 2004). 
Cdc42 seems to function as a master regulator of polarity in eukaryotic cells, and in 
vitro assays have shown that Cdc42 is active towards the front of migrating 
neutrophils (Etienne-Manneville, 2006; Van Keymeulen et al., 2006). This data 
corroborates with the present study in which WASP localization at the leading edge 
of polarised RBL-CCR1 cells would be an indication of Cdc42 activation at these 
new sites of actin polymerisation. Since Arp2/3 is a nucleator of actin 
polymerization (via WASP/Cdc42), future studies should analyse the role of Arp2/3 
on RBL-CCR1 cell motility upon CCR1 and FcεR1 engagement. In addition, the key 
event that determines where actin polymerization occurs in polarized RBL-CCR1 
cells is potentially determined by the localization of active Rac in the cell. This is 
probably achieved by locally produced PI(3,4,5)P3 as previously reported by Welch 
et al., 2003.  
 
Chemoattractant receptors in both neutrophils and Dictyostelium signal through 
similar G proteins. Most systems contain a βγ subunit, in which the βγ-complex is a 
critical mediator for chemotaxis. The chemoattractant receptors in Dictyostelium 
and neutrophils are uniformly distributed along the cell perimeter during chemotaxis 
(Xiao et al., 1997; Servant et al., 1999). Surprisingly, in the present study CCR1 
was localized at the leading edge of polarized RBL-CCR1 cells suggesting that 
these upstream components of the GPCR signal pathways shows a specific 
localization in chemotaxing or polarized RBL-CCR1cells. Asymmetric CCR1 
receptor localisation is consistent with Gomez-Mouton et al., 2004, who 
demonstrated asymmetrical distributions of chemokine receptors on the cell 
surface in response to a chemoattractant gradient. Future studies should analyse 
the spatial and temporal organisation of CCR1 and WASP in RBL-CCR1 cells 
following CCR1 and FcεR1 engagement so as to further define the molecular basis 
of arrested mast cell chemotaxis during the allergic response. This data collectively 
suggests that mast cells may use an ARP 2/3/WASP and GPCR -mediated 
pathways to facilitate chemotaxis during an allergic response, whereby co-
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stimulation by CCR1 and FcεR1 engagement would enhance degranulation and 
mediator release from stationary mast cells, potentially affecting the late phase 
response and recruitment of other immune cells. 
 
Numerous reports implicate PI3K isoforms and PI(3,4,5)P3 link early 
chemoattractant signals with downstream components of the chemotaxis response 
(Devreotes and Janetopoulos, 2003; Sadhu et al., 2003; Iglesias, 2009; 
Vanhaesebroeck et al., 2010). PI(3,4,5)P3 is generated from PtdIns(4,5)P2 by 
PI3Ks in Dicytostelium and in neutrophils and mediates cell polarization, and hence 
chemotaxis. Several studies have reported that the GFP–-PH domain probe is 
recruited selectively to the membrane at the leading edge of Dicytostelium, 
fibroblasts, and neutrophils after exposure of to different chemoattractant stimuli 
(Merlot and Firtel, 2003). This is consistent with the present study which showed 
PI(3,4,5)P3  accumulation (using a GFP–-PH domain probe) at the leading edge of 
polarized RBL-CCR1 cells in response to a Mip-1α gradient, suggesting a potential 
mechanism of RBL-CCR1 polarity and Mip-1α mediated chemotaxis. As it was not 
possible to reproduce these experiments more than twice, the indication that 
chemotaxis of RBL-CCR1 towards the chemokine Mip-1α cells might be mediated 
via a PI(3,4,5)P3 mediated pathway must be interpreted with caution.  
To establish novel therapeutic approaches for allergic diseases and elucidate 
immunological mechanisms, animal models of ocular allergies have been 
developed over the past decade (Merayo-Lloves et al., 1996 ; Izushi et al., 2002; 
Groneberg et al., 2003; Miyazaki et al., 2005). Conjunctival mast cells are well-
established targets for evaluating potential pharmaceutical interventions in ocular 
disease. The accumulation of mast cells into sites of inflammation occur by two 
mechanisms: 1) migration of progenitor mast cells from the blood and 2) re-
localisation of mature mast cells with in the tissue (Abonia et al., 2005; Gurish et 
al., 2001).  Following on from analysing the effects of CCR1 and FcεR1 
engagement on RBL-CCR1 motility in vitro, subsequent experiments analysed 
mast cell motility in murine allergic conjunctivitis. The findings from this study 
showed an increase in conjunctival mast cells in the inflamed conjunctiva 
compared to non-diseased eyes for both models of murine allergic conjunctivitis. 
Previous reports have indicated that increased numbers of mast cell progenitors at 
sites of inflammation may contribute to the accumulation of mature mast cells 
(Mwamtemi et al., 2001; Gurish and Boyce, 2006). However, from the present 
study, whether the increase in mast cell number in the inflamed conjunctivia is a 
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result of mast cell progenitor infiltration from circulation or resident mast cell re-
localisation within the tissue is yet to be determined.  CCR1+ mast cells were 
observed in the bronchial epithelium of patients with asthma (Amin et al., 2005). 
The level of Mip-1α is increased in the asthmatic lung (Bisset and Schmid-
Grendelmeier, 2005; Alam et al., 1996). 
 
In addition to WASP and CCR1 posing potential mechanisms for mast cell 
polarisation and chemotaxis, the data presented in this study is the first to show 
that RGS1 and TRB3 regulate chemotaxis of RBL-CCR1 cells following CCR1 and 
FcεR1 engagement. The primary transducer used by GPCRs is the heterotrimeric 
G protein, which consists of α, β and γ subunits. In the absence of receptor 
stimulation, these subunits co-exist as one complex, in which the α subunit is 
bound to GDP.  Upon GPCR stimulation by chemokine, Gα exchanges GTP for 
GDP and temporarily dissociates from the βγ subunit, in which the βγ subunit is 
essential for chemotaxis via PI3K signalling pathway at the cell membrane. RGS 
proteins accelerate the return of Gα to its inactive GDP-form thereby facilitating the 
re-formation of the Gα-GDP-βγ subunit and promoting more rapid termination of G-
protein signalling pathways (Watson et al., 1996). In the present study, RGS1 
siRNA treated RBL-CCR1 cells co-stimulated with Mip-1α and IgE/antigen 
significantly up-regulated chemotaxis of RBL-CCR1 cells, indicating that RGS1 is a 
negative regulator of RBL-CCR1 chemotaxis. It is possible that this response is 
mediated by the inhibition of RGS activity, which would result in the dissociation of 
the βγ subunit from Gα subunit thereby further promoting PI3K down stream 
signalling and chemotaxis. This mechanism would potentially corroborate with a 
recent study by Bansal et al., 2008 who showed that phosphorylation, and 
chemotaxis induced by CXCL12 were greater in short hairpin RGS13-HMC-1 cells 
compared with control. In addition, RGS13 over-expression inhibited CXCL12-
evoked phosphorylation and chemotaxis. Unlike RGS1, TRB3 modulates several 
cellular processes such as mediator release by interacting with NF-κβ or MAPKs 
(Du et al., 2003; Koo et al., 2004; Hegedus et al., 2007), which would otherwise 
induce cell polarization/chemotaxis and cytokine/chemokine release. The data 
presented here is the first to demonstrate that TRB3 is negative regulator of RBL-
CCR1 chemotaxis, following CCR1 and FcεR1 engagement.  Upon CCR1 and 
FcεR1 engagement TRB3 siRNA treated RBL-CCR1 cells significantly upregulated 
chemotaxis, and it is possible that these affects are mediated via a PI3K/ pathway. 
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However, a previous study by Sung et al., 2007 demonstrated that depletion of 
TRB1 (using siRNA) led to an increase in transmigrated smooth muscle cells cells 
in response to PDGF.  Inhibition of the JNK pathway demolished the effect of 
siRNA TRB1 treatment, suggesting that TRB1 may be a negative regulator of 
smooth muscle chemotaxis via inhibitory activity of the JNK pathway. It is very 
possible that that the basic molecular mechanisms responsible for tribbles action 
are similar for TRB3 to those reported for TRB1 previously. Future experiments 
should further define the role of TRB3 on RBL-CCR1 chemotaxis and its interaction 
with PI3K and JNK signaling pathways upon CCR1 and FcεR1 engagement.  
 
Mast cell activation requires co-ordinated events that result in degranulation and 
mediator release when encountering a given antigen (Furumoto et al., 2004; 
Gilfilian and Tkaczyk, 2006). Mast cells express CCR1, CCR2, CCR3 and CCR5 
(Ono et al., 2003) on their cell surface, where MCP-1 is the respective ligand for 
CCR2. In addition, MCP-1 directly activates mast cells in murine models of airway 
inflammation, and up-regulated levels of MCP-1 have been identified in 
bronchoalvelolar lavage fluid and bronchial tissue in patients with asthma (Alam et 
al., 1996). The present study demonstrated that upon CCR1 and FcεR1 
engagement, depletion of RGS1 and TRB3 significantly upregulated the secretion 
of several cytokines and chemokines, which included MCP-1. This data suggests 
that RGS1 and TRB3 are negative regulators of MCP-1 secretion, by possibly 
promoting NF-κβ activation, and hence gene transcription of MCP-1. Regulation of 
MCP-1 by TRB3 and RGS1 would potentially determine the level of mediator 
release from degranulating mast cells, which are important in the recruitment of 
other mast cells, and hence the allergic inflammatory response.  
 
In conclusion, the mechanisms underlying mast cell accumulation and arrest at 
sites of inflammation are a therapeutic target for allergic diseases. The discovery 
that chemokines control the movement and activation of immune cells, has 
provided attractive new targets for anti-inflammatory drug design. A CCR1 
anatagonist has been shown to decrease the number of clinical symptoms related 
to asthmatic type inflammation in murine models of asthma (Carpenter et al., 
2005). Although a CCR1 antagonist could potentially treat allergic diseases, a 
disadvantage regarding CCR antagonists is that many chemokines are 
promiscuous ligands. RGS proteins expressed in mast cells and lymphocytes 
(Druey et al, 1996; Reif and Cyster et al., 2000; Oliveira-Dos-Santos et al., 2000; 
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Bansal et al., 2008) represent a vital regulatory component of the signalling 
pathways induced by GPCRs in allergic inflammation. Hence, inhibition of RGS 
activity may potentially exhibit profound effects on the specificity and potency of 
GPCR-targeted drugs. A compound that specifically inhibits RGS4 activity in vitro 
has recently shown promise (Roman et al., 2007). In view of the present study, 
RGS1 regulates degranulation, mediator release and chemotaxis in RBL-CCR1 
cells, suggesting that RGS1 might represent a useful target for therapeutic 
intervention for the treatment of allergic diseases. In addition, the findings from this 
study provide evidence that TRB3 can act as a regulator of mast cell chemotaxis. 
Manipulation of TRB3 may be particularly attractive to the pharmaceutical industry 
as the predicted prevention of down-regulation would be to reduce the allergic 
inflammatory response. 
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A schematic model to describe the molecular basis of mast cell motility in 
allergic inflammation based on the findings from this study.  
FcεR1 engagement by antigen (signal 1) and CCR1 engagement by Mip-1α 
(signal 2) independently induce degranulation of mast cells via PI3K. Mip-1α 
(signal 2) induced mast cell chemotaxis is mediated via PI3K, WASP, CCR1 and 
actin polymerisation at the leading edge of the cell. However, co-stimulation by 
Mip-1α and IgE/antigen (signal 1 plus 2) results in inhibition of membrane 
ruffling and arrested chemotaxis. Depletion of RGS1 and TRB3 induce 
increased chemotaxis in the presence of signal 1 and 2.  
KEY: Signal 1= FcεR1 engagement by antigen. Signal 2=CCR1 engagement by 
Mip-1α   
 176 
Chapter 8. References 
 177 
Abe, M., Kurosawa, M., Igarashi, Y., Ishikawa, O. and Miyachi, Y. (2000) Influence 
of IgE-mediated activation of cultured human mast cells on proliferation and type I 
collagen production by human dermal fibroblasts. J. Allergy Clin. Immunol. 106, 
S72–S77 
 
Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, Koni PA, 
Gurish MF. Constitutive homing of mast cell progenitors to the intestine depends on 
autologous expression of the chemokine receptor CXCR2. Blood. 2005 Jun 
1;105(11):4308-13. 
 
Abonia JP, Hallgren J, Jones T, Shi T, Xu Y, Koni P, Flavell RA, Boyce JA, Austen 
KF, Gurish MF. Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential 
for recruitment of mast cell progenitors to the inflamed lung. Blood. 2006 Sep 
1;108(5):1588-94.  
 
Akbari O, Faul JL, Hoyte EG, et al. CD4_ invariant T-cell receptor+natural killer T 
cells in bronchial asthma. N Engl J Med 354:1117–1129, 2006. 
 
Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage 
inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med. 1992 
Sep 1;176(3):781-6. 
 
Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, Ida N. 
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of 
allergic asthmatic patients. Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1398-
404. 
 
Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev 
Immunol. 2003 Jan;3(1):36-50  
 
Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, 
Handel TM, Virgin HW, Fremont DH. Structural basis of chemokine sequestration 
by a herpesvirus decoy receptor. Cell. 2002 Nov 1;111(3):343-56. 
 
 
 
 
 178 
Alexandrakis M, Letourneau R, Kempuraj D, Kandere-Grzybowska K, Huang M, 
Christodoulou S, Boucher W, Seretakis D, Theoharides TC. Flavones inhibit 
proliferation and increase mediator content in human leukemic mast cells (HMC-1). 
Eur J Haematol. 2003 Dec;71(6):448-54. 
 
Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C, Kuehn N, Gray A, 
Giddings J, Peskett E, Fox R, Bruce I, Walker C, Sawyer C, Okkenhaug K, Finan 
P, Vanhaesebroeck B. Essential role for the p110delta phosphoinositide 3-kinase in 
the allergic response. Nature. 2004 Oct 21;431(7011):1007-11. 
 
Amin K, Janson C, Harvima I, Venge P, Nilsson G. CC chemokine receptors CCR1 
and CCR4 are expressed on airway mast cells in allergic asthma. J Allergy Clin 
Immunol. 2005 Dec;116(6):1383-6.  
 
Anderson DW. Cytokines as drug targets. IDrugs. 2001 Apr;4(4):375-7. 
 
Anfossi N, Lucas M, Diefenbach A, Bühring HJ, Raulet D, Tomasello E, Vivier 
E.Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation 
of the RBL-2H3 leukemic mast cell line. Eur J Immunol. 2003 Dec;33(12):3514-22. 
 
Anthony, R. M., Rutitzky, L. I., Urban, J. F., Jr., Stadecker, M. J. and Gause, W. C. 
Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 7, 975–
987. (2007)  
 
Apostolou I, Verginis P, Kretschmer K, et al. Peripherally induced Treg: Mode, 
stability, and role in specific tolerance. J Clin Immunol 28:619–624, 2008. 
 
Applequist, S. E., Wallin, R. P. and Ljunggren, H. G. Variable expression of Toll-like 
receptor in murine innate and adaptive immune cell lines. Int. Immunol. 14, 1065–
1074. (2002)  
 
Aragay AM, Mellado M, Frade JM, Martin AM, Jimenez-Sainz MC, Martinez-A C, 
Mayor F Jr. Monocyte chemoattractant protein-1-induced CCR2B receptor 
desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl 
Acad Sci U S A. 1998 Mar 17;95(6):2985-90. 
 
 179 
Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone DP, Liu FT, Galli SJ, 
Kawakami T. Regulation of mast cell survival by IgE. Immunity. 2001 
Jun;14(6):791-800. 
 
Aspenström P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to 
a protein implicated in the immunodeficiency disorder Wiskott-Aldrich 
syndrome.Curr Biol. 1996 Jan 1;6(1):70-5. 
 
Baecher-Allan C, Brown JA, Freeman GJ, and Hafler DA.CD4+CD25high 
regulatory cells in human peripheral blood. J Immunol 167:1245–1253, 2001. 
 
Baeuerle, P.A. IκB-NF-κB structures: at the interface of inflammation control. Cell 
1998, 95, 729-731. 
 
BaggioliniM. Chemokines and leukocyte traffic. Nature. 1998 Apr 9;392(6676):565-
8.  
 
Baldwin, A.S. Control of oncogenesis and cancer therapy resistance by the 
transcription factor NF-κB. J. Clin. Investig. 2001, 107, 241-246. 
 
Bansal G, DiVietro JA, Kuehn HS, Rao S, Nocka KH, Gilfillan AM, Druey KM. 
RGS13 controls g protein-coupled receptor-evoked responses of human mast cells. 
J Immunol. 2008 Dec 1;181(11):7882-90. 
 
Bansal G, Xie Z, Rao S, Nocka KH, Druey KM. Suppression of immunoglobulin E-
mediated allergic responses by regulator of G protein signaling 13. Nat Immunol. 
2008 Jan;9(1):73-80.  
 
Barlic J, Khandaker MH, Mahon E, Andrews J, DeVries ME, Mitchell GB, 
Rahimpour R, Tan CM, Ferguson SS, Kelvin DJ. beta-arrestins regulate interleukin-
8-induced CXCR1 internalization. J Biol Chem. 1999 Jun 4;274(23):16287-94. 
 
Bear JE, Rawls JF, Saxe CL 3rd. SCAR, a WASP-related protein, isolated as a 
suppressor of receptor defects in late Dictyostelium development. J Cell Biol. 1998 
Sep 7;142(5):1325-35. 
 
 180 
Beaven MA. Our perception of the mast cell from Paul Ehrlich to now.Eur J 
Immunol. 2009 Jan;39(1):11-25. 
 
Beer F, Kuo CH, Morohoshi K, Goodliffe J, Munro P, Aye CC, Dawson M, 
Richardson RM, Jones LH, Ikeda Y, Nakamura T, Toda M, Flynn T, Ohbayashi M, 
Miyazaki D, Ono SJ. Role of beta-chemokines in mast cell activation and type I 
hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies. Immunol 
Rev. 2007 Jun;217:96-104 
 
Beltman JB, Marée AF, de Boer RJ. Analysing immune cell migration. Nat Rev 
Immunol. 2009 Nov;9(11):789-98. Epub 2009 Oct 16.  
 
Bernards A. GAPs galore! A survey of putative Ras superfamily GTPase activating 
proteins in man and Drosophila. Biochim Biophys Acta. 2003 Mar 17;1603(2):47-
82. 
 
Berzat A, Hall A. Cellular responses to extracellular guidance cues. EMBO J. 2010 
Aug 18;29(16):2734-45.  
 
Bilenki L, Yang J, Fan Y, et al. Natural killer T cells contribute to airway eosinophilic 
inflammation induced by ragweed through enhanced IL-4 and eotaxin production. 
Eur J Immunol 34:345–354, 2004 
 
Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J. 2000 Jun 
1;348 Pt 2:241-55. 
 
Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the 
pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med. 
2005 Jan;11(1):35-42.  
 
Bissonnette EY, Enciso JA, Befus AD. TGF-beta1 inhibits the release of histamine 
and tumor necrosis factor-alpha from mast cells through an autocrine pathway.Am 
J Respir Cell Mol Biol. 1997 Mar;16(3):275-82. 
 
Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol. 2003 
Feb;111(2 Suppl):S460-75. 
 
 181 
Bousso P, Bhakta NR, Lewis RS, Robey E. Science. 2002 Jun 7;296(5574):1876-
80. Dynamics of thymocyte-stromal cell interactions visualized by two-photon 
microscopy. 
 
Bowers, A.J.; Scully, S.; Boylan, J.F. SKIP3, a novel Drosophila tribbles   ortholog, 
is overexpressed in human tumors and is regulated by hypoxia. Oncogene 2003, 
18, 2823. 
 
Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, Butcher EC. 
Regulation of chemotactic and proadhesive responses to chemoattractant 
receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem. 
1998 Oct 23;273(43):28040-8. 
 
Byrne, S. N., Limon-Flores, A. Y. and Ullrich, S. E. (2008) Mast cell migration from 
the skin to the draining lymph nodes upon ultraviolet irradiation represents a key 
step in the induction of immune suppression. J. Immunol. 180, 4648–4655 
 
Campellone KG, Webb NJ, Znameroski EA, Welch MD.WHAMM is an Arp2/3 
complex activator that binds microtubules and functions in ER to Golgi 
transport.Cell. 2008 Jul 11;134(1):148-61. 
 
Cammer M, Gevrey JC, Lorenz M, Dovas A, Condeelis J, Cox D.The mechanism of 
CSF-1-induced Wiskott-Aldrich syndrome protein activation in vivo: a role for 
phosphatidylinositol 3-kinase and Cdc42. J Biol Chem. 2009 Aug 
28;284(35):23302-11.  
 
Campbell DJ, and Ziegler SF. FOXP3 modifies the phenotypic and functional 
properties of regulatory T cells. Nat Rev Immunol 7:305–310, 2007. 
 
Cantrell DA. Phosphoinositide 3-kinase signalling pathways. J Cell Sci. 2001 
Apr;114 (Pt 8):1439-45 
 
Carpenter KJ, Ewing JL, Schuh JM, Ness TL, Kunkel SL, Aparici M, Miralpeix M, 
Hogaboam CM. Therapeutic targeting of CCR1 attenuates established chronic 
fungal asthma in mice. Br J Pharmacol. 2005 Aug;145(8):1160-72. 
 
 182 
Castellani ML, Vecchiet J, Salini V, Conti P, Theoharides TC, Caraffa A, Antinolfi P, 
Teté S, Ciampoli C, Cuccurullo C, Cerulli G, Felaco M, Boscolo P. Stimulation of 
CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells. 
Transl Res. 2009 Jul;154(1):27-33. 
 
Chadborn NH, Ahmed AI, Holt MR, Prinjha R, Dunn GA, Jones GE, Eickholt BJ. 
PTEN couples Sema3A signalling to growth cone collapse. J Cell Sci. 2006 Mar 
1;119(Pt 5):951-7. 
 
Chahdi, A., Sorokin, A., Dunn, M. J. and Landry, Y. The Rac/Cdc42 guanine 
nucleotide exchange factor beta1Pix enhances mastoparan-activated Gi-
dependent pathway in mast cells. Biochem. Biophys. Res. Commun. 317, 384–
389. (2004)  
 
Chen L, Janetopoulos C, Huang YE, Iijima M, Borleis J, Devreotes PN.Two phases 
of actin polymerization display different dependencies on PI(3,4,5)P3 accumulation 
and have unique roles during chemotaxis. Mol Biol Cell. 2003 Dec;14(12):5028-37.  
 
Chung CY, Funamoto S, Firtel RA. Signaling pathways controlling cell polarity and 
chemotaxis. Trends Biochem Sci. 2001 Sep;26(9):557-66.  
 
Chung CY, Lee S, Briscoe C, Ellsworth C, Firtel RA. Role of Rac in controlling the 
actin cytoskeleton and chemotaxis in motile cells. Proc Natl Acad Sci U S A. 2000 
May 9;97(10):5225-30. 
 
Chung CY, Potikyan G, Firtel RA. Control of cell polarity and chemotaxis by 
Akt/PKB and PI3 kinase through the regulation of PAKa. Mol Cell. 2001 
May;7(5):937-47. 
 
Chung MJ, Park JK, Park YI. Anti-inflammatory effects of low-molecular weight 
chitosan oligosaccharides in IgE-antigen complex-stimulated RBL-2H3 cells and 
asthma model mice. Int Immunopharmacol. 2012 Feb;12(2):453-9.  
 
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification 
of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors 
produced by CD8+ T cells. Science. 1995 Dec 15;270(5243):1811-5. 
 
 183 
Colditz IG, Schneider MA, Pruenster M, Rot A. Chemokines at large: in-vivo 
mechanisms of their transport, presentation and clearance. Thromb Haemost. 2007 
May;97(5):688-93. 
 
Colgan JD, Hankel IL. Signaling pathways critical for allergic airway inflammation. 
Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):42-7. 
 
Cook EB, Stahl JL, Lilly CM, Haley KJ, Sanchez H, Luster AD, Graziano FM, 
Rothenberg ME. Epithelial cells are a major cellular source of the chemokine 
eotaxin in the guinea pig lung. Allergy Asthma Proc. 1998 Jan-Feb;19(1):15-22. 
 
Coombes JL, Robinson NJ, Maloy KJ, et al. Regulatory T cells and intestinal 
homeostasis. Immunol Rev 204:184 –194, 2005. 
 
Cory GO, Cramer R, Blanchoin L, Ridley AJ. Phosphorylation of the WASP-VCA 
domain increases its affinity for the Arp2/3 complex and enhances actin 
polymerization by WASP. Mol Cell. 2003 May;11(5):1229-39. 
 
Costello PS, Gallagher M, Cantrell DA. Sustained and dynamic inositol lipid 
metabolism inside and outside the immunological synapse. Nat Immunol. 2002 
Nov;3(11):1082-9. 
 
Cravero JD, Carlson CS, Im HJ, Yammani RR, Long D, Loeser RF. Increased 
expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits 
insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis. 
Arthritis Rheum. 2009 Feb;60(2):492-500. 
 
Curnock AP, Ward SG. Development and characterisation of tetracycline-regulated 
phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 
3-kinases in chemokine signaling. J Immunol Methods. 2003 Feb;273(1-2):29-41 
 
Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 
responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol. 
2004 Mar;5(3):337-43. 
 
 184 
Dardalhon V, Awasthi A, Kwon H, et al. IL-4 inhibits TGF- β-induced Foxp3+ T cells 
and, together with TGF-β, generates IL-9+ IL-10+ Foxp3– effector T cells. Nat 
Immunol 2008; 9:1347-1355. 
 
DerMardirossian C, Bokoch GM. GDIs: central regulatory molecules in Rho 
GTPase activation. Trends Cell Biol. 2005 Jul;15(7):356-63. 
 
Derry JM, Ochs HD, Francke U.Isolation of a novel gene mutated in Wiskott-Aldrich 
syndrome. Cell. 1994 Aug 26;78(4):635-44. 
 
Devreotes P, Janetopoulos C. Eukaryotic chemotaxis: distinctions between 
directional sensing and polarization. J Biol Chem. 2003 Jun 6;278(23):20445-8.  
 
Devreotes PN, Zigmond SHChemotaxis in eukaryotic cells: a focus on leukocytes 
and Dictyostelium. Annu Rev Cell Biol. 1988;4:649-86. 
 
Droese J, Mokros T, Hermosilla R, Schülein R, Lipp M, Höpken UE, Rehm A. 
HCMV-encoded chemokine receptor US28 employs multiple routes for 
internalization. Biochem Biophys Res Commun. 2004 Sep 10;322(1):42-9. 
 
Druey KM, Blumer KJ, Kang VH, Kehrl JH. Inhibition of G-protein-mediated MAP 
kinase activation by a new mammalian gene family. Nature. 1996 Feb 
22;379(6567):742-6. 
 
Du, K.; Herzig, S.; Kulkarni, R.N.; Montminy, M. TRB3: a tribbles homolog that 
inhibits Akt/PKB activation by insulin in liver. Science 2003, 3001, 1574-1577. 
 
Du, K.; Tsichlis, P.N. Regulation of the Akt kinase by interacting proteins. 
Oncogene 2005, 24,7401-7409. 
 
Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not 
interleukin 17 by a subset of human. Nat Immunol. 2009 Aug;10(8):857-63.  
 
Echtenacher B, Männel DN, Hültner L.Critical protective role of mast cells in a 
model of acute septic peritonitis. Nature. 1996 May 2;381(6577):75-7. 
 
 185 
Eder K, Guan H, Sung HY, Ward J, Angyal A, Janas M, Sarmay G, Duda E, Turner 
M, Dower SK, Francis SE, Crossman DC, Kiss-Toth E. Tribbles-2 is a novel 
regulator of inflammatory activation of monocytes. Int Immunol. 2008 
Dec;20(12):1543-50.  
 
Eiseman E, Bolen JB. Engagement of the high-affinity IgE receptor activates src 
protein-related tyrosine kinases. Nature. 1992 Jan 2;355(6355):78-80 
 
Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. 
Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 
responses to inhaled antigen. J Exp Med. 2002 Dec 16;196(12):1645-51.  
 
Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002 Dec 
12;420(6916):629-35. 
 
Etienne-Manneville S.In vitro assay of primary astrocyte migration as a tool to study 
Rho GTPase function in cell polarization. Methods Enzymol. 2006;406:565-78. 
 
Eyerich S, Eyerich K, Pennino D, et al. Th22 cells represent a distinct human T cell 
subset involved in epidermal immunity and remodeling. J Clin Invest 119:3573–
3585, 2009. 
 
Fan J, Malik AB. Toll-like receptor-4 (TLR4) signaling augments chemokine-
induced neutrophil migration by modulating cell surface expression of chemokine 
receptors. Nat Med. 2003 Mar;9(3):315-21. 
 
Ferguson GJ, Milne L, Kulkarni S, Sasaki T, Walker S, Andrews S, Crabbe T, Finan 
P, Jones G, Jackson S, Camps M, Rommel C, Wymann M, Hirsch E, Hawkins P, 
Stephens L. PI(3)Kgamma has an important context-dependent role in neutrophil 
chemokinesis. Nat Cell Biol. 2007 Jan;9(1):86-91. 
 
Ferguson SS, Zhang J, Barak LS, Caron MG. Molecular mechanisms of G protein-
coupled receptor desensitization and resensitization. Life Sci. 1998;62(17-
18):1561-5. 
 
Ferry, X., Brehin, S., Kamel, R. and Landry, Y. G protein-dependent activation of 
mast cell by peptides and basic secretagogues. Peptides 23, 1507–1515. (2002)  
 186 
 
Fifadara NH, Aye CC, Raghuwanshi SK, Richardson RM, Ono SJ. CCR1 
expression and signal transduction by murine BMMC results in secretion of TNF-
alpha, TGFbeta-1 and IL-6. Int Immunol. 2009 Aug;21(8):991-1001.  
 
Fifadara NH, Beer F, Ono S, Ono SJ. Interaction between activated chemokine 
receptor 1 and FcepsilonRI at membrane rafts promotes communication and F-
actin-rich cytoneme extensions between mast cells. Int Immunol. 2010 
Feb;22(2):113-28. 
 
Firtel RA, Chung CY. The molecular genetics of chemotaxis: sensing and 
responding to chemoattractant gradients. Bioessays. 2000 Jul;22(7):603-15.  
 
Franchi, L., Park, J. H., Shaw, M. H., Marina-Garcia, N., Chen, G., Kim, Y. G. and 
Nunez, G. Intracellular NOD-like receptors in innate immunity, infection and 
disease. Cell Microbiol. 10, 1–8 (2008)  
 
Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB. The G-protein-coupled 
receptors in the human genome form five main families. Phylogenetic analysis, 
paralogon groups, and fingerprints. Mol Pharmacol. 2003 Jun;63(6):1256-72. 
 
Friedl, P. Prespecification and plasticity: Shifting mechanisms of cell migration. 
Curr. Opin. Cell Biol. 16, 14–23 (2004). 
 
Fruman DA, Cantley LC. Phosphoinositide 3-kinase in immunological systems. 
Semin Immunol. 2002 Feb;14(1):7-18. 
 
Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, Takayama T, Asano T, 
Takeuchi T, Kadowaki T, Hata Ji J, Koyasu S. Selective loss of gastrointestinal 
mast cells and impaired immunity in PI3K-deficient mice. Nat Immunol. 2002 
Mar;3(3):295-304. 
 
Funamoto S, Milan K, Meili R, Firtel RA. Role of phosphatidylinositol 3' kinase and 
a downstream pleckstrin homology domain-containing protein in controlling 
chemotaxis in dictyostelium. J Cell Biol. 2001 May 14;153(4):795-810. 
 
 187 
Furumoto Y, Brooks S, Olivera A, Takagi Y, Miyagishi M, Taira K, Casellas R, 
Beaven MA, Gilfillan AM, Rivera J. J Immunol. Cutting Edge: Lentiviral short hairpin 
RNA silencing of PTEN in human mast cells reveals constitutive signals that 
promote cytokine secretion and cell survival. 2006 May 1;176(9):5167-71. 
 
Furumoto Y, Gonzalez-Espinosa C, Gomez G, Kovarova M, Odom S, Parravicini V, 
Ryana JJ, Rivera J. Rethinking the role of Src family protein tyrosine kinases in the 
allergic response: new insights on the functional coupling of the high affinity IgE 
receptor. Immunol Res. 2004;30(2):241-53 
 
Galli S.J., S. Nakae, M. Tsai. Mast cells in the development of adaptive immune 
responses. Nat Immunol, 6 (2) (2005), pp. 135–142 
 
Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as 
well as positive, regulators of immunity. Nat Rev Immunol. 2008 Jun;8(6):478-86 
 
Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart FX, LeviSchaffer 
F. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice 
contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy. 2002 
Feb;32(2):237-46. 
 
Garman SC, Kinet JP, Jardetzky TS. Crystal structure of the human high-affinity 
IgE receptor. Cell. 1998 Dec 23;95(7):951-61. 
 
Ghosh, S.; Karin, M. Missing pieces in NF-κB puzzle. 2002, 109, S81-S96. 
Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat 
Rev Immunol. 2006 Mar;6(3):218-30.  
 
Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev 
Biochem. 1987;56:615-49. 
 
Goldschmidt, M.E.; McLeod, K.J.; Taylor, W.R. (2001). Integrin-mediated 
mechanotransduction in vascular smooth muscle cells: frequency and force 
response characteristics. Circ. Res. 2001, 88, 674-680. 
 
 
 188 
Gómez-Moutón C, Lacalle RA, Mira E, Jiménez-Baranda S, Barber DF, Carrera 
AC, Martínez-A C, Mañes S. Dynamic redistribution of raft domains as an 
organizing platform for signaling during cell chemotaxis. J Cell Biol. 2004 Mar 
1;164(5):759-68.  
 
Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA, Martinez-A C, 
Marquez G, Goya I, Hamid Q, Fraser CC, Picarella D, Cote-Sierra J, Hodge MR, 
Gutierrez-Ramos JC, Kolbeck R, Coyle AJ. Coordinated involvement of mast cells 
and T cells in allergic mucosal inflammation: critical role of the CC chemokine 
ligand 1:CCR8 axis. 
 
Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor 
necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the 
Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-
alpha during IgE-dependent biological responses. J Exp Med. 1991 Jul 
1;174(1):103-7. 
 
Gordon JR, Galli SJ.Mast cells as a source of both preformed and immunologically 
inducible TNF-alpha/cachectin. Nature. 1990 Jul 19;346(6281):274-6. 
 
Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008 
Mar;8(3):205-17. 
 
Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early 
transcription and silencing of cytokine genes underlie polarization of T helper cell 
subsets. Immunity. 2001 Mar;14(3):205-15. 
 
Groneberg DA, Bielory L, Fischer A, Bonini S, Wahn U. Animal models of allergic 
and inflammatory conjunctivitis. Allergy. 2003 Nov;58(11):1101-13.  
 
Grosshans, J.; Wieschaus, E. A genetic link between morphogenesis and cell 
division during formation of the ventral furrow in Drosophila. Cell 2000, 101, 523-
531. 
 
 
 189 
Guinamard R, Aspenström P, Fougereau M, Chavrier P, Guillemot JC. Tyrosine 
phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is 
regulated by CDC42. FEBS Lett. 1998 Sep 4;434(3):431-6. 
 
Gurish MF, Bryce PJ, Tao H, Kisselgof AB, Thornton EM, Miller HR, Friend DS, 
Oettgen HC. IgE enhances parasite clearance and regulates mast cell responses in 
mice infected with Trichinella spiralis. J Immunol. 2004 Jan 15;172(2):1139-45. 
 
Gurish MF, Tao H, Abonia JP, Arya A, Friend DS, Parker CM, Austen KF. Intestinal 
mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific 
homing.J Exp Med. 2001 Nov 5;194(9):1243-52. 
 
Gurish MF, Boyce JA. Mast cells: ontogeny, homing, and recruitment of a unique 
innate effector cell.J Allergy Clin Immunol. 2006 Jun;117(6):1285-91. 
 
Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus 
through divergent mitogen-activated protein kinase cascades. J Biol Chem. 1998 
Jan 23;273(4):1839-42. 
 
Haidl, I. D., McAlpine, S. M. and Marshall, J. S. Enhancement of mast cell IL-6 
production by combined Toll-like and nucleotide-binding oligomerization domain-
like receptor activation. Int. Arch. Allergy Immunol. 154, 227–235 (2010) 
 
Hallgren J, Jones TG, Abonia JP, Xing W, Humbles A, Austen KF, Gurish 
MF.Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast 
cell progenitors.Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20478-83.  
 
Han IH, Park SJ, Ahn MH, Ryu JS. Involvement of mast cells in inflammation 
induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells. 
Parasite Immunol. 2012 Jan;34(1):8-14. doi: 10.1111/j.1365-3024.2011.01338.x. 
 
Harriague J, Bismuth G. Imaging antigen-induced PI3K activation in T cells. Nat 
Immunol. 2002 Nov;3(11):1090-6. 
 
 
 
 190 
Hashimoto, K., Uchikawa, R., Tegoshi, T., Takeda, K., Yamada, M. and Arizono, N. 
Immunity-mediated regulation of fecundity in the nematode 
Heligmosomoidespolygyrus : the potential role of mast cells. Parasitology 137, 
881–887. (2010)  
 
He Ling; Simmen, F.A.; Mehendale, H.M.; Martin, J.J.R.; Badger, T.M.  Chronic 
ethanol intake impairs insulin signaling in rats by disrupting Akt association with the 
cell membrane: role of TRB3 in inhibition of Akt/protein kinase B activation. J. Biol. 
Chem. 2006, 281, 11126-11134. 
 
Hegedus, Z.; Czibula, A.; Kiss-Toth, E. Tribbles: a family of kinase-like proteins 
with potent signaling regulatory function. Cellular Signaling 2007, 19, 238-250. 
 
Hegedus, Z.; Czibula, Kiss-Toth. Tribbles: novel regulators of cell function; 
evolutionary aspects. Cell Mol. Life Sci. 2006, 63, 1632-1641. 
 
Hepworth MR, Danilowicz-Luebert E, Rausch S, Metz M, Klotz C, Maurer M, 
Hartmann S. Mast cells orchestrate type 2 immunity to helminths through regulation 
of tissue-derived cytokines. Proc Natl Acad Sci U S A. 2012 Apr 9. 
 
Hewson CA, Watson JR, Liu WL, Fidock MD. A differential role for ceramide kinase 
in antigen/FcɛRI-mediated mast cell activation and function. Clin Exp Allergy. 2011 
Mar;41(3):389-98. doi: 10.1111/j.1365-2222.2010.03682.x.  
 
Higgs HN, Pollard TD. Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome 
protein (WASp) stimulates actin nucleation by Arp2/3 complex.J Cell Biol. 2000 
Sep 18;150(6):1311-20. 
 
Higgs HN, Pollard TD. Regulation of actin polymerization by Arp2/3 complex and 
WASp/Scar proteins. J Biol Chem. 1999 Nov 12;274(46):32531-4.  
 
Hoffmann HJ, Frandsen PM, Christensen LH, Schiøtz PO, Dahl R. Cultured human 
mast cells are heterogeneous for expression of the high-affinity IgE receptor FcεRI. 
Int Arch Allergy Immunol. 2012;157(3):246-50.  
 
Hogg, N., Laschinger, M., Giles, K. & McDowall, A. T-cell integrins: More than just 
sticking points. J. Cell Sci. 116, 4695–4705 (2003). 
 191 
Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium 
current in mast cells. Nature. 1992 Jan 23;355(6358):353-6. 
 
Hsu, C. L., Neilsen, C. V. and Bryce, P. J. IL-33 is produced by mast cells and 
regulates IgE-dependent inflammation. PLoS ONE 5, e11944. (2010)  
 
Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, 
Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is 
the ligand of the c-kit receptor, the gene product of the W locus. Cell. 1990 Oct 
5;63(1):225-33. 
 
Huang YE, Iijima M, Parent CA, Funamoto S, Firtel RA, Devreotes P.Receptor-
mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of 
chemotaxing cells. Mol Biol Cell. 2003 May;14(5):1913-22.  
 
Hültner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rüde E, Dörmer P, Van 
Snick J. Mast cell growth-enhancing activity (MEA) is structurally related and 
functionally identical to the novel mouse T cell growth factor P40/TCGFIII 
(interleukin 9). Eur J Immunol. 1990 Jun;20(6):1413-6. 
 
Hültner L, Moeller J. Mast cell growth-enhancing activity (MEA) stimulates 
interleukin 6 production in a mouse bone marrow-derived mast cell line and a 
malignant subline. Exp Hematol. 1990 Sep;18(8):873-7. 
 
Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A, Martin TR, Gerard 
NP, Gerard C. The murine CCR3 receptor regulates both the role of eosinophils 
and mast cells in allergen-induced airway inflammation and 
hyperresponsiveness.Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1479-84. 
 
Hur EM, Kim KT. Cell Signal. G protein-coupled receptor signalling and cross-talk: 
achieving rapidity and specificity.2002 May;14(5):397-405.  
 
Ibarra N, Blagg SL, Vazquez F, Insall RH. Nap1 regulates Dictyostelium cell motility 
and adhesion through SCAR-dependent and -independent pathways. Curr Biol. 
2006 Apr 4;16(7):717-22. 
 192 
Ikeda RK, Nayar J, Cho JY, Miller M, Rodriguez M, Raz E, Broide DH. Resolution 
of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and 
corticosteroids. Am J Respir Cell Mol Biol. 2003 Jun;28(6):655-63. 
 
Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, Nojima Y. 
Expression of interleukin-22 in rheumatoid arthritis: potential role as a 
proinflammatory cytokine. Arthritis Rheum. 2005 Apr;52(4):1037-46. 
 
Insall RH, Machesky LM. Actin dynamics at the leading edge: from simple 
machinery to complex networks. Dev Cell. 2009 Sep;17(3):310-22. 
 
Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, 
Schwartz LB. Recombinant human stem cell factor stimulates differentiation of 
mast cells from dispersed human fetal liver cells. Blood. 1992 Dec 15;80(12):3009-
21. 
 
Ishizaka K, Tomioka H, Ishizaka T. Mechanisms of passive sensitization. I. 
Presence of IgE and IgG molecules on human leukocytes. J Immunol. 1970 
Dec;105(6):1459-67. 
 
Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: Production of 
CD25+CD4+naturally anergic and suppressive T cells as a key function of the 
thymus in maintaining immunologic self-tolerance. J Immunol 162:5317–5326, 
 
Iwaki S, Tkaczyk C, Metcalfe DD, Gilfillan AM.Roles of adaptor molecules in mast 
cell activation. Chem Immunol Allergy. 2005;87:43-58. 
Iwakura Y, and Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 
116:1218 –1222, 2006. 
 
Iynedjian PB. Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-
mediated insulin signalling in primary hepatocytes. Biochem J. 2005 Feb 15;386(Pt 
1):113-8. 
 
Iynedjian, P.B. Lack of evidence for a role of TRB3/NIPK as inhibitor of PKB-
mediated insulin signaling in primary hepatocytes. Biochem. J. 2004, 386,113-118. 
 
 193 
Izushi K, Nakahara H, Tai N, Mio M, Watanabe T, Kamei C. The role of histamine 
H(1)receptors in late-phase reaction of allergic conjunctivitis. Eur J Pharmacol 
2002;440:79–82. 
 
Jabril-Cuenod B, Zhang C, Scharenberg AM, Paolini R, Numerof R, Beaven MA, 
Kinet JP. Syk-dependent phosphorylation of Shc. A potential link between 
FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway 
through SOS and Grb2.J Biol Chem. 1996 Jul 5;271(27):16268-72.  
 
Jamur MC, Moreno AN, Mello LF, Souza Júnior DA, Campos MR, Pastor MV, 
Grodzki AC, Silva DC, Oliver C. Mast cell repopulation of the peritoneal cavity: 
contribution of mast cell progenitors versus bone marrow derived committed mast 
cell precursors. BMC Immunol. 2010 Jun 24;11:32. 
 
Jones, P.L.; Jones, F.S.; Zhou, B.; Rabinovitch, M. Induction of vascular smooth 
muscle cell tenascin-C gene expression by denatured type I collagen is dependent 
upon a beta3 integrin-mediated nitrogen-activated protein kinase  pathway and 
122-base pair promoter element.  J. Cell Sci. 1999, 12, 435-445. 
 
Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP, Krystal G. 
Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine 
production and cell survival. Immunity. 2001 Jun;14(6):801-11. 
 
Karin, M.; Ben-Neriah, Y. Phosphorylation meets uniquitination: the control of NF-
κB activity. Annu. Rev. Immunol. 2000, 18, 621-663. 
 
Karin, M.; Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol. 2002, 3, 
221-222. 
 
Katz HR, Raizman MB, Gartner CS, Scott HC, Benson AC, Austen KF. Secretory 
granule mediator release and generation of oxidative metabolites of arachidonic 
acid via Fc-IgG receptor bridging in mouse mast cells. J Immunol. 1992 Feb 
1;148(3):868-71. 
 
Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by 
IgE. Nat Rev Immunol. 2002 Oct;2(10):773-86. 
 
 194 
Kawamoto K, Aoki J, Tanaka A, Itakura A, Hosono H, Arai H, Kiso Y, Matsuda 
H.Nerve growth factor activates mast cells through the collaborative interaction with 
lysophosphatidylserine expressed on the membrane surface of activated platelets. 
J Immunol. 2002 Jun 15;168(12):6412-9. 
 
Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and 
interleukin-13 signaling connections maps. Science. 2003 Jun 6;300(5625):1527-8. 
 
Khandoga AG, Khandoga A, Reichel CA, Bihari P, Rehberg M, Krombach F.In vivo 
imaging and quantitative analysis of leukocyte directional migration and polarization 
in inflamed tissue. PLoS One. 2009;4(3):e4693. 
 
Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK. Autoinhibition and 
activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 2000 Mar 
9;404(6774):151-8. 
 
Kinet JP, Blank U, Brini A, Jouvin MH, Küster H, Mejan O, Ra C. The high-affinity 
receptor for immunoglobulin E: a target for therapy of allergic diseases. Int Arch 
Allergy Appl Immunol. 1991;94(1-4):51-5. 
 
Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to 
pathology. Annu Rev Immunol. 1999;17:931-72. 
 
Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, Rao VK, Metcalfe 
DD. Characterization of novel stem cell factor responsive human mast cell lines 
LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation 
following aggregation of FcepsilonRI or FcgammaRI. Leuk Res. 2003 
Aug;27(8):677-82. 
 
Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, Caunt JC, Oxley KM, 
Wyllie DH, Polgar T, Harte M, O'neill LA, Qwarnstrom EE, Dower SK. Human 
tribbles, a protein family controlling mitogen-activated protein kinase cascades. J 
Biol Chem. 2004 Oct 8;279(41):42703-8.  
 
 
 
 
 195 
Kiss-Toth, E.; Wyllie, D.H.; Holland, K.; Marsden, L.; Jozsa, V.; Oxley, K.M.; Polgar, 
T.; Qwarnstrom, E.E.; Dower, S.K. Functional mapping and identification of novel 
regulators for the Toll/Interleukin-1 signaling network by transcription cloning. 
Cellular Signaling 2006, 18 (2), 202-214. 
 
Kitamura Y, Shimada M, Hatanaka K, Miyano Y. Development of mast cells from 
grafted bone marrow cells in irradiated mice. Nature. 1977 Aug 4;268(5619):442-3. 
 
Kochan T, Singla A, Tosi J, Kumar A. TLR2 ligand pretreatment attenuates retinal 
microglial inflammatory response but enhances their phagocytic activity towards 
Staphylococcus aureus. Infect Immun. 2012 Mar 19. 
 
Koo, S.H.; Satoh, H.; Herzig, S.; Lee, C; Hedrick, S; Kulkarni, R; Evans, 
R.M.;Olefsky, J.; Montminy, M. PGC-1 promotes insulin resistance in liver through 
PPAR-alpha-dependent induction of TRB3. Nat. Med. 2004, 10, 530-534. 
 
Kool M, Hammad H, Lambrecht BN. Cellular networks controlling Th2 polarization 
in allergy and immunity. F1000 Biol Rep. 2012;4:6.  
 
Koyasu S, Minowa A, Terauchi Y, Kadowaki T, Matsuda S. (2005) The role of 
phosphoinositide-3-kinase in mast cell homing to the gastrointestinal tract. Novartis 
Found. Symp. 271, 152–161 (discussion 161–165, 198–199) 
 
Krupnick JG, Santini F, Gagnon AW, Keen JH, Benovic JL. Modulation of the 
arrestin-clathrin interaction in cells. Characterization of beta-arrestin dominant-
negative mutants. J Biol Chem. 1997 Dec 19;272(51):32507-12. 
 
Kulczycki A Jr, Metzger H. The interaction of IgE with rat basophilic leukemia cells. 
II. Quantitative aspects of the binding reaction. J Exp Med. 1974 Dec 
1;140(6):1676-95. 
 
Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by 
double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy 
Clin Immunol. 2004 Jul;114(1):174-82. 
 
 196 
Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T. Role of structural cells of 
the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog 
Retin Eye Res. 2006 Mar;25(2):165-87.  
 
Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, Altruda F, Hirsch E, 
Wymann MP. Phosphoinositide 3-kinase gamma is an essential amplifier of mast 
cell function. Immunity. 2002 Mar;16(3):441-51. 
 
Lämmermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-Söldner R, Hirsch K, 
Keller M, Förster R, Critchley DR, Fässler R, Sixt M. Rapid leukocyte migration by 
integrin-independent flowing and squeezing. Nature. 2008 May 1;453(7191):51-5. 
 
Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular 
process. Cell. 1996 Feb 9;84(3):359-69.  
 
Lemmon MA, Ferguson KM, Abrams CS. Pleckstrin homology domains and the 
cytoskeleton. FEBS Lett. 2002 Feb 20;513(1):71-6.  
 
Leonardi A, Cortivo R, Fregona I, Plebani M, Secchi AG, Abatangelo G. Effects of 
Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival 
fibroblasts. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):183-9. 
 
Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear 
specimens in seasonal and chronic allergic eye disease and in conjunctival 
fibroblast cultures. Clin Exp Allergy. 2006 Jun;36(6):777-84. 
 
Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin Exp Immunol. 2008 
Sep;153 Suppl 1:17-21.  
 
Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of 
IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol. 1995 
Jun 1;154(11):6174-81. 
 
Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ 
2nd.Prostaglandin D2 generation after activation of rat and human mast cells with 
anti-IgE. J Immunol. 1982 Oct;129(4):1627-31. 
 
 197 
Li ,C.; Xu, Q. Mechanical stress – initiated signal transductions in vascular smooth 
muscle cells. Cell Signal 2000, 12, 435-445. 
 
Linardopoulou EV, Parghi SS, Friedman C, Osborn GE, Parkhurst SM, Trask BJ. 
Human subtelomeric WASH genes encode a new subclass of the WASP family. 
PLoS Genet. 2007 Dec;3(12):e237. 
 
Littlepage LE, Egeblad M, Werb Z. Coevolution of cancer and stromal cellular 
responses.Cancer Cell. 2005 Jun;7(6):499-500. 
 
Locksley, R.M.; Killeen, N.; Lenardo, M.J. The TNF and TNF receptor super 
families: integrating mammalian biology. Cell 2001, 104, 487-501. 
 
Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regulates CC chemokine 
receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med. 
1996 Aug 1;184(2):569-77. 
 
Looney MR, Thornton EE, Sen D, Lamm WJ, Glenny RW, Krummel MF. Stabilized 
imaging of immune surveillance in the mouse lung. Nat Methods. 2011 Jan;8(1):91-
6.  
Lorentz A, Schuppan D, Gebert A, Manns MP, Bischoff SC. Regulatory effects of 
stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular 
matrix proteins. Blood. 2002 Feb 1;99(3):966-72. 
 
Ma W, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, Alenius H, Friend DS, 
Oettgen HC, Gerard C, Geha RS. CCR3 is essential for skin eosinophilia and 
airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin 
Invest. 2002 Mar;109(5):621-8. 
 
Machesky LM, Gould KL. The Arp2/3 complex: a multifunctional actin organizer. 
Curr Opin Cell Biol. 1999 Feb;11(1):117-21.  
 
Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May RC, Hall ME, 
Pollard TD. Scar, a WASp-related protein, activates nucleation of actin filaments by 
the Arp2/3 complex. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3739-44. 
 
 198 
Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil 
influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996 
May 2;381(6577):77-80. 
 
Malaviya, R., Ikeda, T., Ross, E. and Abraham, S. N., Mast cell modulation of 
neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. 
Nature 1996. 381: 77–80. 
 
Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor 
(interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses 
and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199–
1204, 1993. 
 
Manetz TS, Gonzalez-Espinosa C, Arudchandran R, Xirasagar S, Tybulewicz V, 
Rivera J. Mol Cell Biol. 2001 Jun;21(11):3763-74. 
 
Mani M, Venkatasubrahmanyam S, Sanyal M, Levy S, Butte A, Weinberg K, Jahn 
T. Wiskott-Aldrich syndrome protein is an effector of Kit signaling. Blood. 2009 Oct 
1;114(14):2900-8. 
 
Marinissen MJ, Chiariello M, Gutkind JS. Regulation of gene expression by the 
small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes 
Dev. 2001 Mar 1;15(5):535-53. 
 
Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: 
emerging paradigms. Trends Pharmacol Sci. 2001 Jul;22(7):368-76. 
 
Marquardt DL, Walker LL. Dependence of mast cell IgE-mediated cytokine 
production on nuclear factor-kappaB activity. J Allergy Clin Immunol. 2000 
Mar;105(3):500-5.  
 
Marshall JG, Booth JW, Stambolic V, Mak T, Balla T, Schreiber AD, Meyer T, 
Grinstein S. Restricted accumulation of phosphatidylinositol 3-kinase products in a 
plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J 
Cell Biol. 2001 Jun 25;153(7):1369-80 
 
 199 
Martinez-Quiles N, Rohatgi R, Antón IM, Medina M, Saville SP, Miki H, Yamaguchi 
H, Takenawa T, Hartwig JH, Geha RS, Ramesh N. WIP regulates N-WASP-
mediated actin polymerization and filopodium formation. Nat Cell Biol. 2001 
May;3(5):484-91. 
 
Matsuda K, Piliponsky AM, Iikura M, Nakae S, Wang EW, Dutta SM, Kawakami T, 
Tsai M, Galli SJ. Monomeric IgE enhances human mast cell chemokine production: 
IL-4 augments and dexamethasone suppresses the response. J Allergy Clin 
Immunol. 2005 Dec;116(6):1357-63. 
 
Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7-, and TLR9-
mediated production of proinflammatory cytokines and chemokines from murine 
connective tissue type skin-derived mast cells but not from bone marrow-derived 
mast cells. J Immunol. 2004 Jul 1;173(1):531-41. 
 
Maurer, M., Lopez, K. S., Siebenhaar, F., Moelle, K., Metz, M., Knop, J. and von, S. 
E. Skin mast cells control T cell-dependent host defense in Leishmania major 
infections. FASEB J. 20, 2460–2467. (2006)  
 
Maurer, M., Paus, R. and Czarnetzki, B. M. (1995) Mast cells as modulators of hair 
follicle cycling. Exp. Dermatol.4, 266–271 
 
Maurer, M., Wedemeyer, J., Metz, M., Piliponsky, A. M., Weller, K., Chatterjea, D., 
Clouthier, D. E. et al., Mast cells promote homeostasis by limiting endothelin-1-
induced toxicity. Nature 2004. 432: 512–516. 
 
Mayumi-Matsuda. K.; Kojima, S.; Suzuki, H.; Sakata, T.  Identification of a novel 
kinase-like gene induced during neuronal cell death. Biochem. Biophys. Res. 
Commun. 1999, 258,260-264. 
 
McAlpine SM, Issekutz TB, Marshall JS.Virus stimulation of human mast cells 
results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 
ligands. FASEB J. 2012 Mar;26(3):1280-9.  
 
 200 
McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, Abraham 
SN.Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph 
nodes during infection. Nat Immunol. 2003 Dec;4(12):1199-205.  
 
McLachlan, C.P. Shelburne, J.P. Hart, S.V. Pizzo, R. Goyal, R. Brooking-Dixon, 
H.F. Staats, S.N. Abraham. Mast cell activators: a new class of highly effective 
vaccine adjuvants. Nat Med, 14 (5) (2008), pp. 536–541 
 
McLane MP, Haczku A, van de Rijn M, Weiss C, Ferrante V, MacDonald D, 
Renauld JC, Nicolaides NC, Holroyd KJ, Levitt RC. Interleukin-9 promotes allergen-
induced eosinophilic inflammation and airway hyperresponsiveness in transgenic 
mice. Am J Respir Cell Mol Biol. 1998 Nov;19(5):713-20. 
 
Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate 
induce cytokine generation by human mast cells through an interleukin 4-regulated 
pathway that is inhibited by leukotriene receptor antagonists. J Exp Med. 2002 Mar 
4;195(5):583-92. 
 
Mempel, T. R., Henrickson, S. E. & Von Andrian, U. H. T-cell priming by dendritic 
cells in lymph nodes occurs in three distinct phases. Nature 427, 154–159 (2004). 
 
Menon AK, Holowka D, Webb WW, Baird B. Cross-linking of receptor-bound IgE to 
aggregates larger than dimers leads to rapid immobilization. J Cell Biol. 1986 
Feb;102(2):541-50. 
 
Merayo-Lloves J, Zhao TZ, Dutt JE, Foster CS. A new murine model of allergic 
conjunctivitis and effectiveness of nedocromil sodium. J Allergy Clin Immunol 
1996;97:1129–1140. 
 
Merlot S, Firtel RA. Leading the way: Directional sensing through 
phosphatidylinositol 3-kinase and other signaling pathways. J Cell Sci. 2003 Sep 
1;116(Pt 17):3471-8.  
 
Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997 Oct;77(4):1033-
79. 
 
 201 
Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in 
anaphylaxis. J Allergy Clin Immunol. 2009 Oct;124(4):639-46 
 
Metz M, Magerl M, Kühl NF, Valeva A, Bhakdi S, Maurer M. Mast cells determine 
the magnitude of bacterial toxin-induced skin inflammation. Exp Dermatol. 2009 
Feb;18(2):160-6. 
 
Micheau, O.; Lens, S.; Gaide, O.; Alevizopoulos, K.; Tschopp, J. NF-kB signals 
induce the expression of c-FLIP. Mol.Cell Biol. 2001, 21, 5299-5305. 
 
Miki H, Miura K, Takenawa T. N-WASP, a novel actin-depolymerizing protein, 
regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner 
downstream of tyrosine kinases. EMBO J. 1996 Oct 1;15(19):5326-35. 
 
Miki H, Suetsugu S, Takenawa T. WAVE, a novel WASP-family protein involved in 
actin reorganization induced by Rac. EMBO J. 1998 Dec 1;17(23):6932-41. 
 
Millard TH, Sharp SJ, Machesky LM. Signalling to actin assembly via the WASP 
(Wiskott-Aldrich syndrome protein)-family proteins and the Arp2/3 complex. 
Biochem J. 2004 May 15;380(Pt 1):1-17. 
 
Miller MJ, Wei SH, Parker I, Cahalan MD.Two-photon imaging of lymphocyte 
motility and antigen response in intact lymph node.  Science. 2002 Jun 
7;296(5574):1869-73.  
 
Miller, H.R. and Pemberton, A.D. (2002) Tissue-specific expression of mast cell 
granule serine proteinases and their role in inflammation in the lung and gut. 
Immunology 105, 375–390 
 
Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in 
subjects with autosomal dominant hyper- IgE syndrome. Nature 452:773–776, 
2008. 
 
Miyazaki D, Nakamura T, Toda M, Cheung-Chau KW, Richardson RM, Ono SJ. 
Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-
mediated immediate hypersensitivity reactions. J Clin Invest. 2005 Feb;115(2):434-
42. 
 202 
 
Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and 
induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 
108:430–438, 2001. 
 
Monypenny J, Chou HC, Bañón-Rodríguez I, Thrasher AJ, Antón IM, Jones GE, 
Calle Y. Role of WASP in cell polarity and podosome dynamics of myeloid cells. 
Eur J Cell Biol. 2011 Feb-Mar;90(2-3):198-204.  
 
Morin NA, Oakes PW, Hyun YM, Lee D, Chin YE, King MR, Springer TA, Shimaoka 
M, Tang JX, Reichner JS, Kim M. Nonmuscle myosin heavy chain IIA mediates 
integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med. 2008 Jan 
21;205(1):195-205.  
 
Moritz, D. R., Rodewald, H. R., Gheyselinck, J. and Klemenz, R. The IL-1 receptor-
related T1 antigen is expressed on immature and mature mast cells and on fetal 
blood mast cell progenitors. J. Immunol. 161, 4866–4874. (1998)  
 
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of 
murine helper T cell clone. I. Definition according to profiles of lymphokine activities 
and secreted proteins. J Immunol 1986; 136:2348-2357. 
 
Mota I, Vugman I. Effects of anaphylactic shock and compound 48/80 on the mast 
cells of the guinea pig lung. Nature. 1956 Mar 3;177(4505):427-9. 
 
Mueller A, Kelly E, Strange PG. Pathways for internalization and recycling of the 
chemokine receptor CCR5. Blood. 2002 Feb 1;99(3):785-91. 
 
Muller-Eberhard, H.J. 1988. Molecular organization and function of the complement 
system. Annu.Rev. Biochem. 57: 321–347. 
 
Mullins RD, Heuser JA, Pollard TD. The interaction of Arp2/3 complex with actin: 
nucleation, high affinity pointed end capping, and formation of branching networks 
of filaments.Proc Natl Acad Sci U S A. 1998 May 26;95(11):6181-6. 
 
 
 
 203 
Mwamtemi HH, Koike K, Kinoshita T, Ito S, Ishida S, Nakazawa Y, Kurokawa Y, 
Shinozaki K, Sakashita K, Takeuchi K, Shiohara M, Kamijo T, Yasui Y, Ishiguro A, 
Kawano Y, Kitano K, Miyazaki H, Kato T, Sakuma S, Komiyama A. An increase in 
circulating mast cell colony-forming cells in asthma. J Immunol. 2001 Apr 
1;166(7):4672-7. 
 
Myers SA, Han JW, Lee Y, Firtel RA, Chung CY. A Dictyostelium homologue of 
WASP is required for polarized F-actin assembly during chemotaxis.Mol Biol Cell. 
2005 May;16(5):2191-206.  
 
Nadler MJ, Matthews SA, Turner H, Kinet JP. Signal transduction by the high-
affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.Adv 
Immunol. 2000;76:325-55. 
 
Nagasaka, A., Matsue, H., Matsushima, H., Aoki, R., Nakamura, Y., Kambe, N., 
Kon, S., Uede, T. and Shimada, S. (2008) Osteopontin is produced by mast cells 
and affects IgE-mediated degranulation and migration of mast cells. Eur. J. 
Immunol. 38, 489–499 
 
Naiki T, Saijou E, Miyaoka Y, Sekine K, Miyajima A. TRB2, a mouse Tribbles 
ortholog, suppresses adipocyte differentiation by inhibiting AKT and C/EBPbeta. J 
Biol Chem. 2007 Aug 17;282(33):24075-82.  
 
Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ.Mast cells enhance T 
cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A. 
2005 May 3;102(18):6467-72.  
 
Nakano, C. Nishiyama, H. Yagita, A. Koyanagi, H. Akiba, S. Chiba, H. Ogawa, K. 
OkumuraNotch signaling confers antigen-presenting cell functions on mast cells. J 
Allergy Clin Immunol, 123 (1) (2009), pp. 74–81 
 
Naveen B, Shankar BS, Subrahmanyam G. FcepsilonRI cross-linking activates a 
type II phosphatidylinositol 4-kinase in RBL 2H3 cells. Mol Immunol. 2005 
Aug;42(12):1541-9. 
 
Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector 
leukocyte that mediates type-2 immunity. Nature 464:1367–1370, 2010. 
 204 
 
Nilsson G, Blom T, Kusche-Gullberg M, Kjellén L, Butterfield JH, Sundström C, 
Nilsson K, Hellman L. Phenotypic characterization of the human mast-cell line 
HMC-1. Scand J Immunol. 1994 May;39(5):489-98. 
 
Nilsson G, Butterfield JH, Nilsson K, Siegbahn A.Stem cell factor is a chemotactic 
factor for human mast cells. J Immunol. 1994 Oct 15;153(8):3717-23. 
 
Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn 
A, Murphy PM. C3a and C5a are chemotaxins for human mast cells and act 
through distinct receptors via a pertussis toxin-sensitive signal transduction 
pathway. J Immunol. 1996 Aug 15;157(4):1693-8. 
 
Norman MU, Hickey MJ. Mechanisms of lymphocyte migration in autoimmune 
disease. Tissue Antigens. 2005 Sep;66(3):163-72.  
 
Oak JS, Matheu MP, Parker I, Cahalan MD, Fruman DA. Lymphocyte cell motility: 
the twisting, turning tale of phosphoinositide 3-kinase. Biochem Soc Trans. 2007 
Nov;35(Pt 5):1109-13.  
 
Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA.  T helper cell type 2 
cytokine-mediated comitogenic responses and CCR3 expression during 
differentiation of human mast cells in vitro. J Exp Med. 1999 Jul 19;190(2):267-80. 
 
Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, Wright HV, Gonzalez-
Espinosa C, Hibbs ML, Harder KW, Rivera J. Negative regulation of 
immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med. 2004 
Jun 7;199(11):1491-502. 
 
Ohoka, N.; Yoshii, S.; Hattori, T.; Onozaki, K.; Hayashi, H. TRB3, a novel ER  
stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell 
death. EMBO J. 2005, 24, 1243-1255. 
 
Okayama Y, Hagaman DD, Metcalfe DD. A comparison of mediators released or 
generated by IFN-gamma-treated human mast cells following aggregation of Fc 
gamma RI or Fc epsilon RI. J Immunol. 2001 Apr 1;166(7):4705-12. 
 
 205 
Okayama Y, Tkaczyk C, Metcalfe DD, Gilfillan AM. Comparison of Fc epsilon RI- 
and Fc gamma RI-mediated degranulation and TNF-alpha synthesis in human 
mast cells: selective utilization of phosphatidylinositol-3-kinase for Fc gamma RI-
induced degranulation. Eur J Immunol. 2003 May;33(5):1450-9. 
 
Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, 
Okayama Y. Identification of specific gene expression profiles in human mast cells 
mediated by Toll-like receptor 4 and FcepsilonRI. Blood. 2003 Oct 1;102(7):2547-
54. 
 
Oliveira SH, Lukacs NW. Stem cell factor and igE-stimulated murine mast cells 
produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. 
Inflamm Res. 2001 Mar;50(3):168-74. 
 
Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, 
Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, 
Siderovski DP, Penninger JM.Regulation of T cell activation, anxiety, and male 
aggression by RGS2. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12272-7. 
 
Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: 
roles in leukocyte development, trafficking, and effector function. J Allergy Clin 
Immunol. 2003 Jun;111(6):1185-99; 
 
Ord, D.; Ord, T. Characterization of human NIPK (TRB3, SKIP3) gene activation in 
stressful conditions. Biochem. Biophys. Res. Commun. 2005, 330, 210-218. 
 
Ord. D.; Ord T. Mouse NIPK interacts with ATF4 and affects its transcriptional 
activity. Exp. Cell Res. 2003, 286, 308-320. 
 
Orsini MJ, Benovic JL. Characterization of dominant negative arrestins that inhibit 
beta2-adrenergic receptor internalization by distinct mechanisms. J Biol Chem. 
1998 Dec 18;273(51):34616-22. 
 
Ownby DR. Pediatric asthma and development of atopy. Curr Opin Allergy Clin 
Immunol. 2001 Apr;1(2):125-6.  
 
 206 
Palecek SP, Schmidt CE, Lauffenburger DA, Horwitz AF.Integrin dynamics on the 
tail region of migrating fibroblasts.J Cell Sci. 1996 May;109 ( Pt 5):941-52. 
 
Papakonstanti EA, Ridley AJ, Vanhaesebroeck B. The p110delta isoform of PI 3-
kinase negatively controls RhoA and PTEN. EMBO J. 2007 Jul 11;26(13):3050-61.  
 
Parent CA, Devreotes PN.A cell's sense of direction. Science. 1999 Apr 
30;284(5415):765-70.  
 
Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue 
inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133-1141. 
 
Parker LC, Whyte MK, Vogel SN, Dower SK, Sabroe I.  Toll-like receptor (TLR)2 
and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol. 
2004 Apr 15;172(8):4977-86. 
 
Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, Furumoto Y, 
Saitoh S, Samelson LE, O'Shea JJ, Rivera J. Fyn kinase initiates complementary 
signals required for IgE-dependent mast cell degranulation. Nat Immunol. 2002 
Aug;3(8):741-8. 
 
Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, 
Macchia D, Maggi E, Del Prete G, Romagnani S. IL-4 and IFN (alpha and gamma) 
exert opposite regulatory effects on the development of cytolytic potential by Th1 or 
Th2 human T cell clones. J Immunol. 1992 Nov 1;149(9):2977-83. 
 
Pejler, G. et al. (2010) Mast cell proteases: multifaceted regulators of inflammatory 
disease. Blood 115, 4981–4990 
 
Pelletier C, Guérin-Marchand C, Iannascoli B, Marchand F, David B, Weyer A, 
Blank U. Specific signaling pathways in the regulation of TNF-alpha mRNA 
synthesis and TNF-alpha secretion in RBL-2H3 mast cells stimulated through the 
high affinity IgE receptor. Inflamm Res. 1998 Dec;47(12):493-500. 
 
 
 
 207 
Pierce KL, Maudsley S, Daaka Y, Luttrell LM, Lefkowitz RJ. Role of endocytosis in 
the activation of the extracellular signal-regulated kinase cascade by sequestering 
and nonsequestering G protein-coupled receptors.Proc Natl Acad Sci U S A. 2000 
Feb 15;97(4):1489-94. 
 
Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev 
Mol Cell Biol. 2002 Sep;3(9):639-50. 
 
Piliponsky, A. M., Chen, C. C., Grimbaldeston, M. A., Burns-Guydish, S. M., Hardy, 
J., Kalesnikoff, J., Contag, C. H. et al., Mast cell-derived TNF can exacerbate 
mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am. J. 
Pathol. 2010. 176: 926–938. 
 
Piliponsky, A. M., Chen, C.-C., Nishimura, T., Metz, M., Rios, E. J., Dobner, P. R., 
Wada, E. et al., Neurotensin increases mortality and mast cells reduce neurotensin 
levels in a mouse model of sepsis. Nat. Med. 2008. 14:392–398. 
 
Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential 
mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 
2009 Jan 9;4(1):62-72. 
 
Pittet, M. J. & Mempel, T. R. Regulation of T-cell migration and effector functions: 
Insights from in vivo imaging studies. Immunol. Rev. 221, 107–129 (2008). 
 
Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell 
lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to 
calcium ionophores.Nature. 1989 May 4;339(6219):64-7. 
 
Pollard TD. Regulation of actin filament assembly by Arp2/3 complex and formins. 
Annu Rev Biophys Biomol Struct. 2007;36:451-77. 
 
Pollitt AY, Insall RH. Abi mutants in Dictyostelium reveal specific roles for the 
SCAR/WAVE complex in cytokinesis. Curr Biol. 2008 Feb 12;18(3):203-10. 
 
Posner BA, Mukhopadhyay S, Tesmer JJ, Gilman AG, Ross EM. Modulation of the 
affinity and selectivity of RGS protein interaction with G alpha subunits by a 
conserved asparagine/serine residue. Biochemistry. 1999 Jun 15;38(24):7773-9. 
 208 
 
Price KS, Friend DS, Mellor EA, De Jesus N, Watts GF, Boyce JA.  CC chemokine 
receptor 3 mobilizes to the surface of human mast cells and potentiates 
immunoglobulin E-dependent generation of interleukin 13. Am J Respir Cell Mol 
Biol. 2003 Apr;28(4):420-7. 
 
Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC. Impaired mast cell-
dependent natural immunity in complement C3-deficient mice. Nature. 1997 Nov 
13;390(6656):172-5 
 
Prudente S, Morini E, Trischitta V. The emerging role of TRIB3 as a gene affecting 
human insulin resistance and related clinical outcomes. Acta Diabetol. 2009 
Jun;46(2):79-84. 
 
Prudente, S.; Hribal, M.L.; Flex. E.; Turchi, F.; Morini, E.; De Cosmo, S.; Bacci,S.; 
Tassi, V.; Cardellini, M.; Lauro, R.; Sesti, G.; Dallapiccola, B.; Trischitta,V. The 
functional Q84R polymorphism of mammalian tribbles homolog TRB3 is associated 
with insulin resistance and related cardiovascular risk in Caucasians from Italy. 
Diabetes 2005, 54, 2807-2811. 
 
Pushparaj, P. N., Tay, H. K., H’ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. 
Y. and Melendez, A. J. The cytokine interleukin-33 mediates anaphylactic shock. 
Proc. Natl. Acad. Sci. U.S.A. 106, 9773–9778. (2009)  
 
Raja, Sivamani K, Garcia MS, Isseroff RR.Wound re-epithelialization: modulating 
keratinocyte migration in wound healing. Front Biosci. 2007 May 1;12:2849-68 
 
Ramesh N, Antón IM, Hartwig JH, Geha RS. WIP, a protein associated with 
wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in 
lymphoid cells. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14671-6. 
 
Ramji, D.P.; Foka, P. CCAAT/enhancer-binding proteins: structure function and 
regulation. Biochem. J. 2002, 365, 561-575. 
 
Reif K, Cyster JG. RGS molecule expression in murine B lymphocytes and ability to 
down-regulate chemotaxis to lymphoid chemokines. J Immunol. 2000 May 
1;164(9):4720-9. 
 209 
 
Renkawitz J, Schumann K, Weber M, Lämmermann T, Pflicke H, Piel M, Polleux J, 
Spatz JP, Sixt M. Adaptive force transmission in amoeboid cell migration. Nat Cell 
Biol. 2009 Dec;11(12):1438-43 
 
Rickert P, Weiner OD, Wang F, Bourne HR, Servant G. Leukocytes navigate by 
compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol. 2000 
Nov;10(11):466-73. 
 
Ridley AJ, Hall A.The small GTP-binding protein rho regulates the assembly of 
focal adhesions and actin stress fibers in response to growth factors. Cell. 1992 
Aug 7;70(3):389-99. 
 
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding 
protein rac regulates growth factor-induced membrane ruffling. Cell. 1992 Aug 
7;70(3):401-10. 
 
Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle 
trafficking. Trends Cell Biol. 2006 Oct;16(10):522-9.  
 
Ritter U, A. Meissner, J. Ott, H. Körner. Analysis of the maturation process of 
dendritic cells deficient for TNF and lymphotoxin-α reveals an essential role for 
TNF.  J Leukoc Biol, 74 (2003), pp. 216–222 
 
Rivera J, Fierro NA, Olivera A, Suzuki R. New insights on mast cell activation via 
the high affinity receptor for IgE. Adv Immunol. 2008;98:85-120 
 
Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin 
Immunol. 2006 Jun;117(6):1214-25 
 
Rivera J. Molecular adapters in Fc(epsilon)RI signaling and the allergic response. 
Curr Opin Immunol. 2002 Dec;14(6):688-93. 
 
Roberts LJ 2nd, Lewis RA, Oates JA, Austen KF. Prostaglandin thromboxane, and 
12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat 
serosal mast cells. Biochim Biophys Acta. 1979 Nov 21;575(2):185-92. 
 
 210 
Robinson RC, Turbedsky K, Kaiser DA, Marchand JB, Higgs HN, Choe S, Pollard 
TD. Crystal structure of Arp2/3 complex. Science. 2001 Nov 23;294(5547):1679-84. 
 
Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, Kirschner MW. 
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent 
signals to actin assembly. Cell. 1999 Apr 16;97(2):221-31. 
 
Roitt I,  Peter J. Delves, Seamus J. Martin, Dennis R. Burton and Ivan M. . Roitt's 
Essential Immunology (Essentials). 2010. 
 
Romagnani P, Annunziato F, Piccinni MP, Maggi E, Romagnani S. Th1/Th2 cells, 
their associated molecules and role in pathophysiology. Eur Cytokine Netw. 2000 
Sep;11(3):510-1. 
 
Roman DL, Talbot JN, Roof RA, Sunahara RK, Traynor JR, Neubig RR. 
Identification of small-molecule inhibitors of RGS4 using a high-throughput flow 
cytometry protein interaction assay. Mol Pharmacol. 2007 Jan;71(1):169-75.  
 
Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, 
Kozak JA, Wagner SL, Cahalan MD, Veliçelebi G, Stauderman KA. STIM1, an 
essential and conserved component of store-operated Ca2+ channel function. J 
Cell Biol. 2005 May 9;169(3):435-45 
 
Rottem M, Goff JP, Albert JP, Metcalfe DD. The effects of stem cell factor on the 
ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone 
marrow-derived cell cultures. J Immunol. 1993 Nov 1;151(9):4950-63. 
 
Roussos ET, Condeelis JS, Patsialou A.Chemotaxis in cancer. Nat Rev Cancer. 
2011 Jul 22;11(8):573-87.  
 
Roy AA, Baragli A, Bernstein LS, Hepler JR, Hébert TE, Chidiac P. RGS2 interacts 
with Gs and adenylyl cyclase in living cells. Cell Signal. 2006 Mar;18(3):336-48. 
 
Rubtsov YP, Rasmussen JP, Chi EY, et al. Regulatory T cell derived interleukin-10 
limits inflammation at environmental interfaces. Immunity 2008; 28:546-558. 
 
 211 
Ruitenberg EJ, Elgersma A. Absence of intestinal mast cell response in 
congenitally athymic mice during Trichinella spiralis infection.Nature. 1976 Nov 
18;264(5583):258-60. 
 
Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE.Essential role of 
phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol. 
2003 Mar 1;170(5):2647-54. 
 
Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff 
RM, Charo IF. Selective chemokine receptor usage by central nervous system 
myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One. 2010 Oct 
27;5(10):e13693. 
 
Sahai E. Illuminating the metastatic process. Nat Rev Cancer. 2007 Oct;7(10):737-
49. 
 
Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 
101:455– 458, 2000. 
 
Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol. 2008 
Sep;9(9):949-52. 
 
Sallusto, F., Lenig, D., Mackay, C.R. & Lanzavecchia, A. Flexible programs of 
chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. 
J. Exp. Med.187, 875–883 (1998). 
 
Sallusto, F., Mackay, C.R. & Lanzavecchia, A. Selective expression of the eotaxin 
receptor CCR3 by human T helper 2 cells. Science 277, 2005–2007 (1997). 
 
Sanderson MP, Gelling SJ, Rippmann JF, Schnapp A. Comparison of the anti-
allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-
activated RBL-2H3 basophilic cells. Cell Immunol. 2010;262(1):28-34. 
 
Sasaki AT, Chun C, Takeda K, Firtel RA. Localized Ras signaling at the leading 
edge regulates PI3K, cell polarity, and directional cell movement. J Cell Biol. 2004 
Nov 8;167(3):505-18. 
 
 212 
Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, 
Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS,  
 
Suzuki A, Penninger JM. Function of PI3Kgamma in thymocyte development, T cell 
activation, and neutrophil migration. Science. 2000 Feb 11;287(5455):1040-6. 
Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning 
on the switch. Genes Dev. 2002 Jul 1;16(13):1587-609. 
 
Schoeber JP, Topala CN, Wang X, Diepens RJ, Lambers TT, Hoenderop JG, 
Bindels RJ. RGS2 inhibits the epithelial Ca2+ channel TRPV6. J Biol Chem. 2006 
Oct 6;281(40):29669-74. 
 
Schröppel B, Zhang N, Chen P, Zang W, Chen D, Hudkins KL, Kuziel WA, Sung R, 
Bromberg JS, Murphy B. Differential expression of chemokines and chemokine 
receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. 
J Am Soc Nephrol. 2004 Jul;15(7):1853-61. 
 
Schulman ES, Kagey-Sobotka A, MacGlashan DW Jr, Adkinson NF Jr, Peters SP, 
Schleimer RP, Lichtenstein LM. Heterogeneity of human mast cells. J Immunol. 
1983 Oct;131(4):1936-41. 
 
Schwarzer, R.; Dames, S.; Tondera, D.; Kippel, A. Kaufmann, J. TRB3 is a PI3-
kinase dependent indicator for nutrient starvation. Cell Signal 2005, 18, 899-909. 
Seagrave J, Pfeiffer JR, Wofsy C, Oliver JM. Relationship of IgE receptor 
topography to secretion in RBL-2H3 mast cells. J Cell Physiol. 1991 
Jul;148(1):139-51. 
 
Seder RA, Paul WE, Davis MM, and Fazekas de St. Groth B. The presence of 
interleukin 4 during in vitro priming determines the lymphokine-producing potential 
of CD4_ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091–1098, 
1992. 
 
Segal DM, Taurog JD, Metzger H. Dimeric immunoglobulin E serves as a unit 
signal for mast cell degranulation. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2993-
7. 
 
 213 
Selim, E.; Frkanec, J.T.; Cunard, R. Fibrates upregulate TRB3 in lymphocytes 
independent of PPARα by augmenting CCAAT/enhancer-binding proteinβ 
(C/EBPβ) expression. Molec. Immunol. 2007, 44, 1218-1229. 
 
Sepich DS, Solnica-Krezel L (2005) Analysis of cell movements in zebrafish 
embryos: morphometrics and measuring movement of labeled cell populations in 
vivo. Methods Mol Biol 294: 211–233 
 
Sergé A, de Keijzer S, Van Hemert F, Hickman MR, Hereld D, Spaink HP, Schmidt 
T, Snaar-Jagalska BE.Quantification of GPCR internalization by single-molecule 
microscopy in living cells. Integr Biol (Camb). 2011 May 3. 
 
Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, Bourne HR. Polarization of 
chemoattractant receptor signaling during neutrophil chemotaxis.Science. 2000 
Feb 11;287(5455):1037-40. 
 
Servant G, Weiner OD, Neptune ER, Sedat JW, Bourne HR. Dynamics of a 
chemoattractant receptor in living neutrophils during chemotaxis.Mol Biol Cell. 1999 
Apr;10(4):1163-78. 
 
Shevach EM. Mechanisms of foxp3_ T regulatory cell-mediated suppression. 
Immunity 30:636–645, 2009. 
 
Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. RGS13 regulates germinal 
center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and 
CXCL13. J Immunol. 2002 Sep 1;169(5):2507-15. 
 
Silberstein, R., Melnick, M., Greenberg, G. and Minkin, C. (1991) Bone remodeling 
in W/Wv mast cell deficient mice. Bone 12, 227–236 
 
Smith SM, Moran AP, Duggan SP, Ahmed SE, Mohamed AS, Windle HJ, O'Neill 
LA, Kelleher DP. Tribbles 3: a novel regulator of TLR2-mediated signaling in 
response to Helicobacter pylori lipopolysaccharide. J Immunol. 2011 Feb 
15;186(4):2462-71.  
 
Soll DR, Wessels D, Heid PJ, Voss E (2003) Computer-assisted reconstruction and 
motion analysis of the three-dimensional cell. Scientific World J 3: 827–841 
 214 
 
Sozanni S. , P. Allavena, G. D’Amico, W. Luini, G. Bianchi, M. Kataura, T. Imai, O. 
Yoshie, R. Bonecchi, A. Mantovani. Differential regulation of chemokine receptors 
during dendritic cell maturation: a model for their trafficking properties. J Immunol, 
161 (3) (1998), pp. 1083–1086 
 
Stelekati, Z. Orinska, S. Bulfone-Paus. Mast cells in allergy: innate instructors of 
adaptive responses. Immunobiology, 212 (6) (2007), pp. 505–519 
 
Stephens LR, Hughes KT, Irvine RF. Pathway of phosphatidylinositol(3,4,5)-
trisphosphate synthesis in activated neutrophils. Nature. 1991 May 2;351(6321):33-
9. 
 
Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of 
the Wiskott-Aldrich syndrome. J Pediatr. 1994 Dec;125(6 Pt 1):876-85. 
 
Sung HY, Guan H, Czibula A, King AR, Eder K, Heath E, Suvarna SK, Dower SK, 
Wilson AG, Francis SE, Crossman DC, Kiss-Toth E. Human tribbles-1 controls 
proliferation and chemotaxis of smooth muscle cells via MAPK signaling 
pathways.J Biol Chem. 2007 Jun 22;282(25):18379-87.  
 
Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of 
mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J 
Immunol. 2001 Aug 15;167(4):2250-6 
 
Supajatura, V., Ushio, H., Nakao, A. et al. Differential responses of mast cell Toll-
like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest 109,1351–
1359. (2002) 
 
Suto, S. Nakae, M. Kakurai, J.D. Sedgwick, M. Tsai, S.J. Galli. Mast cell-
associated TNF promotes dendritic cell migration. J Immunol, 176 (7) (2006), pp. 
4102–4112 
 
Svitkina TM, Borisy GG. Correlative light and electron microscopy of the 
cytoskeleton of cultured cells. Methods Enzymol. 1998;298:570-92. 
 
 215 
Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, Mccormick F, Francke U, 
Abo A. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase 
CDC42Hs, is implicated in actin polymerization. Cell. 1996 Mar 8;84(5):723-34. 
 
Takenawa T, Suetsugu S. The WASP-WAVE protein network: connecting the 
membrane to the cytoskeleton. Nat Rev Mol Cell Biol. 2007 Jan;8(1):37-48. 
 
Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim 
JJ. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human 
T lymphocytes. J Clin Invest. 1995 Mar;95(3):1370-6. 
 
Temann UA, Ray P, Flavell RA.Pulmonary overexpression of IL-9 induces Th2 
cytokine expression, leading to immune pathology. J Clin Invest. 2002 
Jan;109(1):29-39. 
 
Thakurdas, S. M., Melicoff, E., Sansores-Garcia, L., Moreira, D. C.,Petrova, Y., 
Stevens, R. L. and Adachi, R., The mast cell-restricted tryptase mMCP-6 has a 
critical immunoprotective role in bacterial infections. J. Biol. Chem. 2007. 282: 
20809–20815. 
 
Tharp WG, Yadav R, Irimia D, Upadhyaya A, Samadani A, Hurtado O, Liu SY, 
Munisamy S, Brainard DM, Mahon MJ, Nourshargh S, van Oudenaarden A, Toner 
MG, Poznansky MC. Neutrophil chemorepulsion in defined interleukin-8 gradients 
in vitro and in vivo. J Leukoc Biol. 2006 Mar;79(3):539-54. 
 
Thelen M, Peveri P, Kernen P, von Tscharner V, Walz A, Baggiolini M. Mechanism 
of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB 
J. 1988 Aug;2(11):2702-6. 
 
Thelen M, Stein JV. How chemokines invite leukocytes to dance. Nat Immunol. 
2008 Sep;9(9):953-9. 
Tkaczyk C, Gilfillan AM. Fc(epsilon)Ri-dependent signaling pathways in human 
mast cells. Clin Immunol. 2001 May;99(2):198-210. 
 
 
 
 
 216 
Tkaczyk C, Okayama Y, Metcalfe DD, Gilfillan AM. Fcgamma receptors on mast 
cells: activatory and inhibitory regulation of mediator release. Int Arch Allergy 
Immunol. 2004 Mar;133(3):305-15. 
 
Toda M, Dawson M, Nakamura T, Munro PM, Richardson RM, Bailly M, Ono SJ. 
Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell 
activation and motility. J Biol Chem. 2004 Nov 12;279(46):48443-8.  
 
Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Ihara H, Ikeda Y, Kimoto 
M.Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed 
by novel inhibitory human TLR4 mAbs. Int Immunol. 2012 Apr 12.  
 
Unkeless JC, Eisen HN. Binding of monomeric immunoglobulins to Fc receptors of 
mouse macrophages. J Exp Med. 1975 Dec 1;142(6):1520-33. 
Van Haastert PJ. Chemotaxis: insights from the extending pseudopod. J Cell Sci. 
2010 Sep 15;123(Pt 18):3031-7. 
  
Van Keymeulen A, Wong K, Knight ZA, Govaerts C, Hahn KM, Shokat KM, Bourne 
HR. To stabilize neutrophil polarity, PIP3 and Cdc42 augment RhoA activity at the 
back as well as signals at the front. J Cell Biol. 2006 Jul 31;174(3):437-45.  
 
Van, N. L., Adriaensen, D. and Timmermans, J. P. (2007) The bidirectional 
communication between neurons and mast cells within the gastrointestinal tract. 
Auton. Neurosci. 133, 91–103 
 
Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC. Signalling by PI3K 
isoforms: insights from gene-targeted mice. Trends Biochem Sci. 2005 
Apr;30(4):194-204.  
 
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging 
mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010 
May;11(5):329-41.  
 
Varadaradjalou S, Féger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock 
M. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.Eur 
J Immunol. 2003 Apr;33(4):899-906. 
 
 217 
Velazquez JR, Teran LM. Chemokines and Their Receptors in the Allergic Airway 
Inflammatory Process. Clin Rev Allergy Immunol. 2010 Mar 30. 
Veldhoen M, Uyttenhove C, van Snick J, et al. Transforming growth factor-beta 
“reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-
producing subset. Nat Immunol 9:1341–1346, 2008. 
 
Veldhoen M, Uyttenhove C, van Snick J, et al. Transforming growth factor-beta 
“reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-
producing subset. Nat Immunol 9:1341–1346, 2008. 
 
Venkatesan S, Rose JJ, Lodge R, Murphy PM, Foley JF. Distinct mechanisms of 
agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. 
Mol Biol Cell. 2003 Aug;14(8):3305-24.  
 
Venkatesha RT, Berla Thangam E, Zaidi AK, Ali H. Distinct regulation of C3a-
induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by 
extracellular signal regulated kinase and PI3 kinase. Mol Immunol. 2005 
Mar;42(5):581-7. 
 
Verhagen J, Taylor A, Blaser K, Akdis M, Akdis CA. T regulatory cells in allergen-
specific immunotherapy.Int Rev Immunol. 2005 Sep-Dec;24(5-6):533-48.  
 
Vila-Coro AJ, Mellado M, Martín de Ana A, Martínez-A C, Rodríguez-Frade 
JM.Characterization of RANTES- and aminooxypentane-RANTES-triggered 
desensitization signals reveals differences in recruitment of the G protein-coupled 
receptor complex. J Immunol. 1999 Sep 15;163(6):3037-44. 
 
Vila-Coro AJ, Rodríguez-Frade JM, Martín De Ana A, Moreno-Ortíz MC, Martínez-
A C, Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization 
and activates the JAK/STAT pathway. FASEB J. 1999 Oct;13(13):1699-710. 
 
Villalonga P, Ridley AJ. Rho GTPases and cell cycle control. Growth Factors. 2006 
Sep;24(3):159-64.  
 
Vines CM, Prossnitz ER. Mechanisms of G protein-coupled receptor-mediated 
degranulation. FEMS Microbiol Lett. 2004 Jul 1;236(1):1-6.  
 
 218 
Waern, I., Jonasson, S., Hjoberg, J., Bucht, A., Abrink, M., Pejler, G. and 
Wernersson, S. Mouse mast cell protease 4 is the major chymase in murine 
airways and has a protective role in allergic airway inflammation. J. Immunol. 183, 
6369–6376. (2009)  
 
Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. Lipid 
products of PI(3)Ks maintain persistent cell polarity and directed motility in 
neutrophils. Nat Cell Biol. 2002 Jul;4(7):513-8. 
 
Wang Y, Chen CL, Iijima M. Signaling mechanisms for chemotaxis. Dev Growth 
Differ. 2011 May;53(4):495-502.  
 
Wang Z, Lai Y, Bernard JJ, Macleod DT, Cogen AL, Moss B, Di Nardo A.Skin mast 
cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and 
releasing antimicrobial peptides.J Immunol. 2012 Jan 1;188(1):345-57. 
 
Wang, C.Y.; Mayo, M.W.; Korneluk, R.G.; Goeddel, D.V.; Baldwin, A.S., Jr. NF-
KAPPA B antipoptosis: induction of TRAF-1 and TRAF-2 and C-IAP1 and C-IAP2 
to suppress caspase-8 activation.  Science 1998, 281, 1680-1683. 
 
Ward, S.G. (2004) Do phosphoinositide 3-kinases direct lymphocyte navigation? 
Trends Immunol. 25, 67–74 
 
Watanabe K, Kishihara K, Hamano S, Koga M, Nomoto K, Tada I. Delayed 
expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast 
cell-specific granule chymase, mouse mast cell protease-1. J Exp Med. 2000 Dec 
18;192(12):1849-56. 
 
Watanabe K, Kishihara K, Hamano S, Koga M, Nomoto K, Tada I. Strongyloides 
ratti: implication of mast cell-mediated expulsion through FcepsilonRI-independent 
mechanisms. Parasite. 2009 Sep;16(3):209-14. 
 
Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. RGS family members: 
GTPase-activating proteins for heterotrimeric G-protein alpha-subunits.Nature. 
1996 Sep 12;383(6596):172-5. 
 
 219 
Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR. A 
PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil 
polarity. Nat Cell Biol. 2002 Jul;4(7):509-13. 
 
Welch HC, Coadwell WJ, Stephens LR, Hawkins PT. Phosphoinositide 3-kinase-
dependent activation of Rac. FEBS Lett. 2003 Jul 3;546(1):93-7. 
 
Welch MD, DePace AH, Verma S, Iwamatsu A, Mitchison TJ. The human Arp2/3 
complex is composed of evolutionarily conserved subunits and is localized to 
cellular regions of dynamic actin filament assembly. J Cell Biol. 1997 Jul 
28;138(2):375-84. 
 
Welle, M. (1997) Development, significance, and heterogeneity of mast cells with 
particular regard to the mast cell-specific proteases chymase and tryptase. J. 
Leukocyte Biol. 61, 233–245 
 
Willard MD, Willard FS, Li X, Cappell SD, Snider WD, Siderovski DP. Selective role 
for RGS12 as a Ras/Raf/MEK scaffold in nerve growth factor-mediated 
differentiation.EMBO J. 2007 Apr 18;26(8):2029-40. 
 
Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic 
growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-
mediated activation. Nature. 1989 May 11;339(6220):150-2. 
 
Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AW, Sperr WR, Fritsch G, 
Printz D, Binder BR, Schatzl G, Zwirner J, Maurer G, Huber K, Valent P. C5a 
stimulates production of plasminogen activator inhibitor-1 in human mast cells and 
basophils. Blood. 2002 Jul 15;100(2):517-23. 
 
Wolk K, Witte E, Hoffmann U, Doecke WD, Endesfelder S, Asadullah K, Sterry W, 
Volk HD, Wittig BM, Sabat R. IL-22 induces lipopolysaccharide-binding protein in 
hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol. 2007 
May 1;178(9):5973-81. 
 
Woodfolk JA. High-dose allergen exposure leads to tolerance. Clin Rev Allergy 
Immunol 28:43–58, 2005 
 
 220 
Woodfolk JACytokines as a therapeutic target for allergic diseases: a complex 
picture. Curr Pharm Des. 2006;12(19):2349-63.  
 
Woolhiser MR, Brockow K, Metcalfe DD. Activation of human mast cells by 
aggregated IgG through FcgammaRI: additive effects of C3a. Clin Immunol. 2004 
Feb;110(2):172-80. 
 
Wu, M.; Liang-Guo, X.; Zhonghe, Z.; Hong-Bing, S. SINK is a p65-interacting 
negative regulator of NF-κB-dependent transcription. J. Biol. Chem. 2003, 278, 
27072-27079. 
 
Xiao Z, Zhang N, Murphy DB, Devreotes PN. Dynamic distribution of 
chemoattractant receptors in living cells during chemotaxis and persistent 
stimulation. J Cell Biol. 1997 Oct 20;139(2):365-74. 
Xystrakis E, Boswell SE, and Hawrylowicz CM. T regulatory cells and the control of 
allergic disease. Expert Opin Biol Ther 6:121–133, 2006. 
 
Yamazaki, H. Yokozeki, T. Satoh, I. Katayama, K. Nishioka. TNF-alpha, RANTES, 
and MCP-1 are major chemoattractants of murine langerhans cells to the regional 
lymph nodes. Exp Dermatol, 7 (1) (1998), pp. 35–41 
 
Yang M, Kumar RK, and Foster PS. Interferon-gamma and pulmonary 
macrophages contribute to the mechanisms underlying prolonged airway 
hyperresponsiveness. Clin Exp Allergy 40:163–173, 2010. 
 
Yee NS, Paek I, Besmer P. Role of kit-ligand in proliferation and suppression of 
apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant 
mice. J Exp Med. 1994 Jun 1;179(6):1777-87. 
 
Yu, M., Tsai, M., Tam, S. Y., Jones, C., Zehnder, J. and Galli, S. J. Mast cells can 
promote the development of multiple features of chronic asthma in mice. J. Clin. 
Invest 116, 1633–1641. (2006)  
 
Zhang Y, Foudi A, Geay JF, Berthebaud M, Buet D, Jarrier P, Jalil A, Vainchenker 
W, Louache F. Intracellular localization and constitutive endocytosis of CXCR4 in 
human CD34+ hematopoietic progenitor cells. Stem Cells. 2004;22(6):1015-29. 
 
 221 
Zhong H, Wade SM, Woolf PJ, Linderman JJ, Traynor JR, Neubig RR.  A spatial 
focusing model for G protein signals. Regulator of G protein signaling (RGS) 
protien-mediated kinetic scaffolding. J Biol Chem. 2003 Feb 28;278(9):7278-84.  
 
Zinselmeyer BH, Lynch JN, Zhang X, Aoshi T, Miller MJ. Video-rate two-photon 
imaging of mouse footpad - a promising model for studying leukocyte recruitment 
dynamics during inflammation. Inflamm Res. 2008 Mar;57(3):93-6. 
 
Zong, W.X.; Edelstein, L.C.; Chen, C.; Bash, J.; Gelinas, C. The prosurvival Bcl-2 
homolog Bfl-1/A1 is a direct transcriptional target of NF-B that blocks TNF-induced 
apoptais. Genes Dev. 1999, 13, 382-387. 
 
Zuchero JB, Coutts AS, Quinlan ME, Thangue NB, Mullins RD.p53-cofactor JMY is 
a multifunctional actin nucleation factor. Nat Cell Biol. 2009 Apr;11(4):451-9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 222 
Chapter 9. Publications 
 
